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 Part 1 : Introduction 
 
1. Collection, evaluation and maturation of equine oocytes 
 
Assisted Reproductive Technologies (ARTs) for the horse developed steadily over the last 
two decades. These techniques range from simple procedures such as artificial insemination 
to the complex production of clones. These technologies now enable salvation of otherwise 
lost genetics from either subfertile or even dead animals.  
Further use and development of these techniques highly depends on availability of oocytes 
and their manipulation. These embryotechnologies were first developed in the bovine. Thanks 
to the virtually unlimited availability of bovine abattoir oocytes, research rapidly led to 
efficacious in vitro maturation (IVM) of oocytes and their subsequent in vitro fertilization 
(IVF) and in vitro culture (IVC) of the early embryos produced, allowing in vitro embryo 
production.  
The limited interest of the horse industry for these technologies as well as the scarcity of 
abattoir oocytes available for research and the technical difficulties for their recovery from 
follicles have seriously impeded development of ARTs in this species. This section will focus 
on the clinical aspects of the oocyte recovery, their assessment and their use in assisted 
reproduction in the mare.  
This introductory chapter reviews the state-of-the-art in the different techniques using oocytes 
for in vitro horse embryo production. 
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1.1. Oocyte collection from abattoir ovaries (ex vivo) 
 
1.1.1 Handling and transportation of ovaries 
 
No study directly compares techniques, media and transportation conditions of ovaries from 
abattoirs to the laboratories. Media used for this purpose are crystalloids supplemented with 
antibiotics, phosphate buffered solution (PBS), a complete medium (TCM-199) or 
commercial embryo flush solutions (Hinrichs et al., 1993; Alm and Torner, 1994; Del Campo 
et al., 1995; Franz et al., 2003; Preis et al., 2004).  
Storage periods for shipment ranging from 1 to 24 hours have been studied and it has been 
shown that storage up to 15 hours does not affect oocyte meiotic competence (Shabpareh et 
al., 1993; Del Campo et al., 1995; Guignot et al., 1999). However, high maturation rates 
reported by labs where transportation duration was minimal, suggest that storage time for 
shipment could influence oocytes quality and their subsequent resuming of meiosis (Love et 
al., 2003; Hinrichs et al., 2005). 
Transportation temperature has also been investigated. Based on a morphological study of the 
cumulus and the apoptosis of its cells, it has been suggested that ovaries transported between 
20°C - 30°C and 35°C - 37°C, should ideally be processed within 3 hours and 2 hours 
respectively (Pedersen et al., 2004). Another study showed that maturation rates (Metaphase 
I+II) after 24 hours were higher for oocytes collected immediately than for those retrieved 
after further storage of the ovaries for 15 to 18 hours at 4°C or at room temperature (Love et 
al., 2003). This study also suggests that 4°C is probably too low a temperature for an optimal 
storage of ovaries except when delay between ovaries collection and oocytes retrieval cannot 
be avoided.  
The optimal solution might be found in harvesting oocytes at the slaughterhouse (Love et al., 
2003). The oocytes can then be placed under maturation conditions in a portable incubator 
and undergo IVM during their transport to the lab. Due to its technical difficulties (collection 
facilities in the abattoir, transportation under controlled temperature and atmosphere), this 
method is not widely spread but could potentially optimize maturation rates for abattoir 
oocytes (Caillaud et al., 2008). 
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1.1.2 Oocyte collection from excised ovaries (ex vivo) 
 
Oocyte harvesting can be technically challenging in the equine. In order to preserve oocytes 
quality, each step requires a constant concern for conditions of hygiene, temperature, pH and 
medium quality. Oocytes can be aspirated (Desjardins et al., 1985; Shabpareh et al., 1993) 
with a 18G needle and an aspiration system (+/- 1 bar) or a vacuum pump (100-150mm Hg). 
The ovary can be sliced to gain access to more follicles. The equine oocyte is tightly fixed on 
a short, broad-based cumulus hillock with cumulus cell expansions into the underlying thecal 
pad (Hawley et al., 1995). They are therefore difficult to detach from the follicular wall. 
Consequently, recovering of equine oocytes requires incision of the follicles, scraping of the 
follicle wall with curette and flushing to detach the oocyte and its surrounding cells. Highest 
collection rates, approximating 80%, have been achieved using this technique (Del Campo et 
al., 1995). Most of the oocytes collected by this technique maintain cells immediately 
surrounding the oocyte intact and are imbedded in sheets of granulosa cells, forming Oocyte-
Cumulus Complexes (COCs) (Hinrichs et al., 1993). Conversely, aspirated oocytes often only 
maintain immediately surrounding cells (Hinrichs, 1991). The ovary is then sliced in small 
pieces to gain access to the follicles deeper in the ovarian stroma. Alternatively, the follicles 
can be aspirated and scraped simultaneously using the tip of an injection needle. Despite the 
scraping and the flushing, oocyte recovery remains rather low (3-5 oocytes/ovary), as average 
number of antral follicles present on an equine ovary is 6 (Hinrichs, 1991; Del Campo et al., 
1995). This also reflects in a ten-fold increase in required time and personnel for harvesting of 
equine versus bovine oocytes (Galli et al., 2007). All these technical difficulties and the 
scarce availability of abattoir ovaries represent major limitations for fundamental research on 
equine oocyte and consequently for all the technologies that depend on its success. 
 
1.2. Oocyte collection by ovum pick up (in vivo) 
 
Ovaries recovered from slaughterhouses provide a material with an obvious lack of 
repeatability, delay in time between collection and placement in culture medium and lack of 
information about the stage of cycle and follicular growth and the age of the donor mare.  
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Embryo technologies in species such as cattle and pigs rapidly developed to the point of 
commercial application. By contrast, their development and application in the equine is 
mainly only accessible to a minority of performing horses. Consequently, abattoir derived 
oocytes are almost exclusively of interest for research purposes.  
Most oocytes that are transferred for clinical purposes are collected in vivo from preovulatory 
follicles. Oocytes collections are scheduled based on the induction of the ovulation. This can 
be achieved by administration of hCG or a GnRH analog to the donor (Carnevale, 2004). 
Crude Equine Gonadotropin (CEG) which is not commercially available can also be used for 
research purposes (Duchamp et al., 1987). 
Follicles have been punctured and oocytes collected by laparotomy (Vogelsang et al., 1988), 
colpotomy (Hinrichs and Kenney, 1987), and flank puncture (Vogelsang et al., 1983; Palmer 
et al., 1986). The surgical approaches were rapidly considered too invasive and flank or 
ultrasound guided punctures became the most common methods of oocyte collection. Flank 
puncture is done by manual palpation of the ovary without the aid of an ultrasound machine. 
The ovary is manipulated per rectum and gently pulled against the flank wall. A trocard is 
placed through the flank musculature against the preovulatory follicle. A large gauge needle is 
inserted through the canula into the antral cavity. The follicular fluid is aspirated and the 
follicular antrum is lavaged several times with PBS supplemented with heparin. As there is no 
visual control, this technique can only be successfully used for large follicles.  
Transvaginal ultrasound-guided aspiration as performed in the bovine (McKinnon et al., 
1988; Bruck et al., 1992), was modified for the equine (Bracher et al., 1993; Cook et al., 
1993; Duchamp et al., 1994; Carnevale and Ginther, 1995; Kanitz et al., 1995; Meintjes et al., 
1995; Hinrichs et al., 1998) and is now yielding collection rates ranging from 51 to 86% 
(Cook et al., 1993; Bezard et al., 1995; Meintjes et al., 1995; Goudet et al., 1997a; Scott et 
al., 2001). 
Practically, the donor mare is sedated and a sector transducer is positioned within the anterior 
vagina, lateral to the posterior cervix. The ovary is manipulated transrectally and positioned 
against the transducer. A needle is advanced through a needle guide and the vaginal and 
follicular walls are punctured. Follicular fluid is aspirated and the antral cavity is flushed 
several times with heparinised PBS or an embryo flush solution. Scraping of the follicular 
wall can be achieved by rotating the needle during the aspiration. COCs are searched in 
follicular fluid and flushes under stereomicroscope. Follicles larger than 25mm can be 
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punctured using a single lumen needle. Follicles smaller than 25mm can be punctured with a 
double lumen needle allowing a continuous flush of their antral cavity as described by 
Duchamp and collaborators (Duchamp et al., 1995). 
 
1.3. Oocyte Evaluation 
 
Ex vivo or in vivo collected oocytes can be denuded. However they are usually surrounded by 
a multilayered cumulus investment. Granulosa and cumulus cells are similar in texture. The 
innermost cumulus cells have numerous projections penetrating the zona pellucida and 
establishing close contact with the oolemma (Grondahl et al., 1995). COCs can be 
characterized based on their degree of expansion (Hinrichs et al., 1993; Goudet et al., 1997a; 
Hinrichs and Williams, 1997), which is correlated to the nuclear maturation of the oocyte 
(Zhang et al., 1989; Goudet et al., 1997a; Gable and Woods, 2001). In general, immature 
oocytes are associated with a compact cumulus. Expanded cumuluses are usually associated 
with atretic follicles or the preovulatory stages. Oocytes from atretic follicles are known to 
have a greater ability to resume meiosis and progress from germinal vesicle (GV) stage to 
metaphase of the second meiotic division (MII) (Hinrichs, 1991). It is well established that 
follicles are responsible for meiotic arrest of the oocyte (Pincus and Enzemann, 1935) and this 
has also been confirmed in the horse (Hinrichs et al., 1995). As they undergo atresia, follicles 
lose their capacity to maintain that meiotic arrest (Gougeon and Testart, 1986; Blondin and 
Sirard, 1995). This explains the higher maturation rates for expanded than compact COCs 
obtained in several studies (Hinrichs and Williams, 1997; Hinrichs and Schmidt, 2000; Galli 
et al., 2007).  
The cumulus cells directly surrounding the oocyte are called the corona radiata. They are 
often last to expand resulting in a typical image of a cellular ring around the oocyte. 
Compared to the COC, the oocyte is small and very often difficult to image as its surrounding 
cumulus cells effectively prevent its detailed observation. These cells play an essential role in 
oocyte maturation and early embryonic development. Except for the Intra Cytoplasmic Sperm 
Injection (ICSI), their presence is required for all the techniques involving oocyte transfer, 
making morphological assessment of the oocyte difficult to perform. However, it has been 
shown that ooplasm aspect is correlated to follicular viability assessed by histological 
appearance of the mural granulosa. Oocytes with a homogeneous ooplasm are significantly 
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associated with viable follicles and compact COCs. Conversely, oocytes with a granulous, 
polarized ooplasm, corresponding to an uneven distribution of lipid droplets and organelles, 
are associated with expanded COCs and slightly or moderately atretic follicles (Hinrichs and 
Williams, 1997). 
 
1.4. Oocytes in vitro Maturation (IVM) 
 
Oocyte maturation involves nuclear and cytoplasmic events by which the oocyte acquires its 
developmental competence. The final maturation of the oocyte has been associated with 6 
consecutive stages of nuclear and cytoplasmic changes. These changes have been described 
by Grondahl and co-workers (Grondahl et al., 1995) and can be summarized as : (1) the 
central spherical nucleus stage ; (2) presence of a spherical nucleus located at the periphery of 
the ooplasm ; (3) a peripheral oocyte nucleus in stage II ; (4) oocyte nuclear breakdown also 
termed Germinal Vesicle Break Down (GVBD) ; (5) metaphase I ; and (6) metaphase II with 
metaphase chromosome peripherally located and a polar body within the perivitelline space. 
Observation of the polar body under the stereomicroscope is difficult but it can occasionally 
be seen in the perivitelline space. A specific DNA staining, such as Hoechst 33258 can be 
used on decoronised oocytes allowing chromatin examination and classification into: (1) 
Germinal Vesicle (GV), (2) Dense chromatin, (3) Metaphase I, (4) Metaphase II, (5) 
Degenerated (Hinrichs et al., 1993; Goudet et al., 1998b). 
Most IVM media used for horse oocyte are derived from those used in the bovine species. 
Since the first equine oocyte IVM (Fulka and Okolski, 1981), a variety of media comprising 
synthetic tissue culture media such as TCM-199 (Willis et al., 1991; Dell'Aquila et al., 1997b; 
Galli et al., 2001), or Ham’s F10 (Okolski et al., 1991; Willis et al., 1991; Shabpareh et al., 
1993) have been investigated. Most media now are based on TCM-199, equine maturation 
medium I (EMMI) and with addition of foetal calf serum, various hormones such as LH, FSH, 
oestradiol (Carnevale et al., 2004b) or EGF (Goudet et al., 1998a; Lorenzo et al., 2002). A 
few studies have investigated the effects of co-cultures for IVM (Hinrichs et al., 1995; Li et 
al., 2001; Choi et al., 2002b; Tremoleda et al., 2003). These gave a better understanding of 
the control mechanisms of the meiotic arrest within the follicle but failed to show a significant 
improvement in oocyte maturation.  
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IVM duration has also been extensively investigated (Fulka and Okolski, 1981; Zhang et al., 
1989; Del Campo et al., 1990; Willis et al., 1991; Del Campo et al., 1995; Bezard et al., 
1997). After 30 hours of maturation under a controlled atmosphere (39°C and 5% CO2), 50% 
to 80% oocytes reach the metaphase II stage (Scott et al., 2001). It has also been shown that 
further duration of IVM does not improve maturation rates (Shabpareh et al., 1993). Optimum 
maturation duration depends on the initial degree of maturation of the oocytes, which is 
correlated to the aspect of their COC. Maximum maturation rates for oocytes retrieved from 
expanded and compact COCs were obtained after 24h and 32h respectively for Hinrichs and 
co-workers (Hinrichs et al., 1993) and 24h and 30h for Zhang and collaborators (Zhang et al., 
1989). 
Fertilization of an oocyte requires both its nuclear and cytoplasmic maturation. Nuclear 
maturation can resume spontaneaously when oocytes are removed from their inhibitory 
follicular environment. Nuclear maturation is achieved when metaphase II stage of meiosis is 
reached. This can be readily evaluated by specific DNA staining. Conversely, to date there is 
no reliable marker of cytoplasmic maturation. The ultimate criterion of oocyte competence is 
its ability to be fertilized and develop into a viable embryo. The lack of an efficient in vitro 
embryo production (IVP) system has limited oocyte maturation assessment to the nuclear 
maturation. Although some studies investigated cytoplasmic changes observed during nuclear 
maturation, such as migration of cortical granules or mitochondria (Grondahl et al., 1995; 
Goudet et al., 1997a; Aguilar et al., 2002; Carneiro et al., 2002), they did not measure their 
significance to developmental competence of the oocyte. Cytoplasmic maturation depends on 
the accumulation of proteins and mRNA (Grondahl et al., 1993). As already mentioned, once 
oocytes are removed from their follicular environment they are relieved of its meiotic 
inhibitory effect and they condense their chromatin. This stops transcription and subsequent 
protein production. Consequently, proteins and mRNA storage should obviously be complete 
before meiotic resumption and germinal vesicle breakdown is induced (Sirard, 2001). Based 
on this observation, bovine oocytes have been cultured under conditions that temporally 
maintain meiotic arrest but allow cytoplasmic maturation, which translated into an improved 
developmental competence (Fouladi Nashta et al., 1998; Hashimoto et al., 2002). A similar 
approach has been considered in the horse (Franz et al., 2003) but the effect on cytoplasmic 
maturation has only been studied on small numbers (Hinrichs et al., 2006; Hinrichs et al., 
2007). A better understanding of the control mechanisms of the meiotic arrest might certainly 
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lead to new IVM strategies based on a better synchronisation of nuclear and cytoplasmic 
maturation events in vitro.  
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2. Use of equine oocytes in assisted reproduction 
 
Development of ARTs in the horse has been slow compared to other species, but significantly 
progressed over the last decade. However, the techniques involved require specific equipment 
and expertise, which are most often only accessible in specialised centres.  
Conventional IVF failed to give consistent results in the equine and reports of successes with 
IVF are very few. There are only two live foals reported to be born following conventional 
IVF and both derived from in vivo matured oocytes (Palmer et al., 1991; Bezard et al., 1992). 
Failure of IVF is probably related to inefficient sperm capacitation (Alm et al., 2001), 
changes occurring with the zona pellucida (Dell'Aquila et al., 1999; Hinrichs et al., 2002) or 
to incomplete or imperfect in vitro oocytes maturation (Li et al., 2001). To date, calcium 
ionophore A23187 is the most efficient sperm capacitation treatment, inducing acrosome 
reaction and sperm penetration (Zhang et al., 1990; Alm et al., 2001; Hinrichs et al., 2002) 
although heparin was shown to give similar results in one study (Alm et al., 2001) and a 
recent paper reports even higher penetration rates (60%) after capacitation with modified 
Whittens and hyperactivation with procaine (McPartlin et al., 2009) . In order to overcome 
the barrier of inefficient IVF, research focused on either in vivo or in vitro techniques to 
produce embryos such as intra-follicular and intra-oviductal oocyte transfer, and ICSI.  
 
2.1. Intra-Follicular Oocyte Transfer (IFOT) 
 
IFOT is based on the injection of one or more oocytes into the preovulatory follicle of a 
recipient mare where the oocytes can find the conditions to complete their maturation. When 
ovulation occurs, transferred oocytes are ovulated at the same time as the recipient’s 
preovulatory oocyte. IFOT has been first unsuccessfully attempted in the baboon, bovine and 
porcine, probably due to damage caused to the follicle during manipulations (Fleming et al., 
1985; Hinrichs and Digiorgio, 1991). Thanks to the large size of the ovary, its specific 
anatomy with a peripheral medulla and a surrounding fibrous tunique, the mare appears to be 
a unique model for the study of IFOT. Technically, the procedure is similar to that of the 
ovum pick up. The recipient mare is sedated and a sector transducer is positioned within the 
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anterior vagina, lateral to the posterior cervix. The ovary is manipulated transrectally and 
positioned against the transducer. A needle is advanced through a needle guide and the 
vaginal and follicular walls are punctured. A few millilitres of follicular fluid are aspirated, 
the oocytes are injected into the follicle and the needle is flushed with some follicular fluid. 
Hinrichs and Di Giorgio (Hinrichs and Digiorgio, 1991) developed the technique and 
obtained 12 embryos in excess after transfer of 135 immature oocytes into preovulatory 
follicles. The same technique has been used for a study of the follicular fluid contents during 
the oocyte maturation but there was no attempt to produce embryos (Goudet et al., 1997b). 
Surprisingly, no further studies about IFOT in the mare have been reported probably due to 
rather poor results of early reports. 
 
2.2. Intra-oviductal Oocyte Transfer (OT) 
 
The technique involves surgical transfer of one or more oocytes from a donor mare into the 
oviduct of an inseminated recipient. Subsequent fertilization and early embryo development 
occur within the recipient’s oviduct.  
Alternatively, sperm and oocyte can be transferred together into the recipient’s 
oviduct. This technique called: « Gamete Intra-Fallopian Transfer » (GIFT) has been shown 
to give pregnancy rates similar to those obtained by OT (Carnevale and Ginther, 1995; 
Coutinho da Silva et al., 2002b). However, fresh sperm appears to be more efficient than 
frozen-thawed semen for GIFT (Coutinho da Silva et al., 2002a). Oocyte transfer and GIFT 
are essentially used for research purposes and for mares affected with oviductal, uterine or 
cervical pathologies that preclude embryo transfer as an option to obtain a live foal from these 
mares. Cyclic and non-cyclic mares have been used as recipients with similar pregnancy rates 
(Carnevale et al., 2005) and xenogenous transfer into sheep oviducts has also been reported 
(Wirtu et al., 2004). However, most oocyte transfers involve injection of oocytes into the 
oviduct of a cyclic recipient mare, whose preovulatory oocyte has been aspirated. Oocyte 
transfer in the horse was first described by Mac Kinnon and co-workers (McKinnon et al., 
1988), but their blastocyst rate and those from the subsequent studies (Zhang et al., 1989; Ray 
et al., 1994) remained low. Carnevale and Ginther (Carnevale and Ginther, 1995) first 
reported higher embryo production rates following transfer of in vivo matured oocytes. More 
recent studies transferring a single oocyte collected from a preovulatory follicle 24 hours after 
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an injection of hCG and matured in vitro for another 16 to 20 hours before transfer also 
showed high embryo production rates reaching approximately 85% (Hinrichs et al., 1997) and 
commercial programmes using OT for mares with reproductive abnormalities are now 
available (Carnevale et al., 2001). Intra-oviductal oocyte transfer can nowadays be considered 
a viable clinical alternative to embryo transfer in selected mares (Hinrichs et al., 2002; 
Carnevale, 2004). Birth of a foal following transfer of in vitro matured oocytes collected from 
ovaries after the death of the donor mare was first reported in 2003 (Carnevale et al., 2003). 
The same authors reported embryo development rates of 15% following transfer of oocytes 
(n=191) recovered from commercial mares post-mortem (Carnevale et al., 2004a).  
Reported embryo yields following intra-oviductal transfer of in vitro matured oocytes vary: 
7% (2/29) (Scott et al., 2001), 15% (11/73), 18% (13/73) (Preis et al., 2004), 7% (2/29) 
(Zhang et al., 1989). These results remain lower than those obtained after transfer of 
preovulatory, in vivo matured oocytes, that range from 73% to 83% (Carnevale and Ginther, 
1995; Hinrichs et al., 1998; Scott et al., 2001; Carnevale et al., 2004b). Age of the donor is a 
major factor affecting success of OT (Carnevale, 2004). More morphological abnormalities 
were observed in oocytes from older mares (Carnevale et al., 1999) and significantly more 
oocytes collected from young donor mares can develop into embryonic vesicles (Carnevale 
and Ginther, 1995). 
 
2.3. Intra-Cytoplasmic Sperm Injection (ICSI) 
 
ICSI was developed as an alternative to bypass the inadequacy conventional IVF in the equine 
and fertilize equine oocytes in vitro (Squires et al., 2003; Hinrichs, 2005; Galli et al., 2007). 
Since the first report of a pregnancy established after ICSI in the horse (Squires et al., 1996), 
it has produced several foals after injection of both in vivo and in vitro matured oocytes (Mc 
Kinnon et al., 2000; Li et al., 2001; Galli et al., 2002) 
Briefly, a single motile spermatozoon is immobilized by crushing its tail. It is then injected 
into the cytoplasm of a denuded metaphase II oocyte. This overcomes the barrier of 
capacitation and acrosome reaction and even permits the use of sperm with poor motility and 
performances in vivo (Lazzari et al., 2002). Early studies rapidly reported high fertilization 
rates (40% vs 5% for conventional IVF) (Dell'Aquila et al., 1997a; Dell'Aquila et al., 1997b; 
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Grondahl et al., 1997). Embryo yields following ICSI with either frozen-thawed or fresh 
semen have been shown to be similar (Choi et al., 2002a) as long as a motile sperm is selected 
(Lazzari et al., 2002). In another study, oocytes successfully developed to blastocysts after 
being injected with immotile spermatozoa isolated from semen that had undergone two 
freeze-thaw cycles (Choi et al., 2006a). Enhancement of further development of the zygote to 
the blastocyst stage with oocyte activators has been tested but most only increased 
parthogenesis (Li et al., 2000).  
The culture of 2-cell embryos to the blastocyst stage when they can be transferred into a 
recipient’s uterus is another major limiting step in IVP. Many culture systems for early 
cleavage stage embryos have been investigated, including: co-cultures with oviduct cells 
(Battut et al., 1991), Vero cells (Dell'Aquila et al., 1997b), cumulus cells (Li et al., 2001), 
granulosa cells (Rosati et al., 2002), and culture in defined media : G1.2 (Choi et al., 2002a), 
DMEM-F12 and CZB (Choi et al., 2004), and modified SOF (Galli et al., 2002). In most of 
these systems, however, the percentage of 2-cell embryos developing to blastocysts remained 
rather low, ranging from 4 to 16%. ICSI early embryos can alternatively be transferred into 
the oviduct of a recipient mare (Squires et al., 1996) or a temporary recipient sheep, which 
remains the most successful system for producing equine blastocysts with a blastocyst rate of 
45% (Galli et al., 2002; Lazzari et al., 2002). However, Choi and collaborators (Choi et al., 
2006b; Choi et al., 2006c) recently developed a culture system using DMEMF/F-12 medium 
claimed to have achieved blastocyst development rates (27-38%) similar to those obtained 
after transfer in both the mare and the sheep (approximately 36%) (Galli et al., 2007). 
 
2.4. Conclusion 
 
These in vivo techniques involve transfer of oocytes previously matured in vitro or not in 
surrogate mares. They require availability of recipients, synchronisation between donor and 
recipient mares, surgery or specific equipment and skills. However, they potentially represent 
valuable alternatives to IVF procedures which can be poorly efficient (conventional IVF) or 
technically demanding (ICSI).  
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3. Use of cysteamine in IVM 
 
3.1. Glutathione 
 
Glutathione(GSH), a tripeptide thiol (γ-glutamyl-cysteine-glycine) is the major non-protein 
sulfydryl compound in mammalian cells that plays an important role in protecting the cell 
from oxidative damage (Meister and Tate, 1976; Meister and Anderson, 1983). GSH cellular 
content is regulated by the γ-glutamyl cycle. The reactions involved account for the synthesis 
and degradation of GSH, and the balance of GSH transport out of the cells and that of γ-
glutamyl amino acids into the cells. GSH is synthesised within the cell in two steps. First, γ-
glutamylcysteine synthetase catalyses synthesis of γ-glutamyl-cysteine from glutamate and 
cysteine. Then, glycine is added to the C-terminal of γ-glutamyl-cysteine in the presence of 
GSH synthetase (Meister and Tate, 1976).  
The first step of GSH synthesis appears to determine the upper concentration of cellular GSH 
because of a feedback inhibition by GSH (Richman and Meister, 1975). It has been shown 
that GSH concentration also depends on availability of cysteine for synthesis (Meister, 1983; 
Furnus and de Matos, 1999). Conversely, buthionine sulfoximine (BSO) binds to and inhibits 
γ-glutamylcysteine synthetase and thus induces GSH depletion (Griffith and Meister, 1979; 
Meier and Issels, 1995). 
Glutathione is present in the cell either under its reduced (GSH) or oxidized form (GSSG). In 
the presence of GSH, glutathione peroxidase (GPX) catalyses the reduction of hydrogen 
peroxide to form H2O and GSSG. GSSG is reduced by glutathione reductase in the presence 
of nicotinamide adenine dinucleotide phosphate (NADPH) which maintains a high ratio 
(about 100:1) of GSH to GSSG in the cell (Meister, 1983). GSH peroxidase and GSH catalase 
promote removal of hydrogen peroxide and dismutation product of superoxide radicals 
(Fridovich, 1978).  
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These reactions can be summarized by the following equations: 
2 GSH + H2O2   GSSG + 2 H2O 
  
2 GSSG + NADPH +H+  2GSH + NADP+ 
 
3.2. Low molecular weight thiol compounds and GSH 
 
As mentioned before, GSH synthesis is limited by the availability of cysteine. Except for 
hepatocytes, which are able to synthesize cysteine from methionine via the cystathionine 
pathway, eukaryotic cells depend on extracellular medium for the supply of cysteine (Meier 
and Issels, 1995). Direct supplementation of medium with cysteine is usually avoided as 
cysteine is easily oxidized to cystine in the culture medium (Bannai, 1984) and can exhibit a 
high degree of toxicity (Nishiuch et al., 1976).  
Low molecular thiols such as β-mercaptoethanol (Ishii et al., 1981), N-acetylcysteine, 
cysteamine (Meier and Issels, 1995) can promote cystine uptake. These compounds share a 
free SH group as a common molecular structure. Modification of this free thiol group by 
chemical reaction to form a disulfide bond or the addition of a phosphate moiety to the thiol 
group abolishes the potential of the compound to promote cystine uptake (Meier and Issels, 
1995).  
Effects of extracellular thiols on cystine uptake can be summarized in two steps: 1) formation 
of cysteine and cysteine mixed disulfides (e.g., cysteine-cysteamine) and 2) uptake of cysteine 
and/or the mixed disulfide via cellular transport systems (Ishii et al., 1981; Meier and Issels, 
1995). Within the same species, activity of these transport systems vary from one cellular type 
to the other (Meier and Issels, 1995). Oocytes are deficient in their capacity to take up Cystine 
(cysteine-cysteine). Cysteine is utilized by the oocyte, but it is easily oxidised to cystine in the 
culture medium. Thiol compounds react with cystine to form a mixed disulfide. The mixed 
disulfide is taken up by the cells, where it is reduced to produce a thiol compound and 
cysteine. Thiol compounds do not accumulate in the cells and escape to the medium to react 
with cystine. Thiol compounds are repeatedly taken up by the oocytes in the form of mixed 
disulfide with cysteine and return to the medium in their reduced form. Extracellular cysteine 
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may also be taken up by the oocytes by a transporter system (ASC) shared with other amino 
acids (Alanine, Serine, Cysteine) but at a very low rate as cysteine in the culture medium is 
rapidly oxidized to cystine. A schematic diagram of the action of low molecular weight thiols 
is proposed in Figure 1.  
 
 
Figure 1: Proposed action of thiol compounds on cystine and cysteine utilization by oocytes. 
Adapted from Ishi and collaborators (Ishii et al., 1981). 
 
3.3. GSH and IVM 
 
Under in vitro culture conditions, oxidative modifications of cell components via increased 
Reactive Oxygen Species (ROS), which are responsible for DNA damage, oxidative 
alterations of proteins and lipid peroxidation (Johnson and Nasr-Esfahani, 1994), represent a 
major culture induced stress (Noda et al., 1991; Goto et al., 1993). Anti-oxidant systems can 
attenuate the deleterious effects of oxidative stress by scavenging reactive oxygen species 
(Del Corso et al., 1994). 
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Low molecular weight thiols compounds have been shown to have beneficial effects on 
lymphocyte viability and enhance various cell reactions (Fanger et al., 1970). Addition of 
cysteine or β-mercaptoethanol to culture media for lymphocytes has been shown to increase 
intracellular GSH levels and prevent its decrease during proliferation (Zmuda and Friedenson, 
1983). 
GSH synthesis during oocyte maturation has been reported in mouse (Calvin et al., 1986), 
hamster (Perreault et al., 1988), pig (Yoshida et al., 1993), sheep (de Matos et al., 2002a), 
bovine (de Matos et al., 1996) and equine (Luciano et al., 2006). GSH concentration is highly 
correlated with the presence of cumulus cells (Sawai et al., 1997) however, denuded oocytes 
GSH synthesis has also been shown to be stimulated by thiol compounds, although to a lesser 
extend than COCs (de Matos et al., 1997; Yamauchi and Nagai, 1999). GSH contents increase 
during maturation of oocytes in the ovary and peak at the metaphase II stage (Perreault et al., 
1988) but drops rapidly in early embryos (Zuelke et al., 2003). It has been suggested that 
GSH content in oocytes may serve as a reservoir protecting the zygote and the early embryos 
from oxidative damage before genomic activation and de novo GSH synthesis occur (Furnus 
et al., 1998; de Matos and Furnus, 2000). Moreover, GSH has been shown to play a role 
during fertilization by promoting male pronucleus formation (Yamauchi and Nagai, 1999). 
Quite naturally, effects of supplementation of IVM media with low molecular weight thiols 
have been studied in various species. 
The following sections review the use of cysteamine supplementation for IVM media, its 
effects on and various parameters that can modulate those. 
 
3.3.1 Addition of cysteamine to the IVM medium : dose effect 
 
Most commonly, IVM media have been supplemented with a dose of 100 µM of cysteamine 
in cattle, (de Matos et al., 1995; de Matos et al., 1996; de Matos et al., 1997; de Matos et al., 
2002b; Oyamada and Fukui, 2004; Balasubramanian and Rho, 2007), buffalo (Gasparrini et 
al., 2003; Anand et al., 2008), goats (Rodriguez-Gonzalez et al., 2003b; Urdaneta et al., 2003; 
Zhou et al., 2008), horses (Luciano et al., 2006), pigs (Kobayashi et al., 2006; Kobayashi et 
al., 2007; Song and Lee, 2007), mice (de Matos et al., 2003; Chen et al., 2005), cats (Bogliolo 
et al., 2001) and dogs (Hossein et al., 2007). However, other concentrations of cysteamine, 
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ranging from 50 to 500 µM, have been tested in different species. A summary of the different 
concentrations used in various species is given is Table 1. 
Species Dose of Cysteamine (µM) References 
Bovine 100 de Matos et al., 1995; de Matos et al., 1996; 
de Matos et al., 1997; de Matos et al., 2002b; 
Oyamada and Fukui, 2004; Balasubramanian 
and Rho, 2007 
Buffalo 50 Gasparrini et al., 2003; Singhal et al., 2008 
 100 Gasparrini et al., 2000 
 50, 100, 200 Anand et al., 2008 
Ovine 50, 100, 200 de Matos et al., 2002a 
Caprine 100 Rodriguez-Gonzalez et al., 2003a 
 100, 200, 400 Urdaneta et al., 2003 
 50, 100, 200, 300 Zhou et al., 2008 
Equine 100 Luciano et al., 2006 
Porcine 100 Kobayashi et al., 2006; Kobayashi et al., 
2007; Song and Lee, 2007 
 150 Yamauchi and Nagai, 1999; Bing et al., 2001 
 50, 500 Grupen et al., 1995 
Canine 50, 100, 200 Hossein et al., 2007 
Mice 100 Chen et al., 2005 
 0, 25, 50, 100, 200 de Matos et al., 2003 
Table 1: Summary of the different concentrations used in various species. 
  
19 
Effects of one given concentration of cysteamine supplementation not only depend on the 
species but also on the maturation medium. These differences between media might be 
explained by the presence and the quantities of different factors that can help protect the cell 
from oxidative damage such as citrate (Holm et al., 1999) and pyruvate (Morales et al., 1999). 
Moreover, as most media use TCM-199, it is important to bear in mind that whether the 
cystine it contains (83.2 µM) is sufficient to sustain oocyte IVM of different species is 
unknown (Zhou et al., 2008). 
 
3.3.2 Addition of cysteamine to the IVM medium : effect on nuclear maturation rates 
 
Cysteamine supplementation during IVM, was reported to improve nuclear maturation rates 
in dogs (Hossein et al., 2007), in mice (Chen et al., 2005), in goats (Urdaneta et al., 2003), 
and in pigs (Bing et al., 2001). However, other studies in goats (Zhou et al., 2008), pigs 
(Yamauchi and Nagai, 1999; Kobayashi et al., 2006; Song and Lee, 2007), horses (Luciano et 
al., 2006), buffalos (Singhal et al., 2008) and cattle (Oyamada and Fukui, 2004; 
Balasubramanian and Rho, 2007) could not show any increase in nuclear maturation rates.  
 
3.3.3 Addition of cysteamine to the IVM medium : effect on GSH oocyte content 
 
Cysteamine has been shown to increase intracellular GSH synthesis in bovine (Takahashi et 
al., 1993; de Matos et al., 1995; de Matos et al., 1997; de Matos et al., 2002b; Oyamada and 
Fukui, 2004), buffalo (Gasparrini et al., 2003), canine (Hossein et al., 2007), goats 
(Rodriguez-Gonzalez et al., 2003a; Zhou et al., 2008), mice (de Matos et al., 2003), horses 
(Luciano et al., 2006), sheep (de Matos et al., 2002a) and pigs (Yamauchi and Nagai, 1999; 
Kobayashi et al., 2007). This increase in GSH content has been consistent in all reports 
regardless the species. In sheep, a concomitant decrease in hydrogen peroxide has also been 
demonstrated (de Matos et al., 2002a), illustrating the scavenging effect of GSH synthesis 
stimulation on ROS. 
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3.3.4 Addition of cysteamine to the IVM medium : effect on male pronucleus formation 
 
Effect of cysteamine supplementation during IVM on male pronucleus formation following 
either conventional IVF or ICSI has not been extensively investigated. However, addition of 
cysteamine to the IVM medium has been shown to improve male pronucleus formation in 
goats (Rodriguez-Gonzalez et al., 2003a; Urdaneta et al., 2003), buffalos (Anand et al., 2008) 
and pigs (Grupen et al., 1995; Yamauchi and Nagai, 1999; Bing et al., 2001). Only two 
studies, one in pigs (Kobayashi et al., 2006) and one in cattle (Balasubramanian and Rho, 
2007), reported a lack of effect of cysteamine on male pronucleus formation.  
 
3.3.5 Addition of cysteamine to the IVM medium : effect on cleavage rates 
 
Effect of cysteamine supplementation to IVM media on cleavage rates is controversial. A few 
studies have reported an increase in cleavage rates following IVM with cysteamine in goats 
(Rodriguez-Gonzalez et al., 2003a), pigs (Grupen et al., 1995), cattle (Oyamada and Fukui, 
2004), and buffalos (Anand et al., 2008; Singhal et al., 2008). Conversely, many other reports 
in various species, including species where an increase has been reported, have failed to 
observe any effect of cysteamine supplementation on cleavage rates. This lack of effect has 
been reported in pigs (Kobayashi et al., 2006; Kobayashi et al., 2007; Song and Lee, 2007), 
cattle (de Matos et al., 1995; Balasubramanian and Rho, 2007), buffalos (Gasparrini et al., 
2003), sheep (de Matos et al., 2002a), horses (Luciano et al., 2006) and mice (de Matos et al., 
2003; Chen et al., 2005). 
 
3.3.6 Addition of cysteamine to the IVM medium : effect on blastocyst development 
 
In very few studies in pigs (Kobayashi et al., 2007; Song and Lee, 2007), and mice (Chen et 
al., 2005), blastocyst development has not been shown to be affected by cysteamine 
supplementation. Conversely, many authors reported increased blastocyst development 
following cysteamine supplementation to the IVM medium. This has been observed in cattle 
(Takahashi et al., 1993; de Matos et al., 1995; de Matos et al., 2002b; Oyamada and Fukui, 
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2004; Balasubramanian and Rho, 2007), buffalos (Gasparrini et al., 2003; Anand et al., 2008; 
Singhal et al., 2008), sheep (de Matos et al., 2002a), goats (Zhou et al., 2008), pigs (Grupen 
et al., 1995; Kobayashi et al., 2006) and mice (de Matos et al., 2003). In these studies, 
although cleavage rates are not necessarily affected further development of the blastocysts 
obtained has been positively influenced by cysteamine supplementation.  
 
3.4. Conclusion 
 
Low molecular weight thiol compounds can increase cysteine uptake by oocytes during IVM. 
This subsequently can increase GSH content, which is a major anti-oxidant system that 
protect the cells against the deleterious effects of oxidative stress by scavenging reactive 
oxygen species. Beneficial effects of thiol compounds supplementation to IVM media have 
been observed in many species but they appear to be highly species and dose dependant. 
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 Part 2 : Research Objectives 
 
Research on IVP in the equine is impeded by the limited availability of mature oocytes as the 
mare is mono-ovulating and superovulation is still difficult. Transvaginal ultrasound guided 
follicular aspiration has become an alternative source for mature and immature equine 
oocytes. Despite recent improvement in IVM of equine oocytes, success rates of IVM in that 
species remain low in all culture media tested compared to other species such as cows, goats 
and sows. However, most studies have focused on the percentage of oocytes reaching the 
metaphase II stage (nuclear maturation) but few concentrated on the final oocyte competence 
as measured by its ability to develop into a blastocyst and further evolve into a successful 
pregnancy. Blastocyst production rate is influenced not only by oocyte fertilization, culture 
environment (IVC) but also by oocyte maturation conditions. 
The addition of GSH synthesis precursors, such as cysteamine, has been shown to improve 
IVP in various species by protecting the oocyte and early embryo against ROS. Very little 
information on the use of thiol compounds in the equine is available and there is no published 
report of the effect of IVM medium supplementation with cysteamine on subsequent in vivo 
embryo production. 
The aims of the present work were : 
(1) To investigate the influence of supplementation with 100 µM of cysteamine on 
conventional IVF success rate;  
(2) To determine what in vivo technique could best bypass the lack of an efficient 
conventional IVF procedure; 
(3) To investigate the influence of supplementation with 100 µM of cysteamine on in vitro 
nuclear and cytoplasmic maturation by specific DNA staining and to evaluate the 
ability of oocytes to undergo in vivo fertilization. 
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 Part 3 : Synopsis of experiments 
 
1. Influence of IVM medium cysteamine supplementation on conventional IVF 
 
Introduction 
 
During growth and maturation of the oocyte within the ovary, intracellular GSH content 
increases as the oocyte approaches the time of ovulation (Perreault et al., 1988; Yoshida et 
al., 1993; de Matos and Furnus, 2000). The addition of GSH in IVM media improves the rate 
of male pronuclear formation (de Matos et al., 1995; de Matos and Furnus, 2000). Glutathione 
synthesis can be increased, and thus the intracellular concentration of GSH, by the addition of 
low molecular weight thiols to IVM medium, such as cysteamine and ß-mercaptoethanol 
(Takahashi et al., 1993). This has increased the success of bovine (de Matos et al., 1995; de 
Matos et al., 1996), ovine (de Matos et al., 1999) and porcine (Grupen et al., 1995; Bing et 
al., 2001) embryo development. However, the effect of IVM medium cysteamine 
supplementation on conventional IVF in the equine has not been reported. 
In vitro embryo production is the final result of a three step process: in vitro maturation 
(IVM), in vitro fertilization (IVF) and in vitro culture (IVC) of the embryo to a stage that is 
transferable to the uterus (Dell'Aquila et al., 1996; Hinrichs et al., 2002). Equine spermatozoa 
have been incubated in solutions containing an ionophore or heparin, however it is unclear as 
to which solution is optimal. An in vitro fertilization rate of 30% was achieved in a technique 
where the spermatozoa were prepared with the calcium ionophore A23187 (Palmer et al., 
1991; Bezard et al., 1992). This technique was used to produce the only two live foals 
following an IVF procedure to date (Palmer et al., 1991). Heparin has also been tested as a 
capacitation treatment (Dell'Aquila et al., 1996) and that technique gave similar results to 
those obtained with calcium ionophore (Alm et al., 2001). Heparin also increased the IVF rate 
in cows (Handrow et al., 1989; Farlin et al., 1993) so it may also be useful in equine IVF. 
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Aim of the study 
 
This study was designed to investigate the influence of supplementation with 100 µM of 
cysteamine of IVM medium on the ability of oocytes to undergo conventional in vivo 
fertilization. 
 
Material and methods 
 
The study was conducted in spring using 30 cycling Welsh pony mares from 200 to 300 kg. 
Ovarian activity was monitored daily using transrectal ultrasound scanning. 
Follicular puncture and oocyte recovery 
When a preovulatory follicle ≥ 33 mm was observed, the mares were injected i.v. with 25mg 
of Crude Equine Gonadotropin (CEG), to induce ovulation. Transvaginal ultrasound-guided 
aspiration of follicles ≥ 5 mm was performed 24 hours after CEG injections. Follicles were 
punctured routinely using a transvaginal aspiration technique as previously described 
(Duchamp et al., 1994).  
Culture of cumulus oocyte complexes  
After recovery the cumulus oocyte complexes (COCs) were isolated and classified according 
to cumulus morphology into expanded cumulus or compact cumulus (Goudet et al., 1998b) as 
illustrated in Figure 2. COCs with expanded cumulus were discarded. Compact COCs were 
individually matured at 38,5°C in a humidified atmosphere of 95% air and 5% CO2 for 30 h 
in 20µl of maturation medium under mineral oil (M8410 Sigma, France). Two maturation 
media were used. Medium 1 contained Medium 199 with Earle’s salt (M4530, Sigma, France) 
supplemented with 20% inactivated fetal calf serum (FCS, F4135, Sigma, France) and with 
50ng/ml Epidermal Growth Factor (EGF, E4127, Sigma, France) as described by Goudet et 
al. (Goudet et al., 2000a). Medium 2 was the same base with the addition of cysteamine at 
100µM (M9768, Sigma, France). 
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Fig 2 –A : immature oocyte    Fig 2-B : Compact Cumulus 
 
 
   
Fig 2-C : Expanded Cumulus  Fig 2-D : Metaphase II + Polar body 
 
Figure 2 : classification of COCs as described by Goudet and collaborators (Goudet et al., 
1998b). 
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Influence of spermatozoa media and cysteamine 
Oocytes were rinsed in IVF modified TALP (Tyrode’s medium added with albumine lactate 
and pyruvate) medium and incubated with thawed spermatozoa in 20µl of the medium under 
mineral oil. TALP medium contained 100mM NaCl, 3.1mM KCl, 0.3mM NaH2PO4 2H2O, 
2.1mM CaCl2, 0.4mM MgCl2 6H2O, 25mM NaHCO3, 6mg/ml fatty acid-free albumin 
fraction V (Sigma), 4mg/ml sodium lactate (Sigma), 0.11mg/ml sodium pyruvate (Sigma). 
Cryopreserved semen was used, one ejaculate from three stallions pooled after thawing in a 
37°C waterbath for 30 seconds and washed by centrifugation at 600g for 5 minutes, 
resuspended in medium and then centrifuged again. The sperm pellet was resuspended in IVF 
medium (group A) or Hank’s solution supplemented with BSA (1%) and Hepes buffer 
(20mM) (Palmer et al., 1991) (group B) and adjusted to 16X106 spermatozoa/ml. In group A, 
spermatozoa were supplemented with 1µg/ml heparin. In group B, spermatozoa were 
incubated with 6µM of Ionophore A23187 (free acid, Sigma) at 37°C for 5 minutes (Palmer et 
al., 1991), centrifuged at 600g for 5 minutes and resuspended in IVF medium. The sperm 
suspension was added to the oocytes for a final concentration of 4X105 spermatozoa/ml. 
Oocytes were incubated with spermatozoa for 24 hours at 38.5°C in a humidified atmosphere 
(95% air and 5% CO2), and examined for penetration. 
 
Results 
 
131 oocytes were evaluated for evidence of sperm penetration and fertilization. Overall, 8 of 
them (6%) were penetrated. We observed one oocyte with a decondensed sperm head, six 
oocytes with 2 pronuclei or subsequent stages of mitosis, and one 2 cell-embryo. Four oocytes 
were penetrated by spermatozoa treated with heparin (Group A), and four oocytes were 
penetrated by spermatozoa treated with ionophore (Group B). Of the 8 penetrated oocytes, 4 
came from maturation medium 1, and 4 came from maturation medium 2. 
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Discussion 
 
In the mare, few studies have reported fertilization rates after standard IVF procedures 
(Palmer et al., 1991; Dell'Aquila et al., 1996; Alm et al., 2001; McPartlin et al., 2009). 
Failure of IVF is probably related to inefficient sperm capacitation (Alm et al., 2001), 
changes occurring with the zona pellucida (Dell'Aquila et al., 1999; Hinrichs et al., 2002) or 
to incomplete or imperfect in vitro oocytes maturation (Li et al., 2001). To date, only two 
foals were born from IVF (Palmer et al., 1991) and there is no published report of equine 
pregnancies following both in vitro maturation and conventional IVF. In our study, both 
techniques (ionophore or heparin) yielded 6% of IVF and results were similar for both 
oocytes matured with or without cysteamine. This percentage is low when compared to data 
published by Palmer (Palmer et al., 1991) and Dell’Aquila (Dell'Aquila et al., 1996). 
However these results have not been shown to be repeatable and the IVF rates we observed, 
although rather low, are more comparable to others reported in the horse (Choi et al., 1994; 
Dell'Aquila et al., 1997a). Although, it seems likely that cysteamine did not significantly 
improve IVF rates under our conditions, our general success rates for IVF procedures may be 
too low for us to conclude definitely about the effect of cysteamine. 
These poor results reflect the overall poor results of conventional IVF in the equine. 
Moreover cytoplasmic maturation assessment requires the observation of embryo 
development, which cannot be evaluated by IVF. This confirms the need to further investigate 
other means to assess the effects of cysteamine supplementation.
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2. Efficiency of embryonic development after Intra-Follicular and Intra-
Oviductal transfer of in vitro and in vivo matured horse oocytes 
 
Introduction 
 
The first study failed to show an effect of cysteamine supplementation in IVM media at 
100µM on conventional IVF results. However, due to the poor results of conventional IVF in 
general, and in our study in particular, it would be hazardous to conclude that cysteamine 
supplementation has no effect on cytoplasmic maturation. The ultimate indicator of effective 
cytoplasmic maturation of the oocyte is the ability of the oocyte to produce an embryo and an 
ongoing pregnancy. ICSI is now providing fertilization rates (40%) (Dell'Aquila et al., 1997a; 
Dell'Aquila et al., 1997b; Grondahl et al., 1997) that make it a valuable and repeatable means 
of producing embryos in vitro, allowing cytoplasmic maturation assessment. Unfortunately, 
ICSI technology requires specific equipment and expertise, which is very often not available. 
As an alternative to IVF and ICSI, it was decided to explore which in vivo fertilization option 
was best.  
Transfer of an immature oocyte into the preovulatory follicle of an inseminated recipient mare 
(Intra-Follicular Oocyte Transfer, IFOT) has produced embryos but the success rate was low 
(Hinrichs and Digiorgio, 1991; Goudet et al., 1997b). Collection of embryos following intra-
follicular transfer of in vitro matured oocytes would assess their cytoplasmic maturation as 
shown by their ability to produce an embryo. To our knowledge no intra-follicular transfer of 
oocytes previously matured in vitro has been reported. Similarly, oocyte transfer (OT) into the 
oviduct of an inseminated recipient mare was investigated. Recent studies transferring a 
single oocyte collected from a preovulatory follicle after induction of ovulation showed high 
embryo production rates (Hinrichs et al., 1997) and commercial programmes using OT for 
mares with reproductive abnormalities are now available (Carnevale et al., 2001). Intra-
oviductal oocyte transfer can nowadays be considered a viable clinical alternative to embryo 
transfer in selected mares (Hinrichs et al., 2002; Carnevale, 2004). In addition, OT can be 
used to assess the quality of oocytes after IVM by their ability to undergo in vivo fertilization 
(Carnevale, 2004; Carnevale et al., 2005). 
The aims of this present study were (1) to test if in vitro matured oocytes would complete 
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their maturation and yield embryos following transfer into the preovulatory follicle of an 
inseminated recipient mare and (2) to compare OT following IVM, IFOT following IVM, and 
IFOT immediately after oocyte collection as alternative techniques where ICSI is not 
available. 
 
Materials and methods 
 
The study was conducted in spring using 30 cycling Welsh pony mares from 200 to 300 kg. 
Ovarian activity was monitored daily and follicular puncture and oocyte recovery was 
performed as described in study 1. 
Culture of Cumulus Oocyte Complexes  
After recovery, the cumulus oocyte complexes (COCs) were isolated and classified according 
to cumulus morphology into expanded cumulus and compact cumulus (Goudet et al., 1998b) 
as in study 1. The same classification was used for post IVM examination. Collected oocytes 
were either matured in vitro for 30 hours or prepared for immediate transfer. 
When matured in vitro, COCs were individually matured at 38,5°C in a humidified 
atmosphere of 95% air and 5% CO2 for 30 h in 20µl of maturation medium under mineral oil 
(M8410 Sigma, Saint-Quentin Fallavier, France). Maturation medium contained Medium 199 
with Earle’s salt (M4530, Sigma, France) supplemented with 20% inactivated fetal calf serum 
(FCS, F4135, Sigma, France) and with 50ng/ml Epidermal Growth Factor (EGF, E4127, 
Sigma, France) as described by Goudet et al. (Goudet et al., 2000b). Following IVM, no 
selection based on appearance was performed and intact COCs were assigned to either OT or 
Post-IVM IFOT group. 
Oocytes from sessions that failed to yield more than 3 oocytes were cultured similarly 
and prepared for post IVM examination. They were rinsed in PBS and COCs were stripped 
with small glass pipettes, stained with 1 µg/ml bis-benzamide (Hoechst 33342; Sigma, 
France), evaluated with a fluorescence microscope. Oocytes were classified according to the 
stage of nuclear maturation, membrane integrity and the ooplasm aspect as “germinal 
vesicle”, “dense chromatin”, “metaphase I”, “metaphase II” or “degenerate” as previously 
described by Goudet et al. (Goudet et al., 1998b). Figure 3 illustrates maturation stages after 
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DNA staining with bis-benzamide. 
 
   
Fig 3-A : Germinal Vesicle    Fig 3-B : Dense Chromatin 
 
   
Fig 3-C : Metaphase I   Fig 3-D : Metaphase II 
Fig 3 : Chromatin configuration. Equine oocytes after DNA staining with bis-benzamide 
(X400) 
 
Preparation of oocytes before transfer 
Oocytes for intra-follicular transfer were rinsed three times in 500 µl of PBS and loaded in 
1ml of PBS into a 1ml syringe for transfer after IVM and in 0.2 to 0.5 ml of PBS with 1mL/L 
heparin (Heparin 5 IU/ml; Sanofi, France) for immediate transfer. 
Oocytes for intra-oviductal transfer were rinsed three times in 500 µl of PBS after IVM and 
stored in PBS at 38.5°C. The system to aspirate the oocytes consisted of a blunted sterile glass 
pipette connected to a piece of tube, which was in turn connected to a 1ml syringe. The whole 
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system was kept at 38.5°C. Oocytes were loaded just prior to the oocyte transfer, in a minimal 
volume of PBS between two bubbles of air.  
Intra-Follicular Oocyte Transfer (IFOT) 
Intra-follicular oocyte transfer was performed as previously described by Goudet et al 
(Goudet et al., 1997b). Briefly, the preovulatory follicle was punctured using a single lumen 
needle (length, 600mm; outer diameter, 1.1mm, 17G; Thiebaud Frères, Jouvernex Margencel, 
France), with a specific attention to the needle going through as much ovarian stroma as 
possible before reaching the follicle. Then, 5 ml of follicular fluid were aspirated from the 
preovulatory follicle. The 1ml syringe containing the oocytes in PBS was connected to the 17 
gauge needle, the oocytes were injected and the needle flushed with 4.5ml of follicular fluid. 
Immediately after transfer, the catheter and needle were checked to ensure that no oocytes 
remained logged in them. Recipient mares were injected with their own oocytes, either just 
after collection (Immediate Intra-Follicular Oocyte Transfer) or following IVM (Post-IVM 
Intra-Follicular Oocyte Transfer). Recipient mares were inseminated 24 hours after CEG 
injection, using fresh semen of a stallion with a known normal fertility: 400 X 106 
spermatozoa in 10ml of extender (INRA96®; IMV Technologies, France). 
Intra-oviductal Oocyte Transfer (OT) 
Oocytes from preovulatory follicles were aspirated and discarded. Following their ovum pick 
up session, mares were fasted for 24 hours. Recipient mares were inseminated 5 h prior to 
surgery, using fresh semen of a stallion with a known normal fertility: 400 X 106 spermatozoa 
in 10ml of extender (INRA96®; IMV Technologies, France). Surgical transfers of the 
recipient mare’s own oocytes occurred 30 hours after the oocyte recoveries. The recipient 
mare was treated with antibiotics (about 6 hours before surgery) (4,000,000 IU streptomycin, 
4g procaine penicilline i.m., Intramicine®, Ceva, France). Animals were sedated with 
detomidine (3-5 µg/kg; 0.1ml/animal i.v. Domosedan®; Pfizer, France) for surgical 
preparation of the mare for the standing flank laparotomy. An injection of butorphanol tartrate 
4mg (13-20 µg/kg; 0.4ml/animal i.v. Torbugesic®; Fort Dodge, Southampton, UK) for 
analgesia was followed by a second injection of detomidine (6-10 µg/kg, 0.2ml/animal i.v. 
Domosedan®). A cuffed urinary catheter was placed to allow continuous emptying of the 
bladder during the surgery in order to limit discomfort. After local anesthesia (lidocaïne, 
Laocaïne®, Schering Plough, France), a flank approach was used to gain access to the ovary. 
The skin incision was directed vertically or at a slight oblique and extended 10 to 15 cm. The 
  
34 
muscles of the flank, external and internal abdominal oblique muscles and the transversus 
abdominis muscle were bluntly dissected in the direction of their fibres. The peritoneum was 
perforated and the opening was manually dilated. After the ovary was exteriorised and the 
pipette was inserted into the oviduct. Oocytes were gently injected into the oviduct. The 
different layers were closed using absorbable suture material (Vicryl® 0; Johnson and 
Johnson, UK) in an interrupted pattern. Immediately after surgery, a second insemination with 
200 X 106 spermatozoa in 10ml of semen extender (INRA96®, IMV Technologies, France) 
stored at 15°C was performed. 
Embryo collection  
Embryo collection was performed 10 days after surgery by three successive uterine lavage 
with saline at 38°C. Collection fluid was filtered and embryos were isolated under a 
stereomicroscope.  
Statistical analysis 
To compare maturation rates and embryo yields, a chi-square test was performed. 
Significance was established at p < 0.05. 
 
Results 
 
Oocyte collection 
Following the 31 puncture sessions, a total of 158 oocytes were obtained from 284 immature 
follicles resulting in a recovery rate of 55,6%. Global collection rate was 5.1 immature 
oocytes per puncture session (158/31). 
Maturation rates 
Out of the 158 oocytes, 47 were used for immediate IFOT, 109 oocytes were matured in vitro 
and two oocytes, which were degenerated, were not cultured. Out of these 109 in vitro 
matured oocytes, 55 were transferred into preovulatory follicles (IFOT), 40 were used for 
intra-oviductal oocyte transfer and 14 were used for analysis. Table 2 shows the percentage of 
nuclear maturation of the non-transferred oocytes. 
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Table 2: Evaluation of nuclear maturation after culture 
  Nuclear stage 
  Metaphase II Metaphase I Dense 
chromatin 
Germinal 
vesicle 
Degenerated 
Total 71.3% (10/14) 0% (0/14) 7.2% (1/14) 7.2% (1/14) 14.3% (2/14) 
  
Embryo collection rates 
Table 3 shows the results of embryo collection. When embryo collections yielded one or more 
embryos, one of the embryos was assumed to result from the fertilization of the oocyte from 
the preovulatory follicle. Recovery rates of embryos in excess compared to the number of 
ovulations were calculated. Recovery rates after OT (32.5%, 13/40) were significantly 
different from the 5.5% (3/55) observed in the Post-IVM IFOT group (p=0.001) and the 
12.8% (6/47) of the Immediate IFOT group (p=0.026).  
Table 3 : Results of collected embryos 
 No of 
transfers 
No of 
pregnant 
No of 
transferred 
oocytes  
No of 
embryos 
recovered 
No of 
embryos 
recovered 
in excess 
Embryo  
Collection 
Rate  
Immediate-
IFOT 
10 4 47 10 6 12.8% (6/47) a 
Post-IVM 
IFOT 
8 4 55 7 3 5.5% (3/55) a 
OT 6 5 40 13 13 32.5% (13/40) b 
a, b Values with a different superscript are statistically different (p<0.05) 
 
Following IFOT, 3 mares showed a preovulatory follicle that became diffusely echogenic and 
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showed ultrasonographic signs of clotting. Table 4 shows the results of embryo collections 
without these 3 transfers where mares failed to ovulate. Embryo collection rates were 
recalculated considering only successful transfers. Recovery rates after OT (32.5%, 13/40) 
were significantly different from the 5.8% (3/52) observed in the Post-IVM IFOT group 
(p=0.001) and the 14.6% (6/41) of the Immediate IFOT group (p=0.058).  
 No of 
transfers 
No of 
pregnant 
No of 
transferred 
oocytes  
No of 
embryos 
recovered 
No of 
embryos 
recovered 
in excess 
Embryo  
Collection 
Rate  
Immediate-
IFOT 
8 4 41 10 6 14.6% (6/41) a,b 
Post-IVM 
IFOT 
7 4 52 7 3 5.8% (3/52) a 
OT 6 5 40 13 13 32.5% (13/40) 
b,c 
Table 4 : Results of collected embryos for successful transfers* 
a, b, c Values with a different superscript are statistically different (p<0.05) 
*: transfers were considered successful when ovulation occurred and transferred oocytes were 
released. 
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Table 5 shows the per transfer distribution of number of transferred oocytes and embryos 
collected in excess in both Immediate and Post-IVM groups. 
 Immediate IFOT Post-IVM IFOT 
Transfer 
number 
No of transferred 
oocytes 
No of embryos 
recovered in excess 
No of transferred 
oocytes 
No of embryos 
recovered in excess 
1 4 2 5 0 
2 2 0* 9 0 
3 3 0 3 0* 
4 10 2 7 0 
5 8 1 4 0 
6 4 1 9 1 
7 4 0* 14 2 
8 6 0 4 0 
9 2 0 - - 
10 4 0 - - 
Total 47 6 55 3 
 
Table 5: Per transfer distribution of number of transferred oocytes and embryos collected in 
excess in both Immediate and Post-IVM groups 
 *: refers to transfers where no ovulation occurred and a Corpus Hemorrhagicum was 
observed. 
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Discussion 
 
Our oocyte collection rate of 55.6% after puncture is similar to those reported in the literature 
(Bogh et al., 2002; Galli et al., 2007), although lower collection rates have also been reported 
(Mari et al., 2005). The maturation rate of 71% we observed is similar to those previously 
reported ranging from 40% to 70% in the equine (Goudet et al., 1997a; Bogh et al., 2002; 
Hinrichs et al., 2005; Galli et al., 2007). One of the 14 oocytes matured in vitro had initially 
been prepared for one of the immediate IFOT. However, it was found in the syringe after the 
transfer and subsequently matured in vitro. 
Intra-follicular oocyte transfer has been first unsuccessfully attempted in different species, 
probably due to damage caused to the follicle during manipulations (Fleming et al., 1985). 
Thanks to the large size of the ovary, its specific anatomy with a peripheral medulla and a 
surrounding fibrous tunique, the mare appears to be a unique model for the study of IFOT. 
Hinrichs and Di Giorgio (Hinrichs and Digiorgio, 1991) developed the technique of IFOT in 
the horse and obtained embryos in excess after transferring immature oocytes into 
preovulatory follicles. It was subsequently used by Goudet et al (Goudet et al., 1997b) to 
study follicular contents and maturation rates. Surprisingly, no further studies about IFOT in 
the mare have been reported probably due to rather poor results of early reports. The recovery 
of excess embryos following intra-follicular transfer of oocytes matured in vitro in our study 
shows that they were ovulated, fertilized in the recipient’s oviduct before progressing to the 
uterus. This is the first report of embryonic development following intra-follicular transfer of 
in vitro matured oocytes. Embryo collection rates following immediate transfer of ovum pick 
up oocytes of 12.8% (6/45) did not differ significantly from those observed following transfer 
of in vitro matured oocytes (5.5%; 3/55). This could mean that in vitro maturation of oocytes 
for 30 hours under our conditions and subsequent passage into the preovulatory follicle of a 
recipient for 0 to 18 hours is comparable to in vivo maturation within a preovulatory follicle. 
Alternatively, this could mean that although no statistical difference could be shown in our 
experiment, IVM oocytes suffer some inadequate maturation when compared to in vivo 
matured oocytes or that their expulsion at the time of ovulation is impaired. This is supported 
by Hinrichs and DiGiorgio’s observation (Hinrichs and Digiorgio, 1991) who reported that 
only 3 recent oocytes out of 12 transferred could be recovered from one euthanized mare’s 
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oviduct 3 days after transfer. Inadequate IVM can yield under- or overmature oocytes which 
will not undergo normal fertilization and embryo development (Hinrichs and Digiorgio, 
1991).  
Although echogenic spots have been visualized in some follicles prior to a normal ovulation 
(Carnevale et al., 1988), echogenic spots and fibrous strands are more commonly associated  
with hemorrhagic, anovulatory follicles (Ghinter. O.J, 1986; Goudet et al., 1997b). 
Hemorrhagic follicles have been reported with a spontaneous occurrence of 4.7% (12/255) in 
the mare (Ginther and Pierson, 1989). We observed 3 anovulatory hemorrhagic follicles 
following a total of 18 intra-follicular transfers (16,6%), this is comparable to the 15,8% 
(3/19) Hinrichs and Di Giorgio observed (Hinrichs and Digiorgio, 1991), but statistically 
(p<0.05) different from the 66,6% previously reported by Goudet et al. (Goudet et al., 1997b) 
who punctured the same follicles twice during the oestrus phase. These results suggest that 
IFOT procedure increases the occurrence of hemorrhagic follicles probably due to transfer 
induced damage as invoked by Fleming et al (Fleming et al., 1985). When the 3 transfers with 
anovulatory hemorrhagic follicles were not considered, embryo collection rates showed that 
although a trend was still observable (p=0.058), OT was no longer statistically different from 
IFOT immediately after oocyte recovery. One limitation of IFOT seems to be the increased 
occurrence of anovulatory hemorrhagic follicles, which appears to be related to puncture 
technique and repetition. In order to minimize trauma to the follicle, attempts with thinner 
needles were performed in a preliminary study. However, these needles tended to bend and 
did not allow proper puncture of the follicles. Different approaches for the puncture, either 
more superficial or going through as much ovarian tissue as possible before reaching the 
preovulatory follicle should be compared to see if they can reduce occurrence of hemorrhagic 
follicles. Intra-follicular transfer of immature oocytes is a relatively easy to perform and 
inexpensive procedure compared to surgical intra-oviductal oocyte transfer. It is less invasive 
as it avoids the need for surgery and the donor mare can easily be used as her own recipient to 
yield numerous embryos. Improving the technique, and thus reducing the risk of anovulation, 
might make the IFOT a viable option to increase the number of embryos of selected mares as 
superovulation treatments are yet not very efficient in the mare (Dippert and Squires, 1994; 
Bezard et al., 1995; Alvarenga et al., 2001b). It could also be used to assess the quality of 
oocytes after IVM by their ability to undergo in vivo fertilization as suggested by Hinrichs 
and DiGiorgio (Hinrichs and Digiorgio, 1991). 
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Intra-oviductal oocyte transfer is now considered a viable clinical alternative to embryo 
transfer in selected mares (Hinrichs et al., 2002; Carnevale, 2004). We collected 13 embryos 
on day 10 after transfer of 40 in vitro matured oocytes resulting in a collection rate of 32.5%. 
This is higher than rates of 7% (2/29) (Scott et al., 2001), 15% (11/73) and 18% (13/73) (Preis 
et al., 2004) previously reported but comparable to Zhang’s results who collected 7 embryos 
following transfer of 29 in vitro matured abattoir oocytes (24.1%) (Zhang et al., 1989). 
However, even when expressed in relation to our in vitro maturation rate of 71%, the embryo 
yield of 45.8% remains lower than embryo collection rates or pregnancies obtained following 
transfer of preovulatory  in vivo recovered oocytes ranging from 73 to 83% (Carnevale and 
Ginther, 1995; Hinrichs et al., 1998; Carnevale et al., 2004b). The recovery rate of embryos 
in excess following OT we observed is statistically different from that observed after IFOT, 
either immediately after oocyte recovery or post IVM. IVM oocytes were matured for 30 
hours before transfer either to the preovulatory follicle or the oviduct. Oocytes were readily 
available for fertilization in the OT group. Those from the Post-IVM IFOT group were 
released into the oviduct within 18 hours of transfer. A possible explanation for the poor 
recovery rate of embryos in the Post-IVM IFOT group could be that oocytes were over-
matured when ovulation and fertilization could occur. More regular rectal examinations to 
more accurately determine the exact timing of ovulation could help supporting this 
hypothesis. 
Our results show that, in comparison to IFOT, OT is the most reliable in vivo alternative to in 
vitro fertilization where ICSI technology is not available.  
 
Conclusion 
 
Our results support previous work that immature oocytes can be matured within the follicle of 
a mare in vivo, and be ovulated, fertilized and yield excess embryos following IFOT.  In 
addition, we show for the first time that in vitro-matured oocytes can be used for IFOT and 
result in excess embryos.  General success rate of IFOT was low but tended to be higher when 
immature oocytes were transferred. Improvement of the technique could turn it into an 
inexpensive, easy to perform procedure, which could be an answer to the relative inefficiency 
of superovulation treatments in the mare. 
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We also established that, when ICSI is not an option, intra-oviductal oocyte transfer is to be 
preferred to IFOT as an in vivo alternative to bypass the inadequacy of conventional in vitro 
fertilization and to assess oocyte developmental competence. 
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3. Influence of cysteamine on in vitro maturation and in vivo fertilization of 
equine oocytes 
 
Introduction 
 
Research on IVM in mares is impeded by the limited availability of mature oocytes and early 
embryos for study. Superovulation treatments are not very efficient in the mare (Dippert and 
Squires, 1994; Bezard et al., 1995; Alvarenga et al., 2001a). Ovaries recovered from 
slaughterhouses provide a material with an obvious lack of repeatability, delay in time 
between collection and placement in culture medium and lack of information about the stage 
of cycle and follicular growth. Transvaginal ultrasound guided follicular aspiration has 
become an alternative source for mature and immature equine oocytes since it has been first 
described by Bruck et al. in 1992 (Bruck et al., 1992). Immature oocytes collected by 
transvaginal ultrasound guided follicular aspiration can undergo IVM. However, success rates 
of IVM of equine oocytes (40% to 70%) (Squires, 1996; Goudet et al., 1997a; Bogh et al., 
2002) remain low in all culture media tested compared to other species such as cows, goats 
and sows, (≥ 90%) (Goudet et al., 2000a).  
In order to improve the IVM maturation rates and quality of equine oocytes, the addition of 
compounds that can protect the cell from oxidative damage has been used such as glutathione 
(GSH) (Grupen et al., 1995; de Matos et al., 1996). During growth and maturation of the 
oocyte within the ovary, intracellular GSH content increases as the oocyte approaches the 
time of ovulation (Perreault et al., 1988; Yoshida et al., 1993; de Matos and Furnus, 2000). 
The addition of GSH to IVM medium also improves the rate of male pronuclear formation (de 
Matos et al., 1995; de Matos and Furnus, 2000). As already mentioned, GSH synthesis can be 
increased and thus the intracellular concentration of GSH by the addition of low molecular 
weight thiols to IVM medium, such as cysteamine and ß-mercaptoethanol (Takahashi et al., 
1993). This has improved in vitro maturation rates in the canine (Hossein et al., 2007) but not 
in the bovine (de Matos et al., 1995) or the porcine (Grupen et al., 1995), nevertheless, it has 
increased the success of bovine (de Matos et al., 1995; de Matos et al., 1996), ovine (de 
Matos et al., 1999) and porcine (Grupen et al., 1995; Bing et al., 2001) embryo development. 
However, the influence of cysteamine on IVM and subsequent in vivo fertilization rates has 
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not been reported in mares.  
The assessment of the success of IVM and IVF techniques is difficult because no reliable 
feature of cytoplasmic maturation has been defined in the mare whereas nuclear maturation is 
readily assessed by nuclear fluorescent microscopy. There have been few papers about the 
ultrastructure (Grondahl et al., 1995; Tremoleda et al., 2001; Carneiro et al., 2002) and the 
biochemical changes (Goudet et al., 1998a; Goudet et al., 1998b) of oocytes during 
cytoplasmic maturation in the mare (Neumann et al., 1995; Goudet et al., 1997a). Therefore, 
the best current indicator of effective cytoplasmic maturation of the oocyte remains the ability 
of the oocyte to produce an embryo. 
In order to circumvent the inadequacy of conventional IVF, other methods to produce 
embryos from oocytes have been investigated, such as intra cytoplasmic sperm injection 
(ICSI) (Dell'Aquila et al., 1997a; Dell'Aquila et al., 1997b; Choi et al., 2002a; Galli et al., 
2002), transfer of an immature oocyte into the preovulatory follicle of an inseminated 
recipient mare (Intra-Follicular Oocyte Transfer, IFOT) (Hinrichs and Digiorgio, 1991; 
Goudet et al., 1997b) and oocyte transfer to oviducts of a recipient mare (McKinnon et al., 
1988; Zhang et al., 1989; Ray et al., 1994; Carnevale and Ginther, 1995; Hinrichs et al., 
1997; Scott et al., 2001; Hinrichs et al., 2002; Carnevale, 2004; Preis et al., 2004; Carnevale 
et al., 2005). 
Our second study showed that when ICSI is not an option, intra-oviductal oocyte transfer is to 
be preferred to IFOT as an in vivo alternative to bypass the inadequacy of conventional in 
vitro fertilization and to assess oocyte developmental competence. 
Aims of the study: 
The broad aim of this study was to improve IVM and IVF procedures in the mare. The 
specific aim was to investigate if there is an influence of supplementation with 100 µM of 
cysteamine on in vitro nuclear and cytoplasmic maturation by the ability of oocytes to 
undergo in vivo fertilization. 
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Material and methods 
 
Animals, ovarian activity monitoring, follicular puncture oocyte recovery, were similar to 
what has been described in study 1 and 2.  
After recovery the cumulus oocyte complexes (COCs) were isolated and classified according 
to cumulus morphology into expanded cumulus or compact cumulus (Goudet et al., 1998b). 
COCs with expanded cumulus were discarded. Compact COCs were individually matured at 
38,5°C in a humidified atmosphere of 95% air and 5% CO2 for 30 h in 20µl of maturation 
medium under mineral oil (M8410 Sigma, France). Two maturation media were used. 
Medium 1 contained Medium 199 with Earle’s salt (M4530, Sigma, France) supplemented 
with 20% inactivated fetal calf serum (FCS, F4135, Sigma, France) and with 50ng/ml 
Epidermal Growth Factor (EGF, E4127, Sigma, France) as described by Goudet et al. 
(Goudet et al., 2000a). Medium 2 was the same base with the addition of cysteamine at 
100µM (M9768, Sigma, France). 
 
Oocyte intra-oviductal transfer  
Depending on puncture session yields, oocytes were transferred or analysed after IVM. If the 
puncture session yielded ≥10 oocytes, 10 oocytes were prepared for oocyte transfer. Any 
additional oocytes were prepared for post IVM examination. When puncture sessions yielded 
≤10 oocytes, they were all prepared for post IVM examination. Oocytes for intra-oviductal 
transfer were either prepared and transferred surgically in recipients’oviduct as described in 
study 2 or stained for nuclear maturation assessment as described in study 1 and 2.  
Embryo collection and maternity testing 
Embryo collection was performed 10 days after surgery as previously described. Embryos 
were rinsed 10 times in saline and kept at -20°C until maternity test. For maternity testing 
(Guerand et al., 1997), DNA of each embryo was extracted and typed by radio active PCR 
amplification using 10 characterized micro-satellites ( HMS 1, 2, 5, 6, 7, 8 and HG 3, 4, 6 and 
10). 
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Statistical analysis 
To compare maturation rates and embryo yields, a chi-square test was performed. 
Significance was established at p < 0.05. 
 
Results 
 
Oocytes collection 
A total of 237 oocytes were obtained from 479 immature follicles resulting in a recovery rate 
of 48,5%. 108 oocytes were maturated in medium 1 (Control group) and 124 in medium 2 
(Cysteamine group).  
Maturation rates 
Five oocytes out of the 327 collected were damaged or lost and were not cultured. 
 
Table 6 shows the percentage of nuclear maturation of the non-transferred oocytes. 
Overall maturation rate was 52%. Nuclear maturation was not statistically different (p>0.05) 
between oocytes cultured with or without cysteamine (55% and 47% respectively).  
 Nuclear stage 
IVM medium Metaphase II Metaphase I Dense 
chromatin 
Germinal 
vesicle 
Degenerated 
Control 47% (24/51) 12% (6/51) 12% (6/51) 6% (3/51) 23% (12/51) 
Cysteamine 55% (37/67) 10% (7/67) 8% (5/67) 3% (2/67) 24% (16/67) 
Total 52% (61/118) 11% (13/118) 9% (11/118) 4% (5/118) 24% (28/118) 
 
Table 6: Evaluation of nuclear maturation after culture 
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Oocyte transfers 
Six transfers were performed for a total of 57 oocytes in each group. Three oocytes were 
found in the pipette after one surgery in the control group. Only 7 oocytes from the 
cysteamine group were transferred during the next surgery to keep groups even. 
Embryo collection 
Five embryos were obtained from 57 transferred oocytes (9%) in the cysteamine group and 
ten embryos from 57 transferred oocytes (17%) in the control group (Table 7). Those two 
percentages were not significantly different (p>0.05). 
 
Table 7: Number of collected embryos and result of maternity testing. 
* N embryos total refers to the embryos emerging from the oocytes of both the donor and the 
recipient mares. 
IVM 
medium 
No 
of 
recipients 
No of 
pregnant 
No 
transferred 
oocytes 
No of 
embryos 
Total* 
Embryos 
from the 
recipient 
Embryos 
from the 
donors 
Control 6 6 57 15 5 10 
Cysteamine 6 5 57 10 5 5 
Total   114 25 10 15 
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Discussion 
 
The overall maturation rate of 52% we observed is similar to previous reports, which vary 
from 40% to 70% in the equine (Squires, 1996; Goudet et al., 1997a; Bogh et al., 2002). 
Higher values are usually observed when oocytes are matured in groups (Shabpareh et al., 
1993; Dell'Aquila et al., 1996). Ideally, groups of 10 to 20 oocytes are cultured, which suits 
best conditions where a large number of oocytes are available. However oocytes were 
matured individually in our study so maturation conditions would be the same regardless the 
number of oocytes yielded by the ovum pick up session. Hinrichs et al (Hinrichs et al., 2005) 
recently reported meiotic resumption rates over 70% after individual maturation, with an 
actual metaphase II rate around 50% which is comparable to our results. Maturation rates as 
assessed by the percentage of oocytes reaching metaphase II were not statistically different 
with or without cysteamine supplementation in our study. This is consistent with other reports 
in various species where cysteamine supplementation failed to affect metaphase II rates 
(Yamauchi and Nagai, 1999; Oyamada and Fukui, 2004; Kobayashi et al., 2006; Luciano et 
al., 2006; Balasubramanian and Rho, 2007; Song and Lee, 2007; Zhou et al., 2008) 
A concentration of 100 µM of cysteamine was used in the present study. Reported 
concentrations in various species range from 50 to 500 µM with highly variable results (de 
Matos et al., 1995; Grupen et al., 1995; Yamauchi and Nagai, 1999; Bing et al., 2002; de 
Matos et al., 2002a; Gasparrini et al., 2003; Whitaker and Knight, 2004). Grupen et al 
(Grupen et al., 1995), who compared concentrations of 50 and 500 µM of cysteamine in IVM 
medium for porcine oocytes found that both increased synchronous pronuclear formation 
whereas only the higher concentration significantly enhanced embryonic development. They 
suggested that cysteamine in excess allows cytoplasmic accumulation of thiol compounds 
during IVM which may persist in the cleaving embryo and assist mitotic cell division. 
Conversely, Gasparrini et al (Gasparrini et al., 2000) working on buffalo oocyte, found that 
supplementation with 50 µM of cysteamine significantly improved in vitro embryo 
production whereas concentrations of 100 and 200 µM did not affect cleavage rate compared 
to control group. Similar results were observed in a recent study where cysteamine was added 
to IVM and IVC medium (Anand et al., 2008). It appears effect of cysteamine 
supplementation to IVM medium is highly species and concentration dependant. The 
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inadequacy of the chosen concentration may explain that equine embryo production has not 
been increased by the cysteamine under our conditions as opposed to what has been observed 
in other species such as bovine (Takahashi et al., 1993; de Matos et al., 1995; de Matos et al., 
1996); porcine (Grupen et al., 1995; Bing et al., 2001); ovine (de Matos et al., 2002a); and 
buffalo (Gasparrini et al., 2003). However, our results are in agreement with Luciano et al. 
(Luciano et al., 2006) who recently demonstrated that the addition of 100 µM of cysteamine 
during in vitro maturation of equine oocytes does not influence GSH synthesis. 
Alternatively, contents of IVM medium itself should be considered as a potential reason for 
the absence of effect of cysteamine supplementation in our study. We can hypothesize that 
some substances present in the IVM medium can interfere with GSH synthesis. Bing et al 
(Bing et al., 2001) suggested that FSH and estradiol both affected GSH levels in porcine 
oocytes which in turn increased maturation rates.  It has also been suggested that 
gonadotropins regulate ovarian GSH synthesis (Luderer et al., 2001). Although our 
maturation medium is not supplemented with gonadotropins or estradiol, factors contained in 
fetal calf serum or EGF might have an effect on GSH synthesis. 
In regards to our overall maturation rate of 52% following IVM, it can be considered that only 
roughly 59 metaphase II oocytes were actually transferred. Consequently, 15 blastocysts were 
obtained from 59 genuinely fertilizable oocytes (26%), which is similar to what we (Daels et 
al., 2001) and others (Carnevale et al., 2005) obtained in previous studies where preovulatory 
in vivo recovered oocytes were transferred. The global results, 15 embryos from 114 
transferred oocytes giving a 13 % recovery rate can be compared to those reported in other 
studies. From 29 oocytes aspirated during diestrus stage Scott et al. (Scott et al., 2001) 
obtained 2 pregnancies on day 16 (7%) following in vitro maturation and in vivo fertilization. 
Zhang et al. (Zhang et al., 1989) obtained 7 embryos from 29 oocytes from slaughterhouse 
matured in vitro and fertilized in vivo. Hinrichs et al. (Hinrichs et al., 2002) obtained a high in 
vivo fertilization rate of 77% after in vitro maturation of abattoir oocytes. The recipient mares 
were euthanatized 40 to 44 hours after transfer and oocytes were recovered from the oviduct. 
When comparing the percentage of embryos per transferred oocytes, 18% of the oocytes 
recovered from the oviduct had undergone cleavage (2 cells or more). The discrepancy 
between the fertilization rate and the relatively low embryo recovery rate in all studies 
combined may suggest that the percentage of embryos able to reach the blastocyst stage is 
probably lower. This may be due to a blockage of embryonic development of the embryos 
and/or to an intra-fallopian embryonic reduction. This gives a new light to overall low results 
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obtained following uterine collection. This confirms that in the absence of a reliable marker of 
cytoplasmic maturation, the ultimate test to appreciate the quality of a gamete following in 
vitro culture is by obtaining at least a blastocyst. 
 
Conclusion 
Under our conditions, the addition of 100 µM of cysteamine to a classic culture medium does 
not improve equine oocyte maturation or embryonic development after oocyte transfer. 
Considering its beneficial effects in many other species, supplementation with cysteamine to 
different IVM media should be further investigated; ideally combining different 
concentrations and ICSI in order to determine an optimal concentration and its effects on 
cleavage rates and early embryonic development. 
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PART 4 : GENERAL DISCUSSION, CONCLUSION AND 
PERSPECTIVES 
 Part 4 : General discussion, conclusion and perspectives 
 
In vivo matured oocytes represent a gold standard for ARTs. The mare is mono ovulating and 
to date, there is no efficient superovulation treatment available. This translates into a very 
short supply of in vivo matured oocytes, which has seriously limited the development of 
ARTs in comparison to other species. Research requires large numbers of oocytes, which 
cannot be covered by in vivo matured oocytes. In that context, the quality and the competence 
of in vitro matured oocytes is a keystone to assisted reproduction techniques. However, most 
studies have focused on the percentage of oocytes reaching the metaphase II stage (nuclear 
maturation) but few concentrated on the final oocyte competence as measured by its ability to 
develop into a blastocyst and further establish an ongoing pregnancy. This depends not only 
on the embryo production conditions (IVM, IVF, IVC), but also on the intrinsic quality of the 
oocyte. Aspiration of immature follicles permits retrieval of more oocytes and IVM skips the 
final selection of oocytes during the final steps of folliculogenesis. In vitro processing of 
oocytes thus permits the maturation of oocytes otherwise destined to undergo atresia. It can be 
speculated that, at the time of aspiration, some oocytes have already started this maturation 
process while some others have not. This could explain the population heterogeneity of 
aspirated oocytes and the subsequent variable response to IVM. This explains the need of 
perfectly adapted conditions of IVM to ensure an optimal oocyte competence acquisition. 
Unfortunately, to date there is no marker of oocyte cytoplasmic maturation available. Such a 
marker could prove very usefull in assessing oocyte development competence. This could 
possibly allow adapting IVM conditions to specific requirements of oocytes, based on their 
stage of development at the time of retrieval. Recent improvement in IVM conditions have 
recently been shown to improve cleavage rates and blastocyst development after ICSI, despite 
their lack of significant effect on maturation rates (metaphase II) (Galli et al., 2007). This 
clearly illustrates the crucial importance of the quality of IVM on the further oocyte 
competence and the need to further investigate IVM conditions.  
Under in vitro culture conditions, oxidative alterations of cell components via increased ROS 
represent a major culture induced stress. In order to improve the IVM maturation rates and 
quality of oocytes, the addition of compounds that can protect the cell from oxidative damage 
has been investigated. The addition of GSH synthesis precursors, such as cysteamine, a thiol 
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compound, to IVM media has been shown to improve IVP in various species. Very little 
information on the use of thiol compounds in the equine was available.  
Our first objective was to investigate if there is an influence of supplementation with 100 µM 
of cysteamine on conventional IVF success rate. In our first experiment, oocytes were 
matured in vitro in a medium supplemented with cysteamine and then submitted to 
conventional IVF. The IVF rates we observed (6%), although rather low, were comparable to 
others reported in the horse (Choi et al., 1994; Dell'Aquila et al., 1997a). Although, it seems 
likely that cysteamine did not significantly improve IVF rates under our conditions, our 
general success rates for IVF procedures may be too low for us to conclude definitely about 
the effect of cysteamine. This illustrates how the lack of an efficacious and reproductible 
conventional IVF procedure is a major limitation in assessing oocyte development 
competence in the equine. 
Our second objective was to determine what in vivo technique could best bypass the lack of 
an efficient conventional IVF procedure. Although ICSI is now providing fertilization rates 
(40%) (Dell'Aquila et al., 1997a; Dell'Aquila et al., 1997b; Grondahl et al., 1997) that make it 
a valuable and repeatable means of producing embryos in vitro, it requires specific equipment 
and expertise, which are not easily available in all laboratories. As an alternative to 
conventional IVF and ICSI, it was decided to explore which in vivo fertilization option was to 
be preferred. Oocyte transfer following IVM, intra-follicular oocyte transfer following IVM, 
and intra-follicular oocyte transfer immediately after oocyte collection were tested as 
alternative techniques to ICSI. Embryo collection rates were compared and that following 
oocyte transfer was significantly higher than that following both intra-follicular oocyte 
transfer techniques. We concluded that when ICSI is not an option, intra-oviductal oocyte 
transfer is to be preferred to IFOT as an in vivo alternative to bypass the inadequacy of 
conventional in vitro fertilization and to assess oocyte developmental competence. 
Our final aim was to investigate if there is an influence of supplementation with 100 µM of 
cysteamine on in vitro nuclear and cytoplasmic maturation by specific DNA staining and the 
ability of oocytes to undergo in vivo fertilization. Oocytes were retrieved by ultrasound 
guided aspiration, submitted to IVM with or without cysteamine supplementation and were 
either stained with Hoechst for nuclear maturation assessment or transferred into 
recipients’oviduct. Embryo collection rates following oocyte transfer, were compared to 
assess cytoplasmic maturation and oocyte development competence. Maturation rates after 
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DNA staining were not statistically different with or without cysteamine supplementation in 
our study. This is consistent with other reports in various species where cysteamine 
supplementation failed to affect metaphase II rates (Yamauchi and Nagai, 1999; Oyamada 
and Fukui, 2004; Kobayashi et al., 2006; Luciano et al., 2006; Balasubramanian and Rho, 
2007; Song and Lee, 2007; Zhou et al., 2008). This is also further supported by another study 
where the same dose of cysteamine failed to increase GSH content of equine oocytes 
(Luciano et al., 2006). Effect of cysteamine has been shown to be highly species and dose 
dependant. The dose used in this study was 100 µM. Although this has been used most 
commonly in various species, the inadequacy of the chosen concentration may explain that 
equine embryo production has not been increased by cysteamine under our conditions. 
Alternatively, contents of IVM medium itself should be considered as a potential reason for 
the absence of effect of cysteamine supplementation in our study. We can hypothesize that 
some substances present in the IVM medium can interfere with GSH synthesis. Bing et al 
(Bing et al., 2001) suggested that FSH and estradiol both affected GSH levels in porcine 
oocytes which in turn increased maturation rates. It has also been suggested that 
gonadotropins regulate ovarian GSH synthesis (Luderer et al., 2001). Although our 
maturation medium is not supplemented with gonadotropins or estradiol, factors contained in 
fetal calf serum or EGF might have an effect on GSH synthesis. These differences between 
media might also be explained by the presence and the amount of different factors that can 
help protect the cell against oxidative stress such as citrate (Holm et al., 1999) and pyruvate 
(Morales et al., 1999). Moreover, it is important to remember that TCM-199, which is used in 
most media, contains cystine (83.2 µM) and cysteine (0.11mg/L) and that whether it is 
sufficient to sustain oocyte IVM of different species remains unknown (Zhou et al., 2008). 
Under our conditions, the addition of 100 µM of cysteamine to a classic culture medium does 
not improve equine oocyte nuclear maturation or embryonic development after oocyte 
transfer. Considering its beneficial effects in many other species, where it has been shown to 
be highly on species and concentration dependant, supplementation with cysteamine to 
different IVM media should be further investigated. Ideally, different concentrations of 
cysteamine should be tested and development competence should be assessed after OT and 
after ICSI in order to determine the effect on early embryonic development and pregnancy 
rates. 
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Success rates of IVM of equine oocytes (40% to 70%) (Squires, 1996; Goudet et al., 1997a; 
Bogh et al., 2002) remain low in all culture media tested compared to other species such as 
cows, goats and sows, (≥ 90%) (Goudet et al., 2000a). Since very high maturation rates have 
been achieved in most species, it has been assumed that IVM could no longer be a limiting 
step and research has focused on the next steps of IVP such as IVF, ICSI or IVC. However, 
most studies use the percentage of oocytes reaching the metaphase II stage to assess oocyte 
maturation. Fertilization of an oocyte requires both its nuclear and cytoplasmic maturation. 
Despite their apparent maturation it is likely that post-IVM oocytes do not necessarily achieve 
their cytoplasmic maturation and gain their development competence. This incomplete or 
faulty cytoplasmic maturation only gets to be revealed once oocytes are fertilized and embryo 
development appears to be impaired. 
This work illustrates that although IVM appears to be successful in most species there is still 
a crucial need for improvement. Improving IVM conditions, and gaining a better 
understanding of the oocyte competence acquisition is a necessary step to improve the overall 
in vitro embryo production, in all species in general and in the equine in particular.  
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Abstract 
 
In vivo techniques, such as intra-oviductal Oocyte Transfer (OT) and Intra-Follicular Oocyte 
Transfer (IFOT) can be considered as alternatives to bypass the lack of efficient 
superovulation treatments and the inadequacy of conventional in vitro fertilization techniques 
in the horse. We compared embryo production following transfer of in vivo recovered oocytes 
(1) into a recipient’s oviduct or (2) into her preovulatory follicle either immediately after 
ovum pick up or (3) after in vitro maturation. Recipients were inseminated with fresh semen 
of a stallion with a known normal fertility. Ten days after surgery, rates of embryos collected 
in excess to the number of ovulations were calculated and compared for each group. Embryo 
collection rates were 32.5% (13/40), 5.5% (3/55) and 12.8% (6/47) for OT, post-IVM and 
immediate IFOT respectively. OT significantly yielded more embryos than immediate and 
post-IVM IFOT did. We also showed that in vitro matured oocytes could succesfully be used 
for IFOT. Our results also suggest that improvement of the IFOT technique could turn it into 
an inexpansive and easy to perform procedure that could be an answer to the inefficiency of 
superovulation treatments in the mare.  
 
 
Keywords: horse, oocyte, transfer, intra-follicular, IVM 
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1. Introduction 
 
Conventional in vitro fertilization (IVF) has not been successful in the mare, and a 
repeatable IVF technique has not yet been developed, possibly due to the lack of an efficient 
in vitro capacitation system for stallion spermatozoa [1]. To overcome the limitation of 
conventional IVF procedures, other methods to produce embryos from oocytes, either in vivo 
or in vitro, have been investigated. Among these, intra cytoplasmic sperm injection (ICSI) [2-
5] has recently permitted efficient equine in vitro blastocyst production [6-8]. However, ICSI 
requires specific equipment and skills and the spermatozoon is still arbitrary chosen as, to 
date, no selection criteria for the male gamete have been established. Transfer of an immature 
oocyte into the preovulatory follicle of an inseminated recipient mare (Intra-Follicular Oocyte 
Transfer, IFOT) has produced embryos but the success rate was low [9,10]. These early 
studies used immature oocytes. Collection of embryos following intra-follicular transfer of in 
vitro matured oocytes would assess their cytoplasmic maturation as shown by their ability to 
produce an embryo. To our knowledge no intra-follicular transfer of oocytes previously 
matured in vitro has been reported. Similarely, oocyte transfer (OT) into the oviduct of an 
inseminated recipient mare was investigated. Early studies showed a rather low blastocyst 
development [11-13]. Carnevale and Ginther [14] first reported higher embryo production 
rates following transfer of in vivo matured oocytes. More recent studies transferring a single 
oocyte collected from a preovulatory follicle 24 hours after an injection of hCG and matured 
in vitro for another 16 to 20 hours before transfer also showed high embryo production rates 
[15] and commercial programmes using OT for mares with reproductive abnormalities are 
now available [16]. Intra-oviductal oocyte transfer can nowadays be considered a viable 
clinical alternative to embryo transfer in selected mares [17,18]. Birth of a foal following 
transfer of in vitro matured oocytes collected from ovaries after the death of the donor mare 
was first reported in 2003 [19]. The same authors reported embryo development rates of 15% 
following transfer of oocytes (n=191) recovered from commercial mares post-mortem [20].  
In addition, OT can be used to assess the quality of oocytes after IVM by their ability 
to undergo in vivo fertilization [17,21]. However, using one oocyte from a preovulatory 
follicle, OT as it is generally actually performed, suffers the same limitation as embryo 
transfer to produce more than one embryo at a time. In the absence of an efficient 
superovulation treatment in the mare [22], transfer of immature oocytes into a preovulatory 
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follicle or transfer of in vitro matured oocytes either into a preovulatory follicle or into a 
recipient’s oviduct are options to be considered. Unfortunately, although it is a non-surgical 
procedure, IFOT is poorly documented in the literature and reports of OT have been 
published by various laboratories and under various conditions, making comparisons between 
results and choosing among these as substitutive techniques to ICSI or embryo transfer 
difficult. 
 
2. Aims of the study 
 
The first aim of this study is to test if in vitro matured oocytes would complete their 
maturation and yield embryos following transfer into the preovulatory follicle of an 
inseminated recipient mare. 
The second aim is to compare OT following IVM, IFOT following IVM, and IFOT 
immediately after oocyte collection as alternative techniques where ICSI is not available.  
 
3. Materials and methods 
 
The study was conducted in spring using 30 cycling Welsh pony mares from 200 to 
300 kg. All the procedures have been approved by the Local Committee of Health Guide for 
Care and Use of Laboratory Animals. Ovarian activity was monitored daily using transrectal 
ultrasound scanning using an Aloka 210 with a 5MHz linear probe (Société Bernard, Nantes, 
France). 
 
3.1. Follicular puncture and oocyte recovery 
 
Mares with a preovulatory follicle ≥ 33 mm were injected i.v. with 25mg of Crude 
Equine Gonadotropin (CEG), produced in our lab [23], to induce ovulation. Transvaginal 
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ultrasound-guided aspiration of follicles ≥ 5 mm was performed immediately after CEG 
injections. Follicles were punctured routinely using a transvaginal aspiration technique as 
previously described [24]. Transrectal ultrasound was performed to detect ovulation 48 hours 
after CEG injection in all mares. 
 
3.2. Culture of Cumulus Oocyte Complexes  
 
After recovery, the cumulus oocyte complexes (COCs) were isolated and classified 
according to cumulus morphology into expanded cumulus and compact cumulus [25]. The 
same classification was used for post IVM examination. Collected oocytes were either 
matured in vitro for 30 hours or prepared for immediate transfer. 
When matured in vitro, COCs were individually matured at 38,5°C in a humidified 
atmosphere of 95% air and 5% CO2 for 30 h in 20µl of maturation medium under mineral oil 
(M8410 Sigma, Saint-Quentin Fallavier, France). Maturation medium contained Medium 199 
with Earle’s salt (M4530, Sigma, France) supplemented with 20% inactivated fetal calf serum 
(FCS, F4135, Sigma, France) and with 50ng/ml Epidermal Growth Factor (EGF, E4127, 
Sigma, France) as described by Goudet et al. [26]. Following IVM, no selection based on 
appearance was performed and intact COC’s were assigned to either OT or Post-IVM IFOT 
group. 
Oocytes from sessions that failed to yield more than 3 oocytes were cultured 
similarely and prepared for post IVM examination. They were rinsed in PBS and COCs were 
stripped with small glass pipettes, stained with 1 µg/ml bis-benzamide (Hoechst 33342; 
Sigma, France) and evaluated with a fluorescence microscope. Oocytes were classified 
according to the stage of nuclear maturation, membrane integrity and the ooplasm aspect as 
“germinal vesicle”, “dense chromatin”, “metaphase I”, “metaphase II” or “degenerate” as 
previously described by Goudet et al. [25]. 
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3.3. Preparation of oocytes before transfer 
 
 Oocytes for intra-follicular transfer were rinsed three times in 500 µl of PBS and 
loaded in 1ml of PBS into a 1ml syringe for transfer after IVM and in 0.2 to 0.5 ml of PBS 
with 1mL/L heparin (Heparin 5 IU/ml; Sanofi, France) for immediate transfer. 
Oocytes for intra-oviductal transfer were rinsed three times in 500 µl of PBS after 
IVM and stored in PBS at 38.5°C. The system to aspirate the oocytes consisted of a blunted 
sterile glass pipette connected to a piece of tube, which was in turn connected to a 1ml 
syringe. The whole system was kept at 38.5°C. Oocytes were loaded just prior to the oocyte 
transfer, in a minimal volume of PBS between two bubbles of air.  
 
3.4. Intra-Follicular Oocyte Transfer (IFOT) 
 
Intra-follicular oocyte transfer was performed as previously described by Goudet et al 
[10]. Briefly, the preovulatory follicle was punctured using a single lumen needle (length, 
600mm; outer diameter, 1.1mm, 17G; Thiebaud Frères, Jouvernex Margencel, France), with a 
specific attention to the needle going through as much ovarian stroma as possible before 
reaching the follicle. Then, 5 ml of follicular fluid were aspirated from the preovulatory 
follicle. The 1ml syringe containing the oocytes in PBS was connected to the 17 gauge 
needle, the oocytes were injected and the needle flushed with 4.5ml of follicular fluid. 
Immediately after transfer, the catheter and needle were checked to ensure that no oocytes 
remained logged in them. Recipient mares were injected with their own oocytes, either just 
after collection (Immediate Intra-Follicular Oocyte Transfer) or following IVM (Post-IVM 
Intra-Follicular Oocyte Transfer). Recipient mares were inseminated 24 hours after CEG 
injection, using fresh semen of a stallion with a known normal fertility: 400 X 106 
spermatozoa in 10ml of extender (INRA96®; IMV Technologies, France). 
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3.5. Intra-oviductal Oocyte Transfer (OT) 
 
Oocytes from preovulatory follicles were aspirated and discarded. Following their 
ovum pick up session, mares were fasted for 24 hours. Recipient mares were inseminated 5 h 
prior to surgery, using fresh semen of a stallion with a known normal fertility: 400 X 106 
spermatozoa in 10ml of extender (INRA96®; IMV Technologies, France). Surgical transfers 
of the recipient mare’s own oocytes occurred 30 hours after the oocyte recoveries. The 
recipient mare was treated with antibiotics (about 6 hours before surgery) (4,000,000 IU 
streptomycin, 4g procaine penicilline i.m., Intramicine®, Ceva, France). Animals were 
sedated with detomidine (3-5 µg/kg; 0.1ml/animal i.v. Domosedan®; Pfizer, France) for 
surgical preparation of the mare for the standing flank laparotomy. An injection of 
butorphanol tartrate 4mg (13-20 µg/kg; 0.4ml/animal i.v. Torbugesic®; Fort Dodge, 
Southampton, UK) for analgesia was followed by a second injection of detomidine (6-10 
µg/kg, 0.2ml/animal i.v. Domosedan®). A cuffed urinary catheter was placed to allow 
continuous emptying of the bladder during the surgery in order to limit discomfort. After local 
anesthesia (lidocaïne, Laocaïne®, Schering Plough, France), a flank approach was used to 
gain access to the ovary. The skin incision was directed vertically or at a slight oblique and 
extended 10 to 15 cm. The muscles of the flank, external and internal abdominal oblique 
muscles and the transversus abdominis muscle were bluntly dissected in the direction of their 
fibres. The peritoneum was perforated and the opening was manually dilated. After the ovary 
was exteriorised and the pipette was inserted into the oviduct. Oocytes were gently injected 
into the oviduct. The different layers were closed using absorbable suture material (Vicryl® 
0; Johnson and Johnson, UK) in an interrupted pattern. Immediately after surgery, a second 
insemination with 200 X 106 spermatozoa in 10ml of semen extender (INRA96®, IMV 
Technologies, France) stored at 15°C was performed. 
 
3.6. Embryo collection  
 
Embryo collection was performed 10 days after surgery by three successive uterine 
lavage with saline at 38°C. Collection fluid was filtered and embryos were isolated under a 
stereomicroscope.  
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3.7. Statistical analysis 
 
To compare maturation rates and embryo yields, a chi-square test was performed. 
Significance was established at p < 0.05. 
 
4. RESULTS 
 
4.1. Oocyte collection 
 
Following the 31 puncture sessions, a total of 158 oocytes were obtained from 284 
immature follicles resulting in a recovery rate of 55,6%. Recovery rates ranged from 0% (0/7) 
to 100% (6/6). Global collection rate was 5.1 immature oocytes per puncture session (158/31). 
 
4.2. Maturation rates 
 
Out of the 158 oocytes, 47 were used for immediate IFOT, 109 oocytes were matured 
in vitro and two oocytes, which were degenerated, were not cultured. Out of these 109 in vitro 
matured oocytes, 55 were transferred into preovulatory follicles (IFOT), 40 were used for 
intra-oviductal oocyte transfer and 14 were used for analysis. Table 1 shows the percentage of 
nuclear maturation of the non-transferred oocytes. 
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4.3. Embryo collection rates 
 
Table 2 shows the results of embryo collection. When embryo collections yielded one 
or more embryos, one of the embryos was assumed to result from the fertilization of the 
oocyte from the preovulatory follicle. Recovery rates of embryos in excess compared to the 
number of ovulations were calculated. Recovery rates after OT (32.5%, 13/40) were 
significantly different from the 5.5% (3/55) observed in the Post-IVM IFOT group (p=0.001) 
and the 12.8% (6/47) of the Immediate IFOT group (p=0.026).  
Following IFOT, 3 mares showed a preovulatory follicle that became diffusely 
echogenic and showed ultrasonographic signs of clotting. Table 3 shows the results of embryo 
collections without these 3 transfers where mares failed to ovulate. Embryo collection rates 
were recalculated considering only successful transfers. Recovery rates after OT (32.5%, 
13/40) were significantly different from the 5.8% (3/52) observed in the Post-IVM IFOT 
group (p=0.001) and the 14.6% (6/41) of the Immediate IFOT group (p=0.058).  
Table 4 shows the per transfer distribution of number of transferred oocytes and embryos 
collected in excess in both Immediate and Post-IVM groups. 
 
5. Discussion 
 
Our oocyte collection rate of 55.6% after puncture is similar to those reported in the 
litterature [27,28], although lower collection rates have also been reported [29]. The 
maturation rate of 71% we observed is similar to those previously reported ranging from 40% 
to 70% in the equine [6,27,28,30]. One of the 14 oocytes matured in vitro had initially been 
prepared for one of the immediate IFOT. However, it was found in the syringe after the 
transfer and subsequently matured in vitro. 
Intra-follicular oocyte transfer has been first unsuccessfully attempted in different 
species, probably due to damage caused to the follicle during manipulations [31]. Thanks to 
the large size of the ovary, its specific anatomy with a peripheral medulla and a surrounding 
fibrous tunique, the mare appears to be a unique model for the study of IFOT. Hinrichs and Di 
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Giorgio [9] developed the technique of IFOT in the horse and obtained embryos in excess 
after transferring immature oocytes into preovulatory follicles. It was subsequently used by 
Goudet et al [10] to study follicular contents and maturation rates. Surprisingly, no further 
studies about IFOT in the mare have been reported probably due to rather poor results of early 
reports. The recovery of excess embryos following intra-follicular transfer of oocytes matured 
in vitro in our study shows that they were ovulated, fertilized in the recipient’s oviduct before 
progressing to the uterus. This is the first report of embryonic development following intra-
follicular transfer of in vitro matured oocytes. Embryo collection rates following immediate 
transfer of ovum pick up oocytes of 12.8% (6/45) did not differ significantly from those 
observed following transfer of in vitro matured oocytes (5.5%; 3/55). This could mean that in 
vitro maturation of oocytes for 30 hours under our conditions and subsequent passage into the 
preovulatory follicle of a recipient for 0 to 18 hours is comparable to in vivo maturation 
within a preovulatory follicle. Alternatively, this could mean that although no statistical 
difference could be shown in our experiment, IVM oocytes suffer some inadequate 
maturation when compared to in vivo matured oocytes or that their expulsion at the time of 
ovulation is impaired. This is supported by Hinrichs and DiGiorgio’s observation [9] who 
reported that only 3 recent oocytes out of 12 transferred could be recovered from one 
euthanized mare’s oviduct 3 days after transfer. Inadequate IVM can yield under- or 
overmature oocytes which will not undergo normal fertilization and embryo development [9].  
Although echogenic spots have been visualized in some follicles prior to a normal 
ovulation [32], echogenic spots and fibrous strands are more commonly associated  with 
hemorrhagic, anovulatory follicles [10,33]. Hemorrhagic follicles have been reported with a 
spontaneous occurence of 4.7% (12/255) in the mare [34]. We observed 3 anovulatory 
hemorrhagic follicles following a total of 18 intra-follicular transfers (16,6%), this is 
comparable to the 15,8% (3/19) Hinrichs and Di Giorgio observed [9], but statistically 
(p<0.05) different from the 66,6% previously reported by Goudet et al. [10] who  punctured 
the same follicles twice during the oestrus phase. These results suggest that IFOT procedure 
increases the occurence of hemorrhagic follicles probably due to transfer induced damage as 
invoked by Fleming et al [31]. When the 3 transfers with anovulatory hemorrhagic follicles 
were not considered, embryo collection rates showed that although a trend was still 
observable (p=0.058), OT was no longer statistically different from IFOT immediately after 
oocyte recovery. One limitation of IFOT seems to be the increased occurrence of anovulatory 
hemorrhagic follicles which appears to be related to puncture technique and repetition. In 
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order to minimize trauma to the follicle, attempts with thinner needles were performed in a 
preliminary study. However, these needles tended to bend and did not allow proper puncture 
of the follicles. Different approaches for the puncture, either more superficial or going 
through as much ovarian tissue as possible before reaching the preovulatory  follicle should 
be compared to see if they can reduce occurrence of hemorrhagic follicles. Intra-follicular 
transfer of immature oocytes is a relatively easy to perform and inexpansive procedure 
compared to surgical intra-oviductal oocyte transfer. It is less invasive as it avoids the need 
for surgery and the donor mare can easily be used as her own recipient to yield numerous 
embryos. Improving the technique, and thus reducing the risk of anovulation, might make the 
IFOT a viable option to increase the number of embryos of selected mares as superovulation 
treatments are yet not very efficient in the mare [22,35,36]. It could also be used to assess the 
quality of oocytes after IVM by their ability to undergo in vivo fertilization as suggested by 
Hinrichs and DiGiorgio [9]. 
Intra-oviductal oocyte transfer is now considered a viable clinical alternative to 
embryo transfer in selected mares [17,18]. Intra-oviductal and intra-uterine single 
inseminations of recipients during oocyte transfer result in similar embryo production rates 
when fresh good quality semen is used [14,37,38]. We collected 13 embryos on day 10 after 
transfer of 40 in vitro matured oocytes resulting in a collection rate of 32.5%. This is higher 
than rates of 7% (2/29) [39], 15% (11/73) and 18% (13/73) [40] previously reported but 
comparable to Zhang’s results who collected 7 embryos following transfer of 29 in vitro 
matured abattoir oocytes (24.1%) [13]. However, even when expressed in relation to our in 
vitro maturation rate of 71%, the embryo yield of 45.8% remains lower than embryo 
collection rates or pregnancies obtained following transfer of preovulatory  in vivo recovered 
oocytes ranging from 73 to 83% [14,37,38]. The recovery rate of embryos in excess following 
OT we observed is statistically different from that observed after IFOT, either immediately 
after oocyte recovery or post IVM. IVM oocytes were matured for 30 hours before transfer 
either to the preovulatory  follicle or the oviduct. Oocytes were readily available for 
fertilization in the OT group. Those from the Post-IVM IFOT group were released into the 
oviduct within 18 hours of transfer. A possible explanation for the poor recovery rate of 
embryos in the Post-IVM IFOT group could be that oocytes were over-matured when 
ovulation and fertilization could occur. More regular rectal examinations to more acurately 
determine the exact timing of ovulation could help supporting this hypothesis. 
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Our results show that, in comparison to IFOT, OT is the most reliable in vivo 
alternative to in vitro fertilization where ICSI technology is not available.  
 
6. Conclusion 
 
Our results support previous work that immature oocytes can be matured within the 
follicle of a mare in vivo, and be ovulated, fertilized and yield excess embryos following 
IFOT.  In addition, we show for the first time that in vitro-matured oocytes can be used for 
IFOT and result in excess embryos.  General success rate of IFOT was low but tended to be 
higher when immature oocytes were transferred. Improvement of the technique could turn it 
into an inexpensive, easy to perform procedure which could be an answer to the relative 
inefficiency of superovulation treatments in the mare. 
We also established that, when ICSI is not an option, intra-oviductal oocyte transfer is 
to be preferred to IFOT as an in vivo alternative to bypass the inadequacy of conventional in 
vitro fertilization and to assess oocyte developmental competence. 
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Table 1: Evaluation of nuclear maturation after culture 
 Nuclear stage 
 Metaphase II Metaphase I Dense 
chromatin 
Germinal 
vesicle 
Degenerated 
Total 71.3% (10/14) 0% (0/14) 7.2% (1/14) 7.2% (1/14) 14.3% (2/14) 
 
 
 
 
 
Table 2 : Results of collected embryos 
 No of 
transfers 
No of 
pregnant 
No of 
transferred 
oocytes  
No of 
embryos 
recovered 
No of 
embryos 
recovered 
in excess 
Embryo  
Collection 
Rate  
Immediate-
IFOT 
10 4 47 10 6 12.8% (6/47) a 
Post-IVM 
IFOT 
8 4 55 7 3 5.5% (3/55) a 
OT 6 5 40 13 13 32.5% (13/40) b 
a, b Values with a different superscript are statistically different (p<0.05) 
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Table 3 : Results of collected embryos for successful transfers* 
 No of 
transfers 
No of 
pregnant 
No of 
transferred 
oocytes  
No of 
embryos 
recovered 
No of 
embryos 
recovered 
in excess 
Embryo  
Collection 
Rate  
Immediate-
IFOT 
8 4 41 10 6 14.6% (6/41) a,b 
Post-IVM 
IFOT 
7 4 52 7 3 5.8% (3/52) a 
OT 6 5 40 13 13 32.5% (13/40) b,c 
a, b, c Values with a different superscript are statistically different (p<0.05) 
*: transfers were considered successful when ovulation occurred and transferred oocytes were 
released. 
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Table 4: Per transfer distribution of number of transferred oocytes and embryos collected in 
excess in both Immediate and Post-IVM groups 
 
 Immediate IFOT Post-IVM IFOT 
Transfer 
number 
No of 
transferred 
oocytes 
No of 
embryos 
recovered in 
excess 
No of 
transferred 
oocytes 
No of embryos 
recovered in 
excess 
1 4 2 5 0 
2 2 0* 9 0 
3 3 0 3 0* 
4 10 2 7 0 
5 8 1 4 0 
6 4 1 9 1 
7 4 0* 14 2 
8 6 0 4 0 
9 2 0 - - 
10 4 0 - - 
Total 47 6 55 3 
 
 *: refers to transfers where no ovulation occurred and a Corpus Hemorrhagicum was 
observed. 
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ABSTRACT 
 
The effect of cysteamine on in vitro nuclear and cytoplasmic maturation of equine oocytes 
collected by transvaginal ultrasound guided follicular aspiration was assessed. Oocytes were 
matured in vitro with (cysteamine group) or without (control group) cysteamine. The nuclear 
stage after DNA Hoechst staining, penetration rates after 2 different IVF techniques (IVF 
media with ionophore and Hepes buffer with heparin) and the embryo yield following oocyte 
intra-oviductal transfer were used as a criterion for assessing nuclear and cytoplasmic 
maturation, respectively. Contrary to the data described in other domestic species, there was 
no effect of cysteamine on in vitro nuclear maturation, in vitro fertilization or in vivo 
embryonic development under our conditions. 
Ovum pick up yields (52%) and maturation rates (control group: 47% and cysteamine group: 
55%) were similar to those previously reported. From 57 oocytes transferred to the oviduct in 
each group, the number of embryos collected was 10 (17%) in the control group and 5 in the 
cysteamine group (9%). Those two percentages were not statistically different (p>0.05). No 
effect of IVF technique was seen on the success rate (6%) in each group.  
 
 
Keywords : cysteamine, GIFT, OPU, oocyte, horse, IVF 
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INTRODUCTION 
 
In vitro embryo production is the final result of a three step process: in vitro maturation 
(IVM), in vitro fertilization (IVF) and in vitro culture (IVC) of the embryo to a stage that is 
transferable to the uterus (Dell'Aquila et al. 1996, Hinrichs et al. 2002). In the mare, few 
studies have reported fertilization rates after standard IVF procedures (Alm et al. 2001, 
Dell'Aquila et al. 1996, Palmer et al. 1991) and there is no published report of equine 
pregnancies following both in vitro maturation and conventional IVF. This limited success is 
due to the restricted availability of oocytes and consequent lack of selection, poor 
understanding of oocyte maturation, fertilization and early embryo development. Research on 
IVM in mares is impeded by the limited availability of mature oocytes and early embryos for 
study. Superovulation treatments are not very efficient in the mare (Alvarenga et al. 2001, 
Bezard et al. 1995, Dippert and Squires 1994). Ovaries recovered from slaughterhouses 
provide a material with an obvious lack of repeatability, delay in time between collection and 
placement in culture medium and lack of information about the stage of cycle and follicular 
growth. Transvaginal ultrasound guided follicular aspiration has become an alternative source 
for mature and immature equine oocytes since it has been first described by Bruck et al. in 
1992 (Bruck et al. 1992). Immature oocytes collected by transvaginal ultrasound guided 
follicular aspiration can undergo IVM. However, success rates of IVM of equine oocytes 
(40% to 70%) (Bogh et al. 2002, Goudet et al. 1997a, Squires 1996) remain low in all  culture 
media tested compared to other species such as cows, goats and sows, (≥ 90%) (Goudet et al. 
2000).  
In order to improve the IVM maturation rates and quality of equine oocytes, the addition of 
compounds that can protect the cell from oxidative damage have been used such as 
glutathione (GSH) (de Matos et al. 1996, Grupen et al. 1995). During growth and maturation 
of the oocyte within the ovary, intracellular GSH content increases as the oocyte approaches 
the time of ovulation (Perreault et al. 1988, Yoshida et al. 1993, de Matos and Furnus 2000). 
The addition of GSH also improves the rate of male pronuclear formation (de Matos et al. 
1995, de Matos and Furnus 2000). Glutathione synthesis can be increased and thus the 
intracellular concentration of GSH by the addition of low molecular weight thiols to IVM 
medium, such as cysteamine and ß-mercaptoethanol (Takahashi et al. 1993). This has 
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improved in vitro maturation rates in the canine (Hossein et al. 2007) but not in the bovine (de 
Matos et al. 1995) or the porcine (Grupen et al. 1995), nevertheless, it has increased the 
success of bovine (de Matos et al. 1995, de Matos et al. 1996), ovine (de Matos et al. 1999) 
and porcine (Bing et al. 2001, Grupen et al. 1995) embryo development. However, the 
influence of cysteamine on IVM and IVF rates has not been reported in mares.  
IVF has not been successful in the mare possibly due to the lack of an efficient in vitro 
capacitation system for stallion spermatozoa. Equine spermatozoa have been incubated in 
solutions containing an ionophore and heparin, however it is unclear as to which solution is 
optimal. An in vitro fertilization rate of 30% was achieved in a technique where the 
spermatozoa prepared with the calcium ionophore A23187 (Bezard et al. 1992, Palmer et al. 
1991, Zhang et al. 1990). This technique was used to produce the only two live foals 
following a conventional IVF procedure to date (Palmer et al. 1991). Another method in 
which spermatozoa were treated with heparin has been used in the horse (Dell'Aquila et al. 
1996) and they obtained a 29% penetration rate which is similar to the overall 28,4%  
penetration rate observed by Alm et al. (Alm et al. 2001).  
The assessment of the success of IVM and IVF techniques is difficult because no reliable 
feature of cytoplasmic maturation has been defined in the mare whereas nuclear maturation is 
readily assessed by nuclear fluorescent microscopy. There have been few papers about the 
ultrastructure (Grondahl et al. 1995, Tremoleda et al. 2001, Carneiro et al. 2002) and the 
biochemical changes (Goudet et al. 1998b, Goudet et al. 1998a) of oocytes during 
cytoplasmic maturation in the mare (Neumann et al. 1995, Goudet et al. 1997a).  Therefore, 
the best current indicator of effective cytoplasmic maturation of the oocyte is the ability of the 
oocyte to produce an embryo. 
 
In order to circumvent the inadequacy of conventional IVF, other methods to produce 
embryos from oocytes have been investigated, such as intra cytoplasmic sperm injection 
(ICSI) (Choi et al. 2002, Dell'Aquila et al. 1997a, Dell'Aquila et al. 1997b, Galli et al. 2002), 
which has recently permitted efficient equine in vitro blastocyst production  (Hinrichs et al. 
2005, Choi et al. 2006b, Choi et al. 2006a). Transfer of an immature oocyte into the 
preovulatory follicle of an inseminated recipient mare (Intra-Follicular Oocyte Transfer, 
IFOT) has also been investigated (Hinrichs and Digiorgio 1991, Goudet et al. 1997b). This 
method has produced embryos but the success rate was low therefore the oocyte transfer was 
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investigated. Three early studies showed blastocyst development after oocyte transfer to 
oviducts of a recipient mare ranging from 8% (n=26) (Ray et al. 1994), 13% (n=15) 
(McKinnon et al. 1988) to 17% (n=29) (Zhang et al. 1989). However, these studies used in 
vivo matured oocytes aspirated immediately before ovulation and transferred within one hour 
to the recipient mare’s oviduct. In 1995, Carnevale and Ginther (Carnevale and Ginther 1995) 
reported an 83% rate (n=12) when transferring in vivo matured oocytes. Similarely, Hinrichs 
et al. (Hinrichs et al. 1997) showed a 75% rate (n=8) after transferring a single oocyte 
collected 24 hours after an injection of hCG and matured in vitro for another 16 to 20 hours 
before transfer. These results make this procedure a viable clinical alternative to embryo 
transfer in selected mares (Hinrichs et al. 2002, Carnevale 2004). In addition this method can 
be used to assess the quality of oocytes after IVM and IVF by their ability to undergo in vivo 
fertilization (Carnevale et al. 2005, Carnevale 2004) .  
 
Aims of the study: 
The broad aim of this study was to improve IVM and IVF procedures in the mare. The 
specific aims were to 1) to investigate the effect of the incubation of spermatozoa in two 
different solutions on the success of IVF, 2) to investigate if there is an influence of 
supplementation with 100 µM L-1 of cysteamine on in vitro nuclear and cytoplasmic 
maturation by the ability of oocytes to undergo in vitro and in vivo fertilization. 
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MATERIALS AND METHODS 
 
The study was conducted in spring using 30 cycling Welsh pony mares from 200 to 300 kg. 
All the procedures have been approved by the Local Committee of Health Guide for Care and 
Use of Laboratory Animals. Ovarian activity was monitored daily using transrectal ultrasound 
scanning using an Aloka 210 with a 5MHz linear probe (Société Bernard, Nantes, France). 
 
Follicular puncture and oocyte recovery 
When a preovulatory follicle ≥ 33 mm was seen, the mares were injected i.v. with 25mg of  
Crude Equine Gonadotropin (CEG), produced in our lab (Duchamp et al. 1987), to induce 
ovulation. Transvaginal ultrasound-guided aspiration of follicles ≥ 5 mm was performed 24 
hours after CEG injections. When immature oocytes are collected ex vivo, maturation rates 
are highest when oocytes are collected with that timing (Goudet et al. 1997a, Goudet et al. 
1998b). Follicles were punctured routinely using a transvaginal aspiration technique as 
previously described (Duchamp et al. 1994).  
 
Culture of cumulus oocyte complexes  
After recovery the cumulus oocyte complexes (COCs) were isolated and classified according 
to cumulus morphology. into expanded cumulus and compact cumulus (Goudet et al. 1998b). 
COCs with expanded cumulus were discarded. Compact COCs were individually matured at 
38,5°C in a humidified atmosphere of 95% air and 5% CO2 for 30 h in 20µl of maturation 
medium under mineral oil (M8410 Sigma, Saint-Quentin Fallavier, France). Two maturation 
media were used. Medium 1 contained Medium 199 with Earle’s salt (M4530, Sigma, France) 
supplemented with 20% inactivated fetal calf serum (FCS, F4135, Sigma, France) and with 
50ng/ml Epidermal Growth Factor (EGF, E4127, Sigma, France) as described by Goudet et 
al. (Goudet et al. 2000). Medium 2 was the same base with the addition of cysteamine at 
100µM L-1 (M9768, Sigma, France). 
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Experiment 1: IVF – Influence of spermatozoa media and cysteamine 
In the first experiment, influence of cysteamine on IVF was tested. 
Oocytes for IVF were rinsed in IVF modified TALP medium and incubated with thawed 
spermatozoa in 20µl of the medium under mineral oil. TALP medium contained 100mM 
NaCl, 3.1mM KCl, 0.3mM NaH2PO4 2H2O, 2.1mM CaCl2, 0.4mM MgCl2 6H2O, 25mM 
NaHCO3, 6mg/ml fatty acid-free albumin fraction V (Sigma), 4mg/ml sodium lactate 
(Sigma), 0.11mg/ml sodium pyruvate (Sigma). Cryopreserved semen was used, one ejaculate 
from three stallions pooled after thawing in a 37°C waterbath for 30 seconds and washed by 
centrifugation at 600g for 5 minutes, resuspended in medium and then centrifugated again. 
The sperm pellet was resuspended in IVF medium (group A) or Hank’s solution 
supplemented with BSA (1%) and Hepes buffer (20mM) (Palmer et al. 1991) (group B) and 
adjusted to 16X106 spermatozoa/ml. In group A, spermatozoa were supplemented with 
1µg/ml heparin. In group B, spermatozoa were incubated with 6µM of Ionophore A23187 
(free acid, Sigma) at 37°C for 5 minutes (Palmer et al. 1991), centrifuged at 600g for 5 
minutes and resuspended in IVF medium. The sperm suspension was added to the oocytes for 
a final concentration of 4X105 spermatozoa/ml. Oocytes were incubated with spermatozoa for 
24 hours at 38.5°C in a humidified atmosphere (95% air and 5% CO2), and examined. 
For the examinations oocytes were rinsed in PBS. COCs were stripped with small glass 
pipettes and stained with 1 µg/ml bis-benzamide (Hoechst 33342; Sigma, France) and 
evaluated with a fluorescence microscope. Oocytes were classified as penetrated or not 
penetrated. Oocytes not penetrated were classified according to the stage of nuclear 
maturation, membrane integrity and the ooplasm aspect as “germinal vesicle”, “dense 
chromatin”, “metaphase I”, “metaphase II” or “degenerate” as previously described by 
Goudet et al. (Goudet et al. 1998b). 
 
Experiment 2 : Oocyte intra-oviductal transfer  
In the second experiment, depending on puncture session yields, oocytes were transferred or 
analysed after IVM. 
If the puncture session yielded ≥10 oocytes, 10 oocytes were prepared for oocyte transfer. 
Any additional oocytes were prepared for post IVM examination. When puncture sessions 
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yielded ≤10 oocytes, they were all prepared for post IVM examination. Oocytes for intra-
oviductal transfer were rinsed three times in 500 µl of PBS after IVM and stored in PBS at 
38.5°C. The system to aspirate the oocytes consisted of a blunted sterile glass pipette 
connected to a piece of tube which was in turn connected to a 1ml syringe. The whole system 
was kept at 38.5°C. The oocytes were loaded just prior to the oocyte transfer, in a minimal 
volume of PBS between two bubbles of air.  
Oocyte transfer 
On the day of oocyte recovery from the donor mare, the recipient mare scanned with a follicle 
≥33mm was injected with 25mg of CEG and fasted for 24 hours. Recipient mares were 
inseminated 5 h prior to surgery, using fresh semen of a stallion with a known normal 
fertility: 400 X 106 spermatozoa in 10ml of extender (INRA96®; IMV Technologies, France). 
Surgical transfers of oocytes occurred 30 hours after the oocyte recoveries. The recipient mare 
was treated with antibiotics (about 6 hours before surgery) (4,000,000 IU streptomycin, 4g 
procaine penicilline i.m., Intramycine®, Ceva, France). Animals were sedated with 
detomidine (3-5 µg/kg; 0.1ml/animal i.v. Domosedan®; Pfizer, France) for surgical 
preparation of the mare for the standing flank laparotomy. An injection of butorphanol tartrate 
4mg (13-20 µg/kg; 0.4ml/animal i.v. Torbugesic®; Fort Dodge, Southampton, UK) for 
analgesia was followed by a second injection of detomidine (6-10 µg/kg, 0.2ml/animal i.v. 
Domosedan®). A cuffed urinary catheter was placed to allow continuous emptying of the 
bladder during the surgery in order to limit discomfort. After local anesthesia (lidocaïne, 
Laocaïne®, Schering Plough, France), a flank approach was used to gain access to the ovary. 
The skin incision was directed vertically or at a slight oblique and extended 10 to 15 cm. The 
muscles of the flank, external and internal abdominal oblique muscles and the transversus 
abdominis muscle were bluntly dissected in the direction of their fibres. The peritoneum was 
perforated and the opening was manually dilated. After the ovary was exteriorised and the 
pipette was inserted into the oviduct. Oocytes were gently injected into the oviduct. The 
different layers were closed using absorbable suture material (Vicryl® 0; Johnson and 
Johnson, UK) in an interrupted pattern. Immediately after surgery, a second insemination with 
200 X 106 spermatozoa in 10ml of semen extender (INRA96®, IMV Technologies, France) 
stored at 15°C was performed. 
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Embryo collection and maternity testing 
Embryo collection was performed 10 days after surgery by three successive uterine lavage 
with saline at 38°C. Collection fluid was filtered and embryos were isolated under a 
stereomicroscope. Embryos were rinsed 10 times in saline and kept at -20°C until maternity 
test. For maternity testing (Guerand et al. 1997), DNA of each embryo was extracted and 
typed by radio active PCR amplification using 10 characterized micro-satellites ( HMS 1, 2, 
5, 6, 7, 8 and HG 3, 4, 6 and 10). 
 
Statistical analysis 
To compare maturation rates and embryo yields, a chi-square test was performed. 
Significance was established at p < 0.05. 
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RESULTS 
 
Experiment 1: IVF – Influence of spermatozoa media and cysteamine 
We incubated 131 oocytes that were evaluated for evidence of sperm penetration and 
fertilization. Overall, 8 of them (6%) were penetrated. We observed one oocyte with a 
decondensed sperm head, six oocytes with 2 pronuclei or subsequent stages of mitosis, and 
one 2 cell-embryo. Four oocytes were penetrated by spermatozoa treated with heparin (Group 
A), and four oocytes were penetrated by spermatozoa treated with ionophore (Group B). Of 
the 8 penetrated oocytes, 4 came from maturation medium 1, and 4 came from maturation 
medium 2. 
 
Experiment 2: Oocyte intra-fallopian transfer 
 
Oocytes collection 
Recovery rates in experiment 2 are given in Table I.  
A total of 237 oocytes were obtained from 479 immature follicles resulting in a recovery rate 
of 48,5%. 108 oocytes were maturated in medium 1 (Control group) and 124 in medium 2 
(Cysteamine group).  
 
Maturation rates 
Five oocytes out of the 327 collected were damaged or lost and were not cultured. 
 
Table II shows the percentage of nuclear maturation of the non-transferred oocytes. 
Overal maturation rate was 52%. Nuclear maturation was not statistically different (p>0.05) 
between oocytes cultured with or without cysteamine (55% and 47% respectively).  
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Oocyte transfers 
Six transfers were performed for a total of 57 oocytes in each group. Three oocytes were 
found in the pipette after one surgery in the control group. Only 7 oocytes from the 
cysteamine group were transferred during the next surgery to keep groups even. 
 
Embryo collection 
3 oocytes were found in the pipette. Five embryos were obtained from 57 transferred oocytes 
(9%) in the cysteamine group and ten embryos from 57 transferred oocytes (17%) in the 
control group (Table III). Those two percentages were not significantly different (p>0.05). 
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DISCUSSION 
 
The overal maturation rate of 52% we observed is similar to previous reports, which vary 
from 40% to 70% in the equine (Bogh et al. 2002, Goudet et al. 1997a, Squires 1996). Higher 
values are usually observed when oocytes are matured in groups (Dell'Aquila et al. 1996, 
Shabpareh et al. 1993). Ideally, groups of 10 to 20 oocytes are cultured, which suits best 
conditions where a large number of oocytes are available. However oocytes were matured 
individually in our study so maturation conditions would be the same regardless the number 
of oocytes yielded by the ovum pick up session. Hinrichs et al (Hinrichs et al. 2005) recently 
reported meiotic resumption rates over 70% after individual maturation, with an  actual 
metaphase II rate around 50% which is comparable to our results.  
A concentration of 100 µM L-1 of cysteamine was used in the present study. Reported 
concentrations in various species range from 50 to 500 µM L-1 with highly variable results 
(Whitaker and Knight 2004, de Matos et al. 1995, de Matos et al. 2002, Gasparrini et al. 2003, 
Grupen et al. 1995, Yamauchi and Nagai 1999, Bing et al. 2002). Grupen et al (Grupen et al. 
1995), who compared concentrations of 50 and 500 µM L-1 of cysteamine in IVM medium for 
porcine oocytes found that both increased synchronous pronuclear formation whereas only the 
higher concentration significantly enhanced embryonic development. They suggested that 
cysteamine in excess allows cytoplasmic accumulation of thiol compounds during IVM which 
may persist in the cleaving embryo and assist mitotic cell division. Conversely, Gasparrini et 
al (Gasparrini et al. 2000) working on buffalo oocyte, found that supplementation with 50 µM 
of cysteamine significantly improved in vitro embryo production whereas concentrations of 
100 and 200 µM L-1  did not affect cleavage rate compared to control group. Similar results 
were observed in a recent study where cysteamine was added to IVM and IVC medium 
(Anand et al. 2008). It appears effect of cysteamine supplementation to IVM medium is 
highly species and concentration dependant. The inadequacy of the chosen concentration may 
explain that equine embryo production has not been increased by the cysteamine under our 
conditions as opposed to what has been observed in other species such as bovine (de Matos et 
al. 1995, de Matos et al. 1996, Takahashi et al. 1993); porcine (Bing et al. 2001, Grupen et al. 
1995); ovine (de Matos et al. 2002); and buffalo (Gasparrini et al. 2003). However, our results 
are in agreement with Luciano et al. (Luciano et al. 2006) who recently demonstrated that the 
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addition of 100 µM L-1 of cysteamine during in vitro maturation of equine oocytes does not 
influence GSH synthesis. 
Alternatively, contents of IVM medium itself should be considered as a potential reason for 
the absence of effect of cysteamine supplementation in our study. We can hypothesize that 
some substances present in the IVM medium can interfere with GSH synthesis. Bing et al 
(Bing et al. 2001) suggested that FSH and estradiol both affected GSH levels in porcine 
oocytes which in turn increased maturation rates.  It has also been suggested that 
gonadotropins regulate ovarian GSH synthesis (Luderer et al. 2001). Although our maturation 
medium is not supplemented with gonadotropins or estradiol, factors contained in fetal calf 
serum or EGF might have an effect on GSH synthesis. 
 
In our study, both techniques (ionophore or heparin) yielded 6% of IVF. This percentage is 
low when compared to data published by Palmer (Palmer et al. 1991) and Dell’Aquila 
(Dell'Aquila et al. 1996). However these results have not been shown to be repeatable and the 
IVF rates we observed, although rather low, are more comparable to others reported in the 
horse (Choi et al. 1994, Dell'Aquila et al. 1997a). Nevertheless the general success rates for 
IVF procedures may be too low for us to conclude definitely about the effect of cysteamine. 
In regards to our overall maturation rate of 52% following IVM, it can be considered that only 
roughly 59 metaphase II oocytes were actually transferred. Consequently, 15 embryos were 
obtained from 59 genuinely fertilizable oocytes (26%), which is similar to what we (Daels et 
al. 2001) and others (Carnevale et al. 2005) obtained in previous studies where preovulatory 
in vivo recovered oocytes were transferred. The global results, 15 embryos from 114 
transferred oocytes giving a 13 % recovery rate can be compared to those reported in other 
studies. From 29 oocytes aspirated during diestrus stage Scott et al. (Scott et al. 2001) 
obtained 2 pregnancies on day 16 (7%) following in vitro maturation and in vivo fertilization. 
Zhang et al. (Zhang et al. 1989) obtained 7 embryos from 29 oocytes from slaughterhouse 
matured in vitro and fertilized in vivo. Hinrichs et al. (Hinrichs et al. 2002) obtained a high in 
vivo fertilization rate of 77% after in vitro maturation of abattoir oocytes. The recipient mares 
were euthanasied 40 to 44 hours after transfer and oocytes were recovered from the oviduct. 
When comparing the percentage of embryos per transferred oocytes, 18% of the oocytes 
recovered from the oviduct had undergone cleavage (2 cells or more). The discrepancy 
between the fertilization rate and the relatively low embryo recovery rate in all studies 
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combined may suggest that the percentage of embryos able to reach the blastocyst stage is 
probably lower. This may be due to a blockage of embryonic development of the embryos 
and/or to an intra-fallopian embryonic reduction. This gives a new light to overall low results 
obtained following uterine collection. This confirms that in the absence of a reliable marker of 
cytoplasmic maturation, the ultimate test to appreciate the quality of a gamete following in 
vitro culture is by obtaining at least a blastocyst. 
 
CONCLUSION 
Regardless of sperm treatment (heparin vs ionophore), IVF rates were low with oocytes 
matured in either of two types of solutions. Under our conditions, the addition of 100 µM L-1 
of cysteamine to a classic culture medium does not improve equine oocyte maturation or 
embryonic development after oocyte transfer. Considering its beneficial effects in many other 
species, supplementation with cysteamine to different IVM media should be further 
investigated; ideally combining different concentrations and ICSI in order to determine an 
optimal concentration and its effects on sperm penetration and early embryonic development. 
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Table I: Oocytes recovery rate 
Donor mare No of OPUs No of follicles No of oocytes Recovery rate 
1 2 46 21 45,7% 
2 2 11 6 54,5% 
3 2 16 11 68,8% 
4 2 18 5 27,8% 
5 1 9 4 44,4% 
6 2 27 12 44,4% 
7 1 16 13 81,3% 
8 1 8 2 25,0% 
9 1 14 12 85,7% 
10 2 36 20 55,6% 
11 2 12 6 50,0% 
12 2 19 7 36,8% 
13 1 14 8 57,1% 
14 2 23 12 52,2% 
15 1 13 5 38,5% 
16 2 20 11 55,0% 
17 1 7 5 71,4% 
18 2 21 5 23,8% 
19 1 4 1 25,0% 
20 2 13 4 30,8% 
21 1 6 3 50,0% 
22 2 9 4 44,4% 
23 2 14 9 64,3% 
24 2 29 16 55,2% 
25 2 6 3 50,0% 
26 1 3 1 33,3% 
27 2 17 8 47,1% 
28 1 11 6 54,5% 
29 2 16 6 37,5% 
30 1 6 2 33,3% 
     
Total  479 237 48,5% 
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Table II: Evaluation of nuclear maturation after culture 
 Nuclear stage 
IVM 
medium 
Metaphase II Metaphase I Dense 
chromatin 
Germinal 
vesicle 
Degenerated 
Control 47% (24/51) 12% (6/51) 12% (6/51) 6% (3/51) 23% (12/51) 
Cysteamine 55% (37/67) 10% (7/67) 8% (5/67) 3% (2/67) 24% (16/67) 
Total 52% (61/118) 11% (13/118) 9% (11/118) 4% (5/118) 24% (28/118) 
 
 
Table III: Number of collected embryos and result of maternity testing. 
IVM 
medium 
N 
of 
recipients 
N of 
pregnant 
N 
transferred 
oocytes 
N of 
embryos 
Total* 
Embryos 
from the 
recipient 
Embryos 
from the 
donors 
Control 6 6 57 15 5 10 
Cysteamine 6 5 57 10 5 5 
Total   114 25 10 15 
* N embryos total refers to the embryos emerging from the oocytes of both the donor and the 
recipient mares. 
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RESUME :  
 
Malgré le faible nombre d’ovocytes équins disponibles pour la recherche, des techniques de 
reproduction assistée récemment développées dans cette espèce permettent maintenant de 
produire des embryons en utilisant des étalons et des juments subfertiles ou même de 
sauvegarder leur potentiel génétique après leur mort. Cette revue de littérature décrit les 
aspects cliniques de la collecte d’ovocytes ex vivo ou in vivo, leur évaluation, leur maturation 
in vitro et leur utilisation pour le transfert intra-folliculaire ou salpyngien et l’injection intra-
cytoplasmique de spermatozoïde. 
 
Assisted reproduction in the equine: collection, evaluation, maturation and use of equine 
oocytes. 
 
SUMMARY 
Despite the paucity of equine oocytes available for research, recently developped assisted 
reproduction techniques can now be offered to produce embryos from subfertile stallions and 
mares or to salvage their genetics after their death. This paper describes the clinical aspects of 
oocytes collection either ex vivo or in vivo, their evaluation and in vitro maturation and 
discusses their uses for intra-follicular and intra-oviductal oocyte transfer and intra-
cytoplasmic sperm injection. 
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INTRODUCTION 
 
L’acronyme « ART » pour : « Assisted Reproduction Technologies », ou en Français :  
« Techniques de Reproduction Assistées » (TRA), reprend des procédures allant de la simple 
conduite d’une saillie à la production de clones. Les techniques de reproduction assistée 
permettent de nos jours de préserver le potentiel génétique d’animaux subfertiles ou même 
morts. Ces dernières années, ces techniques ont été utilisées avec succès dans des cas 
cliniques où l’obtention d’une gestation n’était pas possible.  
Le succès et le développement de ces techniques reposent sur la maîtrise de la collecte et les 
manipulations d’ovocytes. Les premiers pas et les premiers grands succès ont été rapportés 
dans l’espèce bovine. Bénéficiant d’un intérêt marqué par le secteur bovin et d’une 
disponibilité quasi illimitée d’ovocytes provenant d’ovaires prélevés en abattoirs, les 
recherches ont rapidement débouché sur des techniques efficaces de production in vitro 
d’embryons reprenant la maturation in vitro (MIV) des ovocytes, la fécondation (FIV) et la 
culture in vitro d’embryons. 
L’industrie du cheval, en refusant encore dans bien des cas le recours à ces biotechnologies, et 
la bien moindre disponibilité d’ovaires d’abattoirs n’ont pas permis un essors aussi rapide des 
techniques de reproduction assistée dans cette espèce. 
Cet article s’intéresse aux aspects cliniques de la récolte d’ovocytes, leur évaluation et leur 
usage en reproduction assistée chez la jument. 
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COLLECTE, EVALUATION ET MATURATION DES OVOCYTES 
 
Collecte des ovocytes ex-vivo 
 
Manipulation et transport des ovaires prélevés à l’abattoir 
 
Bien qu’aucune étude ne compare les méthodes et les milieux de transport des ovaires équins 
depuis l’abattoir jusqu’au laboratoire, différents milieux et conditions de transport ont été 
explorés. Parmi les milieux de transport utilisés, on retrouve des solutions cristalloïdes 
supplémentées en antibiotiques, des solutions commerciales destinées au flush d’embryons, 
un milieu complet de culture cellulaire (TCM-199) et du PBS (phosphate-buffered saline) 
(Hinrichs et al., 1993; Alm et Torner, 1994; Del Campo et al., 1995; Franz et al., 2003; Preis 
et al., 2004).  
Le délai de transport des ovaires jusqu’au laboratoire ne semble pas affecter significativement 
la compétence méiotique des ovocytes pour autant qu’il reste inférieur à 15 heures (Shabpareh 
et al., 1993; Del Campo et al., 1995; Guignot et al., 1999). Néanmoins, des taux de 
maturation relativement élevés ont été rapportés par des laboratoires pour lesquels le délai 
entre l’abattage et la récolte d’ovocytes est court, ce qui suggère que la compétence des 
ovocytes pourrait malgré tout être affectée par ce délai (Love et al., 2003; Hinrichs et al., 
2005). 
La température à laquelle sont conservés les ovaires pendant leur transport a également fait 
l’objet d’études. Une étude qui a évalué la morphologie du cumulus oophorus et l’apoptose 
des cellules de la granulosa suggère que les ovaires ne devraient pas être conservés plus de 3 
heures entre 20 et 30°C afin d’éviter l’apoptose des cellules de la granulosa et pas plus de 2 
heures à 35-37°C pour éviter les modifications morphologiques du cumulus oophorus 
(Pedersen et al., 2004). Une autre étude a montré que les taux de maturation (Metaphase I+II) 
après 24h étaient supérieurs pour des ovocytes collectés immédiatement à l’arrivée des 
ovaires au laboratoire que pour des ovocytes collectés après conservation des ovaires pendant 
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15 à 18h à température ambiante ou à 4°C (Love et al., 2003). Les résultats de cette même 
étude laissent penser que 4°C est sans doute une température trop basse pour une bonne 
conservation des ovaires et que leur réfrigération devrait être envisagée uniquement lorsque la 
durée de conservation est prolongée.  
Une solution optimale serait probablement de réaliser la récolte des ovocytes sur le site même 
de l’abattoir (Love et al., 2003) et de les placer immédiatement dans les conditions de MIV 
dans un incubateur portable pour les ramener au laboratoire. Cette méthode encore peu 
utilisée permettrait sans doute d’obtenir des taux de maturation optimaux, mais comporte des 
difficultés techniques évidentes (lieu et matériel de récolte des ovocytes sur place, transport 
des ovocytes à température et atmosphère contrôlées) (Caillaud et al., 2008). 
 
Collecte d’ovocytes à partir d’ovaires prélevés à l’abattoir (ex vivo) 
 
La récolte des ovocytes équins présente certaines difficultés techniques. L’ensemble des 
étapes doit être réalisé avec un souci constant des conditions d’hygiène, de température, de 
pH et de milieu dans lequel se trouvent les ovocytes afin de les préserver au maximum. Les 
ovocytes peuvent être récoltés par aspiration (Desjardins et al., 1985; Shabpareh et al., 1993) 
à l’aide d’une aiguille 18G et d’un système d’aspiration ( +/- 1 bar) ou d’une pompe à vide 
(100-150mm Hg). L’ovaire peut également être tranché afin d’augmenter le nombre de 
follicules accessibles. L’ovocyte équin présente la particularité d’être fermement ancré sur un 
cumulus oophorus épais et trapus et dont les cellules présentent des extensions s’engrenant 
dans la couche de la thèque (Hawley et al., 1995). Cette caractéristique rend difficile 
l’extraction de l’ovocyte hors de sa cavité. Ceci explique que la technique impliquant un 
grattage de la paroi interne du follicule après incision semble donner les meilleurs taux de 
collectes avec des valeurs d’environ 80% (Del Campo et al., 1995). Cette technique permet de 
récupérer des ovocytes dont la majorité ont encore un Complexe Ovocyte-Cumulus (COC) 
intact (Hinrichs et al., 1993) alors que ceux obtenus par aspiration seule ne présentent souvent 
plus que les cellules de la corona radiata qui forment un anneau ceignant l’ovocyte (Hinrichs, 
1991). Après incision des follicules visibles, leur paroi est grattée à l’aide d’une curette. 
L’ovaire est ensuite disséqué en petits fragments afin d’accéder aux follicules qui se trouvent 
à l’intérieur du parenchyme ovarien. Alternativement, un grattage avec le biseau de l’aiguille 
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peut être réalisé en cours d’aspiration des follicules. Malgré cela, le taux global de récolte 
d’ovocytes équins reste relativement faible (3-5 oocytes/ ovaire) étant donné que l’ovaire 
d’une jument comporte en moyenne 6 follicules antraux (Hinrichs, 1991; Del Campo et al., 
1995). En outre, ceci se traduit par une augmentation du temps et du personnel nécessaires 
pour la collecte d’ovocytes. Galli (Galli et al., 2007) considère qu’en terme de temps et de 
personnel, la collecte d’ovocytes équins est 10 fois plus ardue que celle d’ovocytes bovins. 
Toutes ces difficultés techniques constituent un frein au développement de la recherche 
fondamentale sur l’ovocyte équin et, naturellement, sur toutes les technologies qui en 
découlent. 
 
Collecte d’ovocytes par ovum pick up (in vivo) 
 
Les ovocytes collectés à partir d’ovaires d’abattoirs représentent par définition une population 
très hétérogène et souffrent entre autre, d’un manque d’informations concernant l’âge des 
juments, leur phase du cycle et leur état gestatif. 
Contrairement aux animaux de rente, l’application des biotechnologies pour la production 
d’embryons équins est limitée aux animaux souffrant de troubles de la fertilité ou aux sportifs 
de haut niveau. Il n’y a donc dans cette espèce, en dehors des fins de recherche que peu 
d’intérêt réel à produire des embryons à partir d’ovaires prélevés en abattoirs.  
Pour les utilisations plus cliniques, les ovocytes sont souvent collectés in vivo après initiation 
de la maturation folliculaire et ovocytaire chez une jument en oestrus. Celle-ci peut être 
induite par l’administration de préparations commerciales contenant de l’hCG (effet LH), ou 
un analogue de GnRH (induction d’un pic endogène de LH). A des fins de recherche, des 
extraits hypophysaires (Crude Equine Gonadotropin, CEG) non disponibles 
commercialement, peuvent également être utilisés (Duchamp et al., 1987). 
Différentes approches visant à ponctionner des follicules et collecter leur ovocyte, telles que : 
la laparotomie (Vogelsang et al., 1988), la colpotomie (Hinrichs et Kenney, 1987), et la 
ponction à l’aveugle par le flanc (Palmer et al., 1986) ont été envisagées. Les deux premières 
techniques chirurgicales ont assez rapidement été abandonnées pour des raisons évidentes. La 
ponction par le flanc nécessite très peu de matériel. Pratiquement, un trocard est placé dans la 
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fosse sous-lombaire de la jument, l’ovaire est manipulé par voie trans-rectale et conduit en 
regard du trocard, une aiguille est passée au travers du trocard et le follicule est ponctionné et 
rincé à plusieurs reprises à l’aide de PBS (Phosphate Buffered Saline) hépariné. Cette 
technique ne permet malheureusement pas de visualiser le follicule et l’aiguille d’aspiration et 
ne donne des résultats satisfaisants que pour la ponction de follicules de grande taille. La 
ponction échoguidée par voie transvaginale est-elle devenue la technique de choix. La 
technique adaptée à partir de celle utilisée chez le bovin (McKinnon et al., 1988; Bruck et al., 
1992) a ensuite été modifiée et utilisée par de nombreuses équipes (Bracher et al., 1993; Cook 
et al., 1993; Duchamp et al., 1994; Carnevale et Ginther, 1995; Kanitz et al., 1995; Meintjes 
et al., 1995; Hinrichs et al., 1998) et permet maintenant d’obtenir des taux de collectes qui 
vont de 51 à 86% (Cook et al., 1993; Bezard et al., 1995; Meintjes et al., 1995; Goudet et al., 
1997; Scott et al., 2001). 
Pratiquement, la jument est tranquillisée et une sonde échographique sectorielle est 
introduite dans le vagin antérieur jusqu’au niveau du col (fornix). L’ovaire est manipulé à 
travers la paroi rectale et positionné en regard de la sonde et une aiguille est avancée le long 
de la sonde et introduite dans la cavité antrale au travers de la paroi du vagin. Le liquide 
folliculaire est aspiré, et le follicule est rincé à plusieurs reprises. Des mouvements de rotation 
de l’aiguille sont réalisés en cours d’aspiration pour gratter la paroi folliculaire afin d’en 
détacher l’ovocyte. Le liquide folliculaire et les liquides de rinçage sont récoltés et 
immédiatement transmis en salle de culture pour rechercher l’ovocyte. Les follicules de plus 
de 25mm sont ponctionnés à l’aide d’une aiguille à simple voie et vidangés et remplis à 
plusieurs reprises. Les follicules de moins de 25mm sont ponctionnés à l’aide d’une aiguille à 
double voie comme décrit par Duchamp et al (Duchamp et al., 1995). 
 
Evaluation des ovocytes collectés 
 
Après collecte ex vivo ou in vivo, les ovocytes peuvent être dénudés mais ils sont 
généralement entourés d’une quantité plus ou moins abondante de cellules de la corona 
radiata et du cumulus oophorus. Les couches cellulaires les plus internes présentent des 
projections qui traversent la zone pellucide pour établir un contact intime avec la membrane 
de l’ovocyte (Grondahl et al., 1995). Ces cellules qui entourent l’ovocyte forment avec celui-
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ci l’ensemble complexe ovocyte-cumulus. Les COC’s peuvent être caractérisés en fonction de 
leur degré d’expansion (Hinrichs et al., 1993; Goudet et al., 1997; Hinrichs et Williams, 
1997) et celui-ci est directement corrélé au degré de maturation nucléaire de l’ovocyte (Zhang 
et al., 1989; Goudet et al., 1997; Gable et Woods, 2001). Les ovocytes immatures sont 
associés à des COC’s compacts. Les COC’s expansés sont associés à des follicules en cours 
d’atrésie. Ils présentent une meilleure aptitude à la reprise de la méiose après maturation in 
vitro (Hinrichs, 1991). Il est depuis longtemps établi que les follicules sont responsables du 
blocage de la méiose de l’ovocyte (Pincus et Enzemann, 1935). En s’atrésiant les follicules 
perdent leur capacité à maintenir ce bloquage (Gougeon et Testart, 1986; Blondin et Sirard, 
1995), ceci explique une reprise spontanée de la méiose des ovocytes en leur sein. 
Les couches de cellules de la corona radiata et de la granulosa qui entourent l’ovocyte en 
limitent l’examen morphologique. En dehors de la technique d’injection intra-cytoplasmique 
d’un spermatozoïde (Intra Cytoplasmic Sperm Injection, ICSI), pour l’ensemble des 
procédures impliquant un transfert de l’ovocyte, ces couches cellulaires sont nécessaires au 
bon déroulement des événements de fécondation et de développement embryonnaire précoce. 
Aussi, l’examen de l’ovocyte lui même reste-t-il assez difficile et superficiel à moins de le 
dénuder mécaniquement ou à l’aide de trypsine. Néanmoins, l’aspect de l’ooplasme est 
corrélé à la viabilité des follicules, évaluée sur base de l’aspect des noyaux, le contact entre 
les cellules de la granuleuse et la membrane basale. Les ovocytes présentant un ooplasme 
homogène sont davantage associés à des COC’s compacts et à des follicules viables. 
Inversément, un ooplasme d’aspect granuleux et polarisé, correspondant à une distribution 
irrégulière de gouttelettes lipidiques et d’organelles intra-cellulaires, est davantage associé à 
des follicules atrétiques et à des COC’s expansés (Hinrichs et Williams, 1997). 
 
Maturation in vitro des ovocytes (MIV) 
 
La maturation ovocytaire est le résultat d’un double processus de maturation, au niveau du 
cytoplasme d’une part et au niveau du noyau d’autre part. Les modifications morphologiques 
associées à la maturation de l’ovocyte ont été décrites en 6 étapes par Grondahl et 
collaborateurs (Grondahl et al., 1995). Successivement, l’ovocyte présente : (1) un noyau 
sphérique au centre du cytoplasme, (2) un noyau sphérique à la périphérie de l’ooplasme, (3) 
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un noyau aplati en périphérie de l’ooplasme, (4) la rupture du noyau de l’ovocyte, aussi 
appelé : vésicule germinale d’où le terme de rupture de la vésicule germinale (Germinal 
Vesicle Break Down, GVBD), (5) metaphase I, (6) metaphase II caractérisée par la 
localisation périphérique des chromosomes métaphasiques et la présence d’un globule polaire 
dans l’espace périvitellin. Le globule polaire est généralement difficile à observer sous la 
loupe mais il arrive qu’occasionnellement il puisse être distingué dans l’espace périvitellin. 
La coloration spécifique de l’ADN des ovocytes dénudés par le bis benzamide ou Hoechst 
33258 permet la classification des configurations de la chromatine en (1) vésicule germinale, 
(2) chromatine dense, (3) metaphase I, (4) métaphase II, (5) dégénéré (Hinrichs et al., 1993; 
Goudet et al., 1998). 
Les milieux utilisés pour la MIV d’ovocytes équins dérivent principalement du secteur bovin. 
Depuis la première MIV d’ovocytes équins (Fulka et Okolski, 1981), sur base des milieux 
déjà utilisés chez le bovin, la recherche s’est orientée vers des milieux de culture cellulaire 
synthétiques tels que le TCM-199 (Willis et al., 1991; Dell'Aquila et al., 1997; Galli et al., 
2001), ou le Ham’s F10 (Okolski et al., 1991; Willis et al., 1991; Shabpareh et al., 1993). 
Actuellement, la plupart des milieux utilisent comme base le TCM-199, le EMMI et des 
solutions de sels auxquels sont ajoutées du sérum de veau fœtal (FCS) et des hormones telles 
que la LH, la FSH, le benzoate d’oestradiol (Carnevale et al., 2004) ou l’EGF (Goudet et al., 
1998; Lorenzo et al., 2002). Quelques études (Hinrichs et al., 1995; Li et al., 2001; Choi et 
al., 2002; Tremoleda et al., 2003) ont investigué les cocultures pour la MIV des ovocytes 
équins mais elles ont davantage apporté d’informations sur les mécanismes d’inhibition de la 
méiose au sein du follicule que de bénéfice réel en terme de qualité de maturation. 
La durée de maturation nécessaire a également fait l’objet de nombreuses investigations 
(Fulka et Okolski, 1981; Zhang et al., 1989; Del Campo et al., 1990; Willis et al., 1991; Del 
Campo et al., 1995; Bezard et al., 1997). Il est communément admis maintenant que l’on peut 
espérer un taux de maturation jusqu’au stade de métaphase II de l’ordre de 50 à 80% après 30 
heures d’incubation sous atmosphère contrôlée (39°C et 5% de CO2) (Scott et al., 2001) et 
qu’une durée prolongée d’incubation n’améliore pas ce résultat (Shabpareh et al., 1993). Les 
durées de maturation optimales dépendent du degré de maturation initial des ovocytes qui est 
corrélé à l’aspect de leur COC. Les taux de maturation maximum pour des ovocytes issus de 
COC’s expansés et compacts ont été obtenus respectivement après 24h et 32h de MIV pour 
Hinrichs et collaborateurs (Hinrichs et al., 1993) et 24h et 30h pour l’équipe de Zhang (Zhang 
et al., 1989). 
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Pour qu’un ovocyte puisse être fécondé, il doit achever sa maturation nucléaire et 
cytoplasmique. La maturation cytoplasmique repose principalement sur l’accumulation de 
protéines et d’ARNm dans l’ovocyte (Grondahl et al., 1993). La maturation nucléaire repose 
sur la reprise de la méiose et le développement jusqu’au stade de métaphase II, ce qui peut 
être facilement évalué par des colorations spécifiques de l’ADN. En l’absence de technique de 
FIV conventionnelle efficace, la plupart des études portant sur la MIV des ovocytes se sont 
intéressées à leur maturation nucléaire, d’avantage qu’à leur maturation cytoplasmique pour 
laquelle le seul critère fiable est leur aptitude à produire un embryon. Lorsque des 
modifications cytoplasmiques au cours de la maturation, comme par exemple la migration des 
granules corticaux ou des mitochondries on été décrites (Grondahl et al., 1995; Goudet et al., 
1997; Aguilar et al., 2002; Carneiro et al., 2002), leur importance en matière de compétence 
ovocytaire n’a pas été explorée. 
Lorsque l’ovocyte est soustrait à l’environnement folliculaire, la méiose reprend 
spontanément, la chromatine des ovocytes se condense ce qui bloque la transcription ; il serait 
évidemment préférable que le stock de protéines et d’ARNm soit complet avant que la méiose 
ne reprenne (Sirard, 2001). C’est dans cette logique que des conditions de milieu qui 
maintiennent le blocage méiotique tout en maintenant la transcription avant culture 
d’ovocytes bovins permettent d’améliorer les taux d’embryons produits (Fouladi Nashta et 
al., 1998; Hashimoto et al., 2002). Cette même piste permettra peut être de mieux comprendre 
les mécanismes du blocage de la méiose de l’ovocyte équin et d’améliorer leur maturation 
cytoplasmique. 
 
UTILISATIONS DES OVOCYTES : TECHNIQUES DE REPRODUCTION ASSISTEE 
 
Au cours des dix dernières années, les techniques de reproduction assistée chez le cheval ont 
été largement développées. Cependant, la plupart de ces techniques requièrent des 
équipements spécifiques et une expertise particulière ce qui explique qu’elles restent 
principalement mises en œuvre dans des laboratoires spécialisés.  
La fécondation in vitro (FIV) conventionnelle reste actuellement peu utilisable chez la jument 
et aucune technique reproductible de FIV n’a encore été mise au point. Les raisons invoquées 
concernent principalement l’absence d’une méthode efficace de capacitation des 
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spermatozoïdes équins (Alm et al., 2001), les changements dans la zone pellucide 
(Dell'Aquila et al., 1999; Hinrichs et al., 2002) ou une maturation in vitro des ovocytes 
imparfaite (Li et al., 2001). A ce jour, le seul traitement qui induise la capacitation, la réaction 
acrosomiale des spermatozoïdes équins et qui permette leur pénétration dans l’ovocyte est 
l’ionophore calcique A23187 (Zhang et al., 1990; Alm et al., 2001; Hinrichs et al., 2002). 
C’est par ailleurs le traitement de capacitation utilisé pour produire les deux seuls poulains 
nés après FIV d’ovocytes maturés in vivo (Palmer et al., 1991; Bezard et al., 1992). Pour 
contourner ces difficultés, différentes approches pour produire des embryons à partir 
d’ovocytes soit in vitro, soit in vivo ont été explorées. Parmi celles-ci, le transfert intra-
folliculaire d’ovocytes, le transfert intra-salpyngien d’ovocytes et l’injection intra-
cytoplasmique de spermatozoïde. 
 
Transfert d’Ovocyte Intra-Folliculaire (TOIF) 
 
La technique consiste à injecter un ou plusieurs ovocytes dans le follicule préovulatoire d’une 
receveuse afin que ceux-ci trouvent les conditions favorables à leur maturation et soient 
ovulés en même temps que l’ovocyte du follicule préovulatoire. Le transfert intra-folliculaire 
a été initialement tenté chez le babouin, le bovin et le porc mais toujours sans succès, 
probablement suite aux dommages subis par le follicules lors des manipulations (Fleming et 
al., 1985; Hinrichs et Digiorgio, 1991). Grâce à l’anatomie particulière de son ovaire 
présentant une médullaire périphérique et une tunique albuginée épaisse et résistante la 
jument constitue un modèle privilégié pour l’étude du TOIF. Pratiquement, la procédure 
s’apparente à celle décrite pour l’ovum pick up. Le follicule préovulatoire est ponctionné et 
quelques millilitres de liquide folluclaire sont aspirés. Les ovocytes sont injectés dans le 
follicule et le circuit est flushé avec le liquide folliculaire initialement prélevé. Hinrichs et Di 
Giorgio (Hinrichs et Digiorgio, 1991) ont développé la technique et ont été les premiers à 
obtenir des embryons équins après transfert d’ovocytes immatures dans des follicules 
préovulatoires. La technique a été ensuite utilisée pour l’étude endocrinologique de la liqueur 
folliculaire au cours de la maturation folliculaire et celle des taux de maturation ovocytaire 
(Goudet et al., 1997). Plus récemment, des embryons ont été obtenus après TOIF d’ovocytes 
préalablement maturés in vitro (Deleuze et al., 2009). Les taux rapportés d’embryons en excès 
par rapport aux ovocytes des receveuses varient de 12,8% (6 embryons en excès / 45 ovocytes 
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transférés) après transfert d’ovocytes immatures et 5,5% ( 3/55) après transfert d’ovocytes 
maturés 30h in vitro pour Deleuze et collaborateurs (Deleuze et al., 2009) et 12 embryons en 
excès récoltés après transfert de 135 ovocytes immatures (8.9%) pour Hinrichs et Di Giorgio 
(Hinrichs et Digiorgio, 1991). Le TOIF semble augmenter l’incidence des follicules 
anovulatoires mais il reste cependant une procédure relativement simple et peu invasive qui 
pourrait être envisagée pour contourner l’absence de protocoles efficaces de superovulation 
chez la jument (Deleuze et al., 2009). 
 
Transfert d’Ovocytes intra-salpyngien (Oocyte Transfer, OT) 
 
La technique consiste à transférer chirurgicalement un ou plusieurs ovocytes d’une donneuse 
dans l’oviducte d’une receveuse. Brièvement, une laparotomie par le flanc permet l’accès à 
l’ovaire et à l’oviducte, une pipette est introduite dans sa lumière et les ovocytes y sont 
déposés (Deleuze et al., 2008). Les ovocytes peuvent être maturés in vivo et récoltés à partir 
d’un follicule préovulatoire ou bien être obtenus à partir de follicules en dioestrus et ensuite 
maturés in vitro. La receveuse est inséminée avant et après transfert des ovocytes afin que  
la fécondation et le développement embryonnaire se déroulent dans l’oviducte et dans 
l’utérus. Alternativement, les spermatozoïdes peuvent être déposés dans l’oviducte en même 
temps que les ovocytes ; on parlera alors de GIFT pour  « Gamete Intra-Falopian Transfer ». 
L’utilisation de sperme frais pour le GIFT donne de meilleurs résultats que le sperme congelé 
(Coutinho da Silva et al., 2002), mais le transfert d’ovocytes seuls suivi de l’insémination de 
la receveuse est plus largement utilisé. L’application clinique majeure du transfert intra-
salpyngien d’ovocytes concerne les juments qui souffrent de pathologies utérines, cervicales 
ou salpyngiennes qui ne leur permettent pas de produire un embryon qui pourrait être collecté 
et transféré dans l’utérus d’une jument receveuse. Bien qu’il ait été démontré que des juments 
cycliques et non-cycliques pouvaient être utilisées comme receveuses sans affecter le taux de 
gestation (Carnevale et al., 2005), et que certaines études rapportent l’utilisation de brebis 
comme receveuses (Wirtu et al., 2004), la plupart des transferts utilisent des juments 
cycliques dont l’ovocyte du follicule dominant a été retiré avant transfert afin d’éviter les 
manipulations hormonales des juments non-cyclées destinées à mimer la phase oestrale. 
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Le premier transfert d’ovocytes chez la jument a été rapporté par Mac Kinnon et 
collaborateurs (McKinnon et al., 1988), mais leurs taux de blastocystes et ceux des études 
consécutives (Zhang et al., 1989; Ray et al., 1994) sont restés globalement bas. Des études 
plus récentes utilisant des ovocytes issus de follicules préovulatoires, maturés in vivo avec 
(Hinrichs et al., 1997) ou sans (Carnevale et Ginther, 1995) maturation in vitro avant transfert 
ont permis d’obtenir des taux de blastocystes avoisinant les 85%. Le transfert d’ovocytes dans 
l’oviducte d’une receveuse peut actuellement être considéré comme une solution alternative 
au transfert d’embryon chez les juments infertiles (Hinrichs et al., 2002; Carnevale, 2004). Le 
premier poulain issu du transfert d’ovocytes récoltés à partir d’ovaires après la mort de la 
jument donneuse et ensuite maturés in vitro, est né en 2003 (Carnevale et al., 2003). Les 
mêmes auteurs rapportent un taux de développement embryonnaire de 15% (n= 191) après 
transfert d’ovocytes collectés post-mortem à partir de juments de grande valeur (Carnevale et 
al., 2004). Les taux de développement embryonnaire après transfert intra-salpyngien 
d’ovocytes maturés in vitro rapportés dans la littérature sont variables : 7% (2/29) (Scott et 
al., 2001), 15% (11/73) et 18% (13/73) (Preis et al., 2004), 13% (15/114) (Deleuze et al., 
2008). Même les taux les plus élevés : 24,1% (2/29) (Zhang et al., 1989) et 32,5% (13/40) 
(Deleuze et al., 2009) restent plus faibles que ceux obtenus après transfert d’ovocytes maturés 
in vivo et collectés à partir de follicules préovulatoires qui varient de 73% à 83% (Carnevale 
et Ginther, 1995; Hinrichs et al., 1998; Scott et al., 2001; Carnevale et al., 2004). Un facteur 
majeur affectant le taux de succès reste l’âge de la jument donneuse. Les ovocytes de juments 
donneuses âgées présentent davantage d’anomalies morphologiques (Carnevale et al., 1999) 
et produisent significativement moins de vésicules embryonnaires (Carnevale et Ginther, 
1995). 
 
Injection Intra-Cytoplasmique de Spermatozoïde (Intra-Cytoplasmic Sperm Injection : ICSI) 
 
Alors que les techniques conventionnelles de FIV restent décevantes dans l’espèce équine, 
l’ICSI s’est avérée une méthode efficace pour réaliser la fécondation in vitro des ovocytes 
équins (Squires et al., 2003; Hinrichs, 2005; Galli et al., 2007). 
La technique repose sur la micromanipulation d’un spermatozoïde qui est injecté dans 
l’ooplasme d’un ovocyte dénudé en métaphase II. Pratiquement, l’ovocyte est immobilisé et à 
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l’aide d’un micro-injecteur, un spermatozoïde est déposé dans le cytoplasme. Cette technique 
élimine la difficulté de la capacitation du sperme équin, du passage de la zone pellucide de 
l’ovocyte et permet même l’usage de sperme de qualité médiocre ou d’étalons 
oligospermiques. Les résultats avec du sperme frais et du sperme congelé sont comparables 
(Choi et al., 2002) pour autant qu’un spermatozoide mobile soit sélectionné pour l’injection 
intra-cytoplasmique (Lazzari et al., 2002). Une fois la fécondation obtenue, l’ovocyte peut 
éventuellement être activé chimiquement. Ensuite, l’embryon doit encore être cultivé jusqu’au 
stade morula ou blastocyste afin de pouvoir être transféré dans l’utérus d’une jument 
receveuse. Cette étape de culture in vitro reste délicate et les jeunes embryons issus de l’ICSI 
peuvent alternativement être transférés dans l’oviducte d’une jument receveuse afin d’y 
poursuivre leur développement. La culture des embryons peut également être réalisée in vivo 
dans les oviductes de brebis avant d’être transférés dans l’utérus d’une jument receveuse 
(Hinrichs, 2005). 
Depuis la naissance en 1996 d’un premier poulain né après ICSI (Squires et al., 1996), la 
technique n’a cessé de s’améliorer et plusieurs poulains sont nés depuis en utilisant cette 
méthode (Squires et al., 1996; Mc Kinnon et al., 2000; Li et al., 2001; Galli et al., 2002). Des 
études récentes rapportent des taux de clivage après ICSI de 50-80% (Choi et al., 2002). 
Malheureusement, seul un faible pourcentage de ces zygotes clivés poursuivent leur 
développement en culture jusqu’à former un blastocyste. Différents milieux de culture des 
jeunes embryons jusqu’au stade où ils peuvent être transférés ont été investigués : G1.2 (Choi 
et al., 2002), DMEM-F12 et CZB (Choi et al., 2004), et du SOF modifié (Galli et al., 2002) 
mais les taux de développement jusqu’au stade blastocyste dans ces études sont restés faibles 
(4 à 16%). D’autres ont étudié les effets de co-cultures avec différents types cellulaires : des 
cellules Vero (Dell'Aquila et al., 1997), des cellules épithéliales de l’oviducte (Battut et al., 
1991), des cellules de la granulosa (Rosati et al., 2002), ou des cellules du cumulus (Li et al., 
2001) ; mais les taux de blastocystes sont restés faibles (4 à 16%) pour tous ces milieux. Par 
contre, la mise en culture des zygotes potentiels (soit les ovocytes après ICSI) in vivo dans 
l’oviducte d’une jument (Choi et al., 2004) ou d’une brebis receveuse (Galli et al., 2002; 
Lazzari et al., 2002) permet un meilleur taux de développement embryonnaire 
(approximativement 36%) (Galli et al., 2007), les meilleurs résultats ayant été obtenus après 
culture dans l’oviducte d’une brebis (45%) (Galli et al., 2002; Lazzari et al., 2002). 
Cependant, récemment un milieu de culture in vitro utilisant du DMEM-F12 sous atmosphère 
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mixte contrôlée a permis d’obtenir des taux de développement de blastocystes (27-38%) se 
rapprochant de ces résultats (Choi et al., 2006; Choi et al., 2006; Galli et al., 2007). 
 
CONCLUSION 
 
La qualité de la maturation ovocytaire constitue un élément clé pour la mise en œuvre des 
techniques qui viennent d’être abordées. Les ovocytes maturés in vivo représentent les 
meilleurs candidats pour leur application. Malheureusement, la jument étant une espèce 
mono-ovulante chez qui la superovulation est décevante, ces ovocytes maturés in vivo restent 
peu nombreux et difficiles à obtenir. Le grand nombre d’ovocytes nécessaires à la recherche 
et à ses applications justifie les efforts pour améliorer les résultats de MIV. La compétence 
ovocytaire peut être mesurée par le taux de production de blastocystes après fécondation. 
Celui-ci dépend, non seulement du milieu de culture de l’embryon, mais aussi des conditions 
de maturation de l’ovocyte lui même. Les conditions de maturation in vitro de l’ovocyte sont 
déterminantes pour son aptitude ultérieure à voir se développer un embryon. Galli et 
collaborateurs (Galli et al., 2007) ont récemment mis en évidence une amélioration 
significative de leurs taux de clivage et de développement des blastocystes après ICSI suite au 
changement de leur milieu de maturation sans amélioration significative de leurs taux de 
métaphase II. Ceci illustre l’importance de la compétence ovocytaire acquise durant la MIV. 
Des progrès énormes ont été accomplis dans le domaine de la récolte et la manipulation des 
ovocytes équins. Ceci a conduit au développement de techniques de reproduction assistée et 
d’applications cliniques et commerciales qui permettent dorénavant d’obtenir des descendants 
d’étalons et de juments de faible fertilité ou de sauver leur potentiel génétique après leur mort. 
  
129 
Références 
 
AGUILAR J., LOSINNO L., KONCURAT M., MIRAGAYA M.H. Nuclear cytoplasmic and 
mitochondrial paterns of ovulated oocytes in young and aged mares. Theriogenology, 2002, 
58, 689-692. 
ALM H., TORNER H. In vitro maturation of horse oocytes. Theriogenology, 1994, 42, 345-
349. 
ALM H., TORNER H., BLOTTNER S., NURNBERG G., KANITZ W. Effect of sperm 
cryopreservation and treatment with calcium ionophore or heparin on in vitro fertilization of 
horse oocytes. Theriogenology, 2001, 56, 817-829. 
BATTUT I., BEZARD J., PALMER E. Establishment of equine oviduct cell monolayers for 
co-culture with early equine embryos. J. Reprod. Fertil. Suppl., 1991, 44, 393-403. 
BEZARD J., GOUDET G., DUCHAMP G., PALMER E. Preovulatory maturation of ovarian 
follicles and oocytes in unstimulated and superovulatory mares. biol Reprod Mono, 1995, 1, 
261-271. 
BEZARD J., MAGISTRINI M., BATTUT I., DUCHAMP G., PALMER E. Fecondation in 
vitro chez les équidés. Rec Med Vet, 1992, 168, 993-1003. 
BEZARD J., MEKARSKA A., GOUDET G., DUCHAMP G., PALMER E. Timing of in 
vivo maturation of equine preovulatory oocytes and competence for in vitro maturation of 
immature oocytes collected simultaneously. Equine Vet. J. Suppl., 1997, 33-37. 
BLONDIN P., SIRARD M.A. Oocyte and follicular morphology as determining 
characteristics for developmental competence in bovine oocytes. Mol. Reprod. Dev., 1995, 41, 
54-62. 
BRACHER V., PARLEVIET J., FAZELI A.R., PIETERSE M.C., VOS P., DIELEMAN S.J., 
TAVERNE M., COLENBRANDER B. Repeated transvaginal ultrasound-guided follicle 
aspiration in the mare. Equine Vet. J., 1993, 15, 75-78. 
BRUCK I., RAUN K., SYNNESTVEDT B., GREVE T. Follicle aspiration in the mare using 
a transvaginal ultrasound-guided technique. Equine Vet. J., 1992, 24, 58-59. 
  
130 
CAILLAUD M., REIS A.P., ACHARD E., SEIGNOBOS F., PALMER E. Oocyte maturation 
in aportable incubator: an alternative for laboratories situated far from abattoirs. In: 7th. 
International Symposium on Equine Embry Transfer, Cambridge, UK, 2008, 10-11. 
CARNEIRO G.F., LIU I.K., HYDE D., ANDERTSON G.B., LORENZO P.L., BALL B.A. 
Quantification and distribution of equine oocyte cortical granules during meiotic maturation 
and after activation. Mol. Reprod. Dev., 2002, 63, 451-458. 
CARNEVALE E., COUTINHO DA SILVA M.A., PREIS K.A., STOKES J.E., SQUIRES 
E.L. Establishment of pregnancies from oocytes collected from ovaries of euthanized mares. 
In: 50th Annual Convention of the American Association of Equine Practitioners, Denver 
(CO), 2004, AAEP, 531-533. 
CARNEVALE E., USON M., BOZZOLA J., KING S., SCHMITT S., GATES H. 
Comparison of oocytes from young and old mares with light and electron microscopy. 
Theriogenology, 1999, 51, 299. 
CARNEVALE E.M. Oocyte transfer and gamete intrafallopian transfer in the mare. Anim. 
Reprod. Sci., 2004, 82-83, 617-624. 
CARNEVALE E.M., COUTINHO DA SILVA M.A., MACLELLAN L.J., SEIDEL G.E., 
JR., SQUIRES E.L. Use of parentage testing to determine optimum insemination time and 
culture media for oocyte transfer in mares. Reproduction, 2004, 128, 623-628. 
CARNEVALE E.M., COUTINHO DA SILVA M.A., PANZANI D., STOKES J.E., 
SQUIRES E.L. Factors affecting the success of oocyte transfer in a clinical program for 
subfertile mares. Theriogenology, 2005, 64, 519-527. 
CARNEVALE E.M., GINTHER O.J. Defective oocytes as a cause of subfertility in old 
mares. biol Reprod Mono, 1995, 1, 209-214. 
CARNEVALE E.M., MACLELLAN L.J., COUTINHO DA SILVA M.A., SQUIRES E.L. 
Pregnancies attained after collection and transfer of oocytes from ovaries of five euthanatized 
mares. J. Am. Vet. Med. Assoc., 2003, 222, 60-62. 
CHOI Y.H., LOVE C.C., LOVE L.B., VARNER D.D., BRINSKO S., HINRICHS K. 
Developmental competence in vivo and in vitro of in vitro-matured equine oocytes fertilized 
  
131 
by intracytoplasmic sperm injection with fresh or frozen-thawed spermatozoa. Reproduction, 
2002, 123, 455-465. 
CHOI Y.H., LOVE C.C., VARNER D.D., HINRICHS K. Equine blastocyst development 
after intracytoplasmic injection of sperm subjected to two freeze-thaw cycles. 
Theriogenology, 2006, 65, 808-819. 
CHOI Y.H., LOVE L.B., VARNER D.D., HINRICHS K. Factors affecting developmental 
competence of equine oocytes after intracytoplasmic sperm injection. Reproduction, 2004, 
127, 187-194. 
CHOI Y.H., LOVE L.B., VARNER D.D., HINRICHS K. Holding immature equine oocytes 
in the absence of meiotic inhibitors: Effect on germinal vesicle chromatin and blastocyst 
development after intracytoplasmic sperm injection. Theriogenology, 2006, 66, 955-963. 
CHOI Y.H., ROASA L.M., LOVE C.C., VARNER D.D., BRINSKO S.P., HINRICHS K. 
Blastocyst formation rates in vivo and in vitro of in vitro-matured equine oocytes fertilized by 
intracytoplasmic sperm injection. Biol. Reprod., 2004, 70, 1231-1238. 
CHOI Y.H., SHIN T., LOVE C.C., JOHNSON C., VARNER D.D., WESTHUSIN M.E., 
HINRICHS K. Effect of co-culture with theca interna on nuclear maturation of horse oocytes 
with low meiotic competence, and subsequent fusion and activation rates after nuclear 
transfer. Theriogenology, 2002, 57, 1005-1011. 
COOK N.L., SQUIRES E.L., RAY B.S., JASKO D.J. Transvaginal ultrasound-guided 
follicular aspiration of equine oocytes. Equine Vet. J., 1993, 15, 71-74. 
COUTINHO DA SILVA M.A., CARNEVALE E.M., MACLELLAN L.J., PREIS K.A., 
LEAO K.M., SQUIRES E.L. Use of fresh, cooled and frozen semen during gamete 
intrafallopian transfer in mares. Theriogenology, 2002, 58, 763-766. 
DEL CAMPO M.R., DONOSO M.X., PARRISH J.J., GHINTER O.J. In vitro fertilization of 
in vitro matured equine oocytes. Equine Vet Sci, 1990, 10, 18-22. 
DEL CAMPO M.R., DONOSO X., PARRISH J.J., GINTHER O.J. Selection of follicles, 
preculture oocyte evaluation, and duration of culture for in vitro maturation of equine oocytes. 
Theriogenology, 1995, 43, 1141-1153. 
  
132 
DELEUZE S., DUBOIS C.S., CAILLAUD M., BRUNEAU B., GOUDET G., DUCHAMP 
G. Influence of cysteamine on in vitro maturation, in vitro and in vivo fertilization of equine 
oocytes. Reprod. Domest. Anim., 2008, in press. 
DELEUZE S., GOUDET G., CAILLAUD M., LAHUEC C., DUCHAMP G. Efficiency of 
embryonic development after Intra-Follicular and Intra-Oviductal transfer of in vitro and in 
vivo matured horse oocytes. Theriogenology, 2009, 72, 203-209. 
DELL'AQUILA M.E., CHO Y.S., MINOIA P., TRAINA V., LACALANDRA G.M., 
MARITATO F. Effects of follicular fluid supplementation of in-vitro maturation medium on 
the fertilization and development of equine oocytes after in-vitro fertilization or 
intracytoplasmic sperm injection. Hum. Reprod., 1997, 12, 2766-2772. 
DELL'AQUILA M.E., DE FELICI M., MASSARI S., MARITATO F., MINOIA P. Effects of 
fetuin on zona pellucida hardening and fertilizability of equine oocytes matured in vitro. Biol. 
Reprod., 1999, 61, 533-540. 
DESJARDINS M., KING W.A., BOUSQUET D. In vitro maturation of horse oocytes. 
Theriogenology, 1985, 23, 187. 
DUCHAMP G., BEZARD J., PALMER E. Oocyte yield and the consequences of puncture of 
all follicles larger than 8 millimeters in mares. In: 6th International Symposium on Equine 
Reproduction, Caxambu (BRA), 1994, Society for the Study of Reproduction, Ann Arbor 
(USA), 233-241. 
DUCHAMP G., BEZARD J., PALMER E. Oocyte yield and the consequences of puncture of 
all follicles larger than 8 millimeters in mares. Biol Reprod Monogr, 1995, 1, 233-241. 
DUCHAMP G., BOUR B., COMBARNOUS Y., PALMER E. Alternative solutions to hCG 
induction of ovulation in the mare. J. Reprod. Fertil. Suppl., 1987, 35, 221-228. 
FLEMING A.D., SALGADO R., KUEHL T.J. Maturation of baboon or cow oocytes 
transplanted into a surrogate dominant follicle in vivo. Theriogenology, 1985, 23, 193. 
FOULADI NASHTA A.A., WADDINGTON D., CAMPBELL K.H. Maintenance of bovine 
oocytes in meiotic arrest and subsequent development In vitro: a comparative evaluation of 
antral follicle culture with other methods. Biol. Reprod., 1998, 59, 255-262. 
  
133 
FRANZ L.C., CHOI Y.H., SQUIRES E.L., SEIDEL G.E., JR., HINRICHS K. Effects of 
roscovitine on maintenance of the germinal vesicle in horse oocytes, subsequent nuclear 
maturation, and cleavage rates after intracytoplasmic sperm injection. Reproduction, 2003, 
125, 693-700. 
FULKA J., JR., OKOLSKI A. Culture of horse oocytes in vitro. J. Reprod. Fertil., 1981, 61, 
213-215. 
GABLE T.L., WOODS G.L. Confocal microscopy of germinal vesicle-stage equine oocytes. 
Theriogenology, 2001, 55, 1417-1430. 
GALLI C., COLLEONI S., DUCHI R., LAGUTINA I., LAZZARI G. Developmental 
competence of equine oocytes and embryos obtained by in vitro procedures ranging from in 
vitro maturation and ICSI to embryo culture, cryopreservation and somatic cell nuclear 
transfer. Anim. Reprod. Sci., 2007, 98, 39-55. 
GALLI C., CROTTI G., DUCHI R., MARI G., ZAGAGLIA G., DUCHAMP G., DAELS P., 
LAZZARI G. Frozen-thawed embryos produced by Ovum Pick Up of immature oocytes and 
ICSI are capable to establish pregnancies in the horse. Theriogenology, 2002, 58, 705-708. 
GALLI C., CROTTI G., NOTARI C., TURINI P., DUCHI R., LAZZARI G. Embryo 
production by ovum pick up from live donors. Theriogenology, 2001, 55, 1341-1357. 
GOUDET G., BELIN F., BEZARD J., GERARD N. Maturation-promoting factor (MPF) and 
mitogen activated protein kinase (MAPK) expression in relation to oocyte competence for in 
vitro maturation in the mare. Mol. Hum. Reprod., 1998, 4, 563-570. 
GOUDET G., BEZARD J., BELIN F., DUCHAMP G., PALMER E., GERARD N. Oocyte 
competence for in vitro maturation is associated with histone H1 kinase activity and is 
influenced by estrous cycle stage in the mare. Biol. Reprod., 1998, 59, 456-462. 
GOUDET G., BEZARD J., DUCHAMP G., GERARD N., PALMER E. Equine oocyte 
competence for nuclear and cytoplasmic in vitro maturation: effect of follicle size and 
hormonal environment. Biol. Reprod., 1997, 57, 232-245. 
GOUDET G., BEZARD J., DUCHAMP G., PALMER E. Transfer of immature oocytes to a 
preovulatory follicle: an alternative to in vitro maturation in the mare? Equine Vet. J. Suppl., 
1997, 25, 54-59. 
  
134 
GOUGEON A., TESTART J. Germinal vesicle breakdown in oocytes of human atretic 
follicles during the menstrual cycle. J Reprod Fertil, 1986, 78, 389-401. 
GRONDAHL C., GRONDAHL N., ERIKSEN T., GREVE T., HYTTEL P. In vitro 
fertilisation and initial embryogenesis in the mare. Equine Vet. J. Suppl., 1993, 15, 79-83. 
GRONDAHL C., HYTTEL P., GRONDAHL M.L., ERIKSEN T., GOTFREDSEN P., 
GREVE T. Structural and endocrine aspects of equine oocyte maturation in vivo. Mol. 
Reprod. Dev., 1995, 42, 94-105. 
GUIGNOT F., BEZARD J., PALMER E. Effect of time during transport of excised mare 
ovaries on oocyte recovery rate and quality after in vitro maturation. Theriogenology, 1999, 
52, 757-766. 
HASHIMOTO S., MINAMI N., TAKAKURA R., IMAI H. Bovine immature oocytes acquire 
developmental competence during meiotic arrest in vitro. Biol. Reprod., 2002, 66, 1696-1701. 
HAWLEY L.R., ENDERS A.C., HINRICHS K. Comparison of equine and bovine oocyte-
cumulus morphology within the ovarian follicle. Biol Reprod Monogr, 1995, 1, 243-252. 
HINRICHS K. The relationship of follicle atresia to follicle size, oocyte recovery rate on 
aspiration, and oocyte morphology in the mare. Theriogenology, 1991, 36, 157-168. 
HINRICHS K. Update on equine ICSI and cloning. Theriogenology, 2005, 64, 535-541. 
HINRICHS K., CHOI Y.H., LOVE L.B., VARNER D.D., LOVE C.C., WALCKENAER 
B.E. Chromatin configuration within the germinal vesicle of horse oocytes: changes post 
mortem and relationship to meiotic and developmental competence. Biol. Reprod., 2005, 72, 
1142-1150. 
HINRICHS K., DIGIORGIO L.M. Embryonic development after intra-follicular transfer of 
horse oocytes. J. Reprod. Fertil. Suppl., 1991, 44, 369-374. 
HINRICHS K., KENNEY R.M. A colpotomy procedure to increase recovery rates on 
aspiration of equine preovulatory follicles. Theriogenology, 1987, 27, 237. 
HINRICHS K., LOVE C.C., BRINSKO S.P., CHOI Y.H., VARNER D.D. In vitro 
fertilization of in vitro-matured equine oocytes: effect of maturation medium, duration of 
  
135 
maturation, and sperm calcium ionophore treatment, and comparison with rates of fertilization 
in vivo after oviductal transfer. Biol. Reprod., 2002, 67, 256-262. 
HINRICHS K., MARTIN M.G., SCHMIDT A.L., FRIEDMAN P.P. Effect of follicular 
components on meiotic arrest and resumption in horse oocytes. J. Reprod. Fertil., 1995, 104, 
149-156. 
HINRICHS K., MATTHEWS G.L., FREEMAN D.A. Effect of oocyte maturation time on 
embryo development after oocyte transfer in the mare. Theriogenology, 1997, 47, 392. 
HINRICHS K., MATTHEWS G.L., FREEMAN D.A., TORELLO E.M. Oocyte transfer in 
mares. J. Am. Vet. Med. Assoc., 1998, 212, 982-986. 
HINRICHS K., SCHMIDT A.L., FRIEDMAN P.P., SELGRATH J.P., MARTIN M.G. In 
vitro maturation of horse oocytes: characterization of chromatin configuration using 
fluorescence microscopy. Biol. Reprod., 1993, 48, 363-370. 
HINRICHS K., WILLIAMS K.A. Relationships among oocyte-cumulus morphology, 
follicular atresia, initial chromatin configuration, and oocyte meiotic competence in the horse. 
Biol. Reprod., 1997, 57, 377-384. 
KANITZ W., BECKER F., ALM H., TORNER H. Ultrasound-guided follicular aspiration in 
mares. Biol Reprod Monogr, 1995, 1, 225-231. 
LAZZARI G., CROTTI A., TURINI P., DUCHI R., MARI G., ZAVAGLIA G., 
BARBACINI S., GALLI A. Equine embryos at the compacted morula and blastocyst stage 
can be obtained by intracytoplasmic injection (ICSI) of in vitro matured oocytes with frozen-
thawed spermatozoa from semen of different feritilities. Theriogenology, 2002, 58, 709-712. 
LI X., MORRIS L.H., ALLEN W.R. Influence of co-culture during maturation on the 
developmental potential of equine oocytes fertilized by intracytoplasmic sperm injection 
(ICSI). Reproduction, 2001, 121, 925-932. 
LORENZO P.L., LIU I.K., CARNEIRO G.F., CONLEY A.J., ENDERS A.C. Equine oocyte 
maturation with epidermal growth factor. Equine Vet. J., 2002, 34, 378-382. 
LOVE L.B., CHOI Y.H., LOVE C.C., VARNER D.D., HINRICHS K. Effect of ovary storage 
and oocyte transport method on maturation rate of horse oocytes. Theriogenology, 2003, 59, 
765-774. 
  
136 
MC KINNON A.O., LACHAM-KAPLAN O., TROUNSON A. Pregnancies produced from 
fertile and infertile stallions by intracytoplasmic sperm injection (ICSI) of single 
frozen/thawed spermatozoa into in vivo-matured mare oocytes. J. Reprod. Fertil., 2000, 56, 
513-517. 
MCKINNON A.O., CARNEVALE E.M., SQUIRES E.L. Heterogenous and xenogenous 
fertilization of equine oocytes. J Equine Vet Sci, 1988, 8, 143-147. 
MEINTJES M., BELLOW M.S., PAUL J.B., BROUSSARD J.R., LI L.Y., PACCAMONTI 
D., EILTS B.E., GODKE R.A. Transvaginal ultrasound-guided oocyte retrieval from cyclic 
and pregnant horse and poney mares for in vitro fertilization. Biol Reprod Monogr, 1995, 1, 
281-292. 
OKOLSKI A., BEZARD J., MAGISTRINI M., PALMER E. Maturation of oocytes from 
normal and atretic equine ovarian follicles as affected by steroid concentrations. J. Reprod. 
Fertil. Suppl., 1991, 44, 385-392. 
PALMER E., BEZARD J., MAGISTRINI M., DUCHAMP G. In vitro fertilization in the 
horse. A retrospective study. J. Reprod. Fertil. Suppl., 1991, 44, 375-384. 
PALMER E., DUCHAMP G., BEZARD J., MAGISTRINI M., KING A., BOUSQUET D., 
BETTERIDGE K. Recovery of follicular fluid and oocytes of mares by non-surgical 
punctures of the preovulatory follicle. Theriogenology, 1986, 25, 178. 
PEDERSEN H.G., WATSON E.D., TELFER E.E. Effect of ovary holding temperature and 
time on equine granulosa cell apoptosis, oocyte chromatin configuration and cumulus 
morphology. Theriogenology, 2004, 62, 468-480. 
PINCUS G., ENZEMANN E.V. The comparative behavior of mammalian eggs in vivo and in 
vitro. J. Exp. Med., 1935, 62, 665-675. 
PREIS K.A., CARNEVALE E.M., COUTINHO DA SILVA M.A., CARACCIOLO DI 
BRIENZA V., GOMES G.M., MACLELLAN L.J., SQUIRES E.L. In vitro maturation and 
transfer of equine oocytes after transport of ovaries at 12 or 22 degrees C. Theriogenology, 
2004, 61, 1215-1223. 
RAY B.S., SQUIRES E.L., COOK N.L. Pregnancy following gamete intrafallopian transfer 
in the mare. J Equine Vet Sci, 1994, 14, 27-30. 
  
137 
ROSATI I., BERLINGUER F., BOGLIOLO L., LEONI G., LEDDA S., NAITANA S. The 
effect of co-culture on the development of in vitro matured equine oocytes after 
intracytoplastic sperm injection. Equine Vet. J., 2002, 34, 673-678. 
SCOTT T.J., CARNEVALE E.M., MACLELLAN L.J., SCOGGIN C.F., SQUIRES E.L. 
Embryo development rates after transfer of oocytes matured in vivo, in vitro, or within 
oviducts of mares. Theriogenology, 2001, 55, 705-715. 
SHABPAREH V., SQUIRES E.L., SEIDEL G.E., JASKO D.J. Methods for collecting and 
maturing equine oocytes in vitro. Theriogenology, 1993, 40, 1161-1175. 
SIRARD M.A. Resumption of meiosis: mechanism involved in meiotic progression and its 
relation with developmental competence. Theriogenology, 2001, 55, 1241-1254. 
SQUIRES E.L., CARNEVALE E.M., MCCUE P.M., BRUEMMER J.E. Embryo 
technologies in the horse. Theriogenology, 2003, 59, 151-170. 
SQUIRES E.L., WILSON J.M., KATO H., BLASZCZYK A. A pregnancy after 
intracytoplasmic sperm injection into equine oocytes  matured in vitro. Theriogenology, 1996, 
45, 306. 
TREMOLEDA J.L., THARASANIT T., VAN TOL H.T., STOUT T.A., COLENBRANDER 
B., BEVERS M.M. Effects of follicular cells and FSH on the resumption of meiosis in equine 
oocytes matured in vitro. Reproduction, 2003, 125, 565-577. 
VOGELSANG M.M., KREIDER J.L., BOWEN M.J., POTTER G.D., FORREST D.W., 
KRAEMER D.C. Methods for collecting follicular oocytes from mares. Theriogenology, 
1988, 29, 1007-1018. 
WILLIS P., CAUDLE A.B., FAYRER-HOSKEN R.A. Equine oocyte in vitro maturation: 
influences of sera, time, and hormones. Mol. Reprod. Dev., 1991, 30, 360-368. 
WIRTU G., BAILEY T.L., CHAUHAN M.S., PARKER N.A., DASCANIO J.J., 
GWAZDAUSKAS F.C., LEY W.B. Xenogenous fertilization of equine oocytes following 
recovery from slaughterhouse ovaries and in vitro maturation. Theriogenology, 2004, 61, 381-
391. 
ZHANG J.J., BOYLE M.S., ALLEN W.R. Recent studies on in vitro fertilization of equine 
oocytes. Equine Vet. J., 1989, 21, 101-104. 
  
138 
ZHANG J.J., MUZS L.Z., BOYLE M.S. In vitro fertilization of horse follicular oocytes 
matured in vitro. Mol. Reprod. Dev., 1990, 26, 361-365. 
 
 
 
 
  
139 
 
CYSTEAMINE SUPPLEMENTATION OF IN VITRO 
MATURATION MEDIA  : A REVIEW.  
 
 
 
S. DELEUZE1, G. GOUDET2. 
 
1 Faculté de Médecine Vétérinaire, Département des Sciences Cliniques-Clinique Equine, 
Université de Liège, Bvd de Colonster B41, B-4000 Liège, Belgium. 
 
2 Physiologie de la Reproduction et des Comportements, INRA-CNRS-Université de Tours-
Haras Nationaux, IFR 135, 37380 Nouzilly, France. 
 
 
 
 
 
 
Reproduction in domestic animals, 2009 
 
  
140 
Content 
 
Under in vitro culture conditions, oxidative modifications of cell components via increased 
Reactive Oxygen Species (ROS), represent a major culture induced stress. Anti-oxidant 
systems such as glutathione (GSH) can attenuate the deleterious effects of oxidative stress by 
scavenging ROS. It has been suggested that GSH content in oocytes may serve as a reservoir 
protecting the zygote and the early embryos from oxidative damage before genomic activation 
and de novo GSH synthesis occur. 
Addition of low molecular weight compounds to culture media, such as cysteamine, can 
increase GSH levels by increasing cysteine uptake. Quite naturally, effects of 
supplementation of in vitro maturation (IVM) media with low molecular weight thiols have 
been studied in various species. 
This paper reviews the use of cysteamine supplementation for IVM, its effects on maturation 
rates and further embryo development. 
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Glutathione 
 
Glutathione (GSH), a tripeptide thiol (γ-glutamyl-cysteine-glycine) is the major non-protein 
sulfydryl compound in mammalian cells that plays an important role in protecting the cell 
from oxidative damage (Meister and Anderson 1983, Meister and Tate 1976). GSH cellular 
content is regulated by the γ-glutamyl cycle. The reactions involved account for the synthesis 
and degradation of GSH, and the balance of GSH transport out of the cells and that of γ-
glutamyl amino acids into the cells. GSH is synthesised within the cell in two steps. First, γ-
glutamylcysteine synthetase catalyses synthesis of γ-glutamyl-cysteine from glutamate and 
cysteine. Then, glycine is added to the C-terminal of γ-glutamyl-cysteine in the presence of 
GSH synthetase (Meister and Tate 1976).  
The first step of GSH synthesis appears to determine the upper concentration of cellular GSH 
because of a feedback inhibition by GSH (Richman and Meister 1975). It has been shown that 
GSH concentration also depends on availability of cysteine for synthesis (Furnus and de 
Matos 1999, Meister 1983). Conversely, buthionine sulfoximine (BSO) binds to and inhibits 
γ-glutamylcysteine synthetase and thus induces GSH depletion (Griffith and Meister 1979, 
Meier and Issels 1995). 
Glutathione is present in the cell either under its reduced (GSH) or oxidized form (GSSG). In 
the presence of GSH, glutathione peroxidase (GPX) catalyses the reduction of hydrogen 
peroxide to form H2O and GSSG. GSSG is reduced by glutathione reductase in the presence 
of nicotinamide adenine dinucleotide phosphate (NADPH) which maintains a high ratio 
(about 100:1) of GSH to GSSG in the cell (Meister 1983). GSH peroxidase and GSH catalase 
promote removal of hydrogen peroxide and dismutation product of superoxide radicals 
(Fridovich 1978).  
These reactions can be summarized by the following equations: 
2 GSH + H2O2   GSSG + 2 H2O 
  
2 GSSG + NADPH +H+  2GSH + NADP+ 
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Low molecular weight thiol compounds and GSH 
 
As mentioned before, GSH synthesis is limited by the availability of cysteine. Except for 
hepatocytes, which are able to synthesize cysteine from methionine via the cystathionine 
pathway, eukaryotic cells depend on extra cellular medium for the supply of cysteine (Meier 
and Issels 1995). Direct supplementation of medium with cysteine is usually avoided as 
cysteine is easily oxidized to cystine in the culture medium (Bannai 1984) and can exhibit a 
high degree of toxicity (Nishiuch et al. 1976).  
Low molecular thiols such as β-mercaptoethanol (Ishii et al. 1981), N-acetylcysteine, 
cysteamine (Meier and Issels 1995) can promote cystine uptake. These compounds share a 
free SH group as a common molecular structure. Modification of this free thiol group by 
chemical reaction to form a disulfide bond or the addition of a phosphate moiety to the thiol 
group abolishes the potential of the compound to promote cystine uptake (Meier and Issels 
1995).  
Effects of extracellular thiols on cystine uptake can be summarized in two steps: 1) formation 
of cysteine and cysteine mixed disulfides (e.g., cysteine-cysteamine) and 2) uptake of cysteine 
and/or the mixed disulfide via cellular transport systems (Meier and Issels 1995, Ishii et al. 
1981). Within the same species, activity of these transport systems vary from one cellular type 
to the other (Meier and Issels 1995). Oocytes are deficient in their capacity to take up Cystine 
(cysteine-cysteine). Cysteine is utilized by the oocyte, but it is easily oxidised to cystine in the 
culture medium. Thiol compounds react with cystine to form a mixed disulfide. The mixed 
disulfide is taken up by the cells, where it is reduced to produce a thiol compound and 
cysteine. Thiol compounds do not accumulate in the cells and escape to the medium to react 
with cystine. Thiol compounds are repeatedly taken up by the oocytes in the form of mixed 
disulfide with cysteine and return to the medium in their reduced form. Extra cellular cysteine 
may also be taken up by the oocytes by a transporter system (ASC) shared with other amino 
acids (Alanine, Serine, Cysteine) but at a very low rate as cysteine in the culture medium is 
rapidly oxidized to cystine. A schematic diagram of the action of low molecular weight thiols 
is proposed in Figure 1.  
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GSH and in vitro maturation (IVM) 
 
Under in vitro culture conditions, oxidative modifications of cell components via increased 
Reactive Oxygen Species (ROS), which are responsible for DNA damage, oxidative 
alterations of proteins and lipid peroxidation (Johnson and Nasr-Esfahani 1994), represent a 
major culture induced stress (Noda et al. 1991, Goto et al. 1993). Anti-oxidant systems can 
attenuate the deleterious effects of oxidative stress by scavenging reactive oxygen species 
(Del Corso et al. 1994). 
Low molecular weight thiols compounds have been shown to have beneficial effects on 
lymphocyte viability and enhance various cell reactions (Fanger et al. 1970). Addition of 
cysteine or β-mercaptoethanol to culture media for lymphocytes has been shown to increase 
intracellular GSH levels and prevent its decrease during proliferation (Zmuda and Friedenson 
1983). 
GSH synthesis during oocyte maturation has been reported in mouse (Calvin et al. 1986), 
hamster (Perreault et al. 1988), pig (Yoshida et al. 1993), sheep (de Matos et al. 2002a), 
bovine (de Matos et al. 1996) and equine (Luciano et al. 2006). GSH concentration is highly 
correlated with the presence of cumulus cells (Sawai et al. 1997) however, denuded oocytes 
GSH synthesis has also been shown to be stimulated by thiol compounds, although to a lesser 
extend than COCs (Yamauchi and Nagai 1999, de Matos et al. 1997). GSH contents increase 
during maturation of oocytes in the ovary and peak at the metaphase II stage (Perreault et al. 
1988) but drops rapidly in early embryos (Zuelke et al. 2003). It has been suggested that GSH 
content in oocytes may serve as a reservoir protecting the zygote and the early embryos from 
oxidative damage before genomic activation and de novo GSH synthesis occur (de Matos and 
Furnus 2000, Furnus et al. 1998). Moreover, GSH has been shown to play a role during 
fertilization by promoting male pronucleus formation (Yamauchi and Nagai 1999). Quite 
naturally, effects of supplementation of IVM media with low molecular weight thiols have 
been studied in various species. 
The following sections review the use of cysteamine supplementation for IVM media, its 
effects on IVM and further embryo development. 
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Addition of cysteamine to the IVM medium : dose effect 
 
Most commonly, IVM media have been supplemented with a dose of 100 µM of cysteamine 
in cattle, (Balasubramanian and Rho 2007, de Matos et al. 1997, de Matos et al. 1995, de 
Matos et al. 1996, de Matos et al. 2002b, Oyamada and Fukui 2004), buffalo (Gasparrini et al. 
2003, Anand et al. 2008), goats (Rodriguez-Gonzalez et al. 2003b, Urdaneta et al. 2003, Zhou 
et al. 2008), horses (Luciano et al. 2006, Deleuze et al. 2008), pigs (Kobayashi et al. 2007, 
Kobayashi et al. 2006, Song and Lee 2007), mice (Chen et al. 2005, de Matos et al. 2003), 
cats (Bogliolo et al. 2001) and dogs (Hossein et al. 2007). However, other concentrations of 
cysteamine, ranging from 50 to 500 µM, have been tested in different species. A summary of 
the different concentrations used in various species is given is Table 1. 
Effects of one given concentration of cysteamine supplementation not only depend on the 
species but also on the maturation medium. These differences between media might be 
explained by the presence and the quantities of different factors that can help protect the cell 
from oxidative damage such as citrate (Holm et al. 1999) and pyruvate (Morales et al. 1999). 
Moreover, as most media use TCM-199, it is important to bear in mind that whether the 
cystine it contains (83.2 µM) is sufficient to sustain oocyte IVM of different species is 
unknown (Zhou et al. 2008). 
 
Addition of cysteamine to the IVM medium : effect on nuclear maturation rates 
 
Cysteamine supplementation during IVM, was reported to improve nuclear maturation rates 
in dogs (Hossein et al. 2007), in mice (Chen et al. 2005), in goats (Urdaneta et al. 2003), and 
in pigs (Bing et al. 2001). However, other studies in goats (Zhou et al. 2008), pigs (Kobayashi 
et al. 2006, Song and Lee 2007, Yamauchi and Nagai 1999), horses (Luciano et al. 2006, 
Deleuze et al. 2008), buffalos (Singhal et al. 2008) and cattle (Balasubramanian and Rho 
2007, Oyamada and Fukui 2004) could not show any increase in nuclear maturation rates.  
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Addition of cysteamine to the IVM medium : effect on GSH oocyte content 
 
Cysteamine has been shown to increase intracellular GSH synthesis in bovine (de Matos et al. 
1997, de Matos et al. 1995, de Matos et al. 2002b, Oyamada and Fukui 2004, Takahashi et al. 
1993), buffalo (Gasparrini et al. 2003), canine (Hossein et al. 2007), goats (Rodriguez-
Gonzalez et al. 2003a, Zhou et al. 2008), mice (de Matos et al. 2003), horses (Luciano et al. 
2006), sheep (de Matos et al. 2002a) and pigs (Kobayashi et al. 2007, Yamauchi and Nagai 
1999). This increase in GSH content has been consistent in all reports regardless the species. 
In sheep, a concomitant decrease in hydrogen peroxide has also been demonstrated (de Matos 
et al. 2002a), illustrating the scavenging effect of GSH synthesis stimulation on ROS. 
 
Addition of cysteamine to the IVM medium : effect on male pronucleus formation 
 
Effect of cysteamine supplementation during IVM on male pronucleus formation following 
either conventional IVF or ICSI has not been extensively investigated. However, addition of 
cysteamine to the IVM medium has been shown to improve male pronucleus formation in 
goats (Rodriguez-Gonzalez et al. 2003a, Urdaneta et al. 2003), buffalos (Anand et al. 2008) 
and pigs (Bing et al. 2001, Grupen et al. 1995, Yamauchi and Nagai 1999). Only two studies, 
one in pigs (Kobayashi et al. 2006) and one in cattle (Balasubramanian and Rho 2007), 
reported a lack of effect of cysteamine on male pronucleus formation.  
 
Addition of cysteamine to the IVM medium : effect on cleavage rates 
 
Effect of cysteamine supplementation to IVM media on cleavage rates is controversial. A few 
studies have reported an increase in cleavage rates following IVM with cysteamine in goats 
(Rodriguez-Gonzalez et al. 2003a), pigs (Grupen et al. 1995), cattle (Oyamada and Fukui 
2004), and buffalos (Anand et al. 2008, Singhal et al. 2008). Conversely, many other reports 
in various species, including species where an increase has been reported, have failed to 
observe any effect of cysteamine supplementation on cleavage rates. This lack of effect has 
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been reported in pigs (Kobayashi et al. 2007, Kobayashi et al. 2006, Song and Lee 2007), 
cattle (Balasubramanian and Rho 2007, de Matos et al. 1995), buffalos (Gasparrini et al. 
2003), sheep (de Matos et al. 2002a), horses (Luciano et al. 2006, Deleuze et al. 2008) and 
mice (Chen et al. 2005, de Matos et al. 2003). 
 
Addition of cysteamine to the IVM medium : effect on blastocyst development 
 
In very few studies in pigs (Kobayashi et al. 2007, Song and Lee 2007), horse (Deleuze et al. 
2008) and mice (Chen et al. 2005), blastocyst development has not been shown to be affected 
by cysteamine supplementation. Conversely, many authors reported increased blastocyst 
development following cysteamine supplementation to the IVM medium. This has been 
observed in cattle (Balasubramanian and Rho 2007, de Matos et al. 1995, de Matos et al. 
2002b, Oyamada and Fukui 2004, Takahashi et al. 1993), buffalos (Gasparrini et al. 2003, 
Anand et al. 2008, Singhal et al. 2008), sheep (de Matos et al. 2002a), goats (Zhou et al. 
2008), pigs (Grupen et al. 1995, Kobayashi et al. 2006) and mice (de Matos et al. 2003). In 
these studies, although cleavage rates are not necessarily affected further development of the 
blastocysts obtained has been positively influenced by cysteamine supplementation.  
 
Conclusion 
 
Low molecular weight thiol compounds can increase cysteine uptake by oocytes during IVM. 
This subsequently can increase GSH content, which is a major anti-oxidant system that 
protect the cells against the deleterious effects of oxidative stress by scavenging reactive 
oxygen species. Although it generally doesn’t affect nuclear maturation rates, IVM medium 
supplementation with cysteamine can improve pronucleus formation, cleavage rates and 
further embryo development, suggesting a beneficial effect on cytoplasmic maturation and 
oocyte competence. Beneficial effects of thiol compounds supplementation to IVM media 
have been observed in many species but they appear to be highly species and dose dependant. 
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Figure 1: Proposed action of thiol compounds on cystine and cysteine utilization by oocytes. 
Adapted from Ishi and collaborators (Ishii et al. 1981). 
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Table 1: Summary of the different concentrations used in various species. 
Species Dose of Cysteamine (µM) References 
Bovine 100 (Balasubramanian and Rho 2007, de Matos 
et al. 1997, de Matos et al. 1995, de Matos et 
al. 1996, de Matos et al. 2002b, Oyamada 
and Fukui 2004) 
Buffalo 50 (Gasparrini et al. 2003, Singhal et al. 2008) 
 100 (Gasparrini et al. 2000) 
 50, 100, 200 (Anand et al. 2008) 
Ovine 50, 100, 200 (de Matos et al. 2002a) 
Caprine 100 (Rodriguez-Gonzalez et al. 2003a) 
 100, 200, 400 (Urdaneta et al. 2003) 
 50, 100, 200, 300 (Zhou et al. 2008) 
Equine 100 (Luciano et al. 2006, Deleuze et al. 2008) 
Porcine 100 (Kobayashi et al. 2007, Kobayashi et al. 
2006, Song and Lee 2007) 
 150 (Bing et al. 2001, Yamauchi and Nagai 1999) 
 50, 500 (Grupen et al. 1995) 
Canine 50, 100, 200 (Hossein et al. 2007) 
Mice 100 (Chen et al. 2005) 
 0, 25, 50, 100, 200 (de Matos et al. 2003) 
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Research on in vitro embryo production (IVP) in the equine is impeded by the limited 
availability of mature oocytes as the mare is mono ovulating and superovulation is still 
difficult (Dippert and Squires, 1994; Bezard et al., 1995; Alvarenga et al., 2001b). Despite 
recent improvement in IVM of equine oocytes, success rates of IVM in that species remain 
low in all culture media tested compared to other species (Goudet et al., 2000b). However, 
most studies have focused on the percentage of oocytes reaching the metaphase II stage 
(nuclear maturation) but few concentrated on the final oocyte competence as measured by its 
ability to develop into a blastocyst and further establish a pregnancy. Blastocyst production 
rate is influenced not only by culture environment but also by oocyte maturation conditions. 
Under in vitro culture conditions, oxidative modifications of cell components via increased 
ROS represent a major culture induced stress (Johnson and Nasr-Esfahani, 1994). Anti-
oxidant systems can attenuate the deleterious effects of oxidative stress by scavenging ROS 
(Del Corso et al., 1994). Glutathione, a tripeptide thiol, is the major non-protein sulfydryl 
compound in mammalian cells that plays an important role in protecting the cell from 
oxidative damage (Meister and Tate, 1976; Meister and Anderson, 1983). It has been 
suggested that GSH content in oocytes may serve as a reservoir protecting the zygote and the 
early embryos from oxidative damage before genomic activation and de novo GSH synthesis 
occur (Furnus et al., 1998; de Matos and Furnus, 2000). The addition of GSH synthesis 
precursors, such as cysteamine, a thiol compound, to IVM media has been shown to improve 
IVP in various species (Takahashi et al., 1993; de Matos et al., 1995; Grupen et al., 1995; de 
Matos et al., 2002a; de Matos et al., 2002b; de Matos et al., 2003; Gasparrini et al., 2003; 
Oyamada and Fukui, 2004; Balasubramanian and Rho, 2007; Anand et al., 2008; Singhal et 
al., 2008; Zhou et al., 2008). Very little information on the use of thiol compounds in the 
equine is available. 
Conventional in vitro fertilization (IVF) has not been successful in the mare, and a repeatable 
IVF technique has not yet been developed (Alm et al., 2001). To overcome the limitation of 
conventional IVF procedures, other methods to produce embryos from oocytes, either in vivo 
or in vitro, have been investigated. Among these, intra cytoplasmic sperm injection (ICSI) has 
permitted efficient equine in vitro blastocyst production (Galli et al., 2002; Lazzari et al., 
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2002; Choi et al., 2006a; Choi et al., 2006c). However, ICSI requires specific equipment and 
skills. Transfer of an immature oocyte into the preovulatory follicle of an inseminated 
recipient mare (Intra-Follicular Oocyte Transfer, IFOT) has produced embryos but the success 
rate was low (Hinrichs and Digiorgio, 1991). Similarly, oocyte transfer (OT) into the oviduct 
of an inseminated recipient mare was investigated (McKinnon et al., 1988; Carnevale, 1996; 
Hinrichs et al., 1997; Carnevale et al., 2001; Carnevale et al., 2003; Carnevale, 2004), and 
commercial programs using OT for mares with reproductive abnormalities are now available 
(Carnevale et al., 2001). Unfortunately, IFOT is poorly documented in the literature and 
reports of OT have been published by various laboratories and under various conditions, 
making comparisons between results and choosing among these as substitutive techniques to 
ICSI or embryo transfer difficult. 
The first aim of the present work was to investigate if there is an influence of 
supplementation with 100 µM of cysteamine on conventional IVF success rate. Cumulus 
oocytes complexes (COCs) retrieved by transvaginal ultrasound guided aspiration were 
matured in vitro with or without cysteamine supplementation and were then submitted to 
conventional IVF using either calcium ionophore or heparin as capacitation treatment for 
spermatozoa. A total of 131 oocytes were evaluated for evidence of sperm penetration. Both 
techniques (ionophore or heparin) yielded 6% of IVF and results were similar both for the 
cysteamine and the control group. This success rate of IVF is low compared to some 
published data (Palmer et al., 1991; Dell'Aquila et al., 1996; McPartlin et al., 2009) but 
similar to what others reported in the literature (Choi et al., 1994; Dell'Aquila et al., 1997a). 
Although, it seems likely that cysteamine did not significantly improve IVF rates under our 
conditions, our general success rates for IVF procedures may be too low for us to conclude 
definitely about the effect of cysteamine.  
As ICSI was not available to us, the second aim of this work was to determine what in 
vivo technique could best bypass the lack of an efficient conventional IVF procedure. We 
compared embryo production following transfer of in vivo recovered oocytes (1) into a 
recipient’s oviduct or (2) into her preovulatory follicle either immediately after ovum pick up 
or (3) after in vitro maturation. Recipients were inseminated with fresh semen of a stallion 
with a known normal fertility. Ten days after transfer, rates of embryos collected in excess to 
the number of ovulations were calculated and compared for each group. Embryo collection 
rates were 32.5% (13/40), 5.5% (3/55) and 12.8% (6/47) for OT, post-IVM and immediate 
IFOT respectively. OT significantly yielded more embryos than immediate and post-IVM 
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IFOT did. These results show that, when ICSI is not an option, intra-oviductal oocyte transfer 
is to be preferred to IFOT, as an in vivo alternative, to bypass the inadequacy of conventional 
in vitro fertilization and to assess oocyte developmental competence.  
After it was established that in comparison to IFOT, OT is the most reliable in vivo 
alternative to in vitro fertilization where ICSI technology is not available, this technique was 
used to assess the effect of cysteamine supplementation on nuclear maturation and oocyte 
competence. The third aim of this work was to investigate the influence of supplementation 
with 100 µM of cysteamine on in vitro nuclear and cytoplasmic maturation by specific DNA 
staining and the ability of oocytes to undergo in vivo fertilization after OT. Oocytes were 
collected by transvaginal ultrasound guided aspiration and matured in vitro with (cysteamine 
group) or without (control group) cysteamine. The nuclear stage after DNA Hoechst staining 
and the embryo yield following OT were used as a criterion for assessing nuclear and 
cytoplasmic maturation, respectively. Overall maturation rate was 52%, which is rates 
reported in the literature ranging from 40 to 70% in the equine (Goudet et al., 1997a; Bogh et 
al., 2002; Hinrichs et al., 2005; Galli et al., 2007). Nuclear maturation was not statistically 
different (p>0.05) between oocytes cultured with or without cysteamine (55% and 47% 
respectively). From 57 oocytes transferred to the oviduct in each group, the number of 
embryos collected was 10 (17%) in the control group and 5 in the cysteamine group (9%). 
Those two percentages were not statistically different (p>0.05). Contrary to the data described 
in other domestic species, there was no effect of cysteamine on in vitro nuclear maturation, or 
in vivo embryonic development under our conditions. Under our conditions, the addition of 
100 µM of cysteamine to a classic culture medium does not improve equine oocyte 
maturation or embryonic development after OT. The same dose failed to increase GSH 
content in the equine (Luciano et al., 2006). However, the effect of cysteamine 
supplementation is highly species and concentration dependant. The inadequacy of the chosen 
concentration may explain that equine embryo production has not been increased by the 
cysteamine under our conditions as opposed to what has been observed in many other species. 
Alternatively, we can hypothesize that some substances present in the IVM medium can 
interfere with GSH synthesis. This has been suggested for FSH and estradiol (Bing et al., 
2001) and, although our maturation medium is not supplemented with gonadotropins or 
estradiol, factors contained in fetal calf serum or EGF might also have an effect on GSH 
synthesis. 
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Considering its beneficial effects in many other species, supplementation with cysteamine to 
different IVM media should be further investigated in the equine. Ideally combining different 
concentrations and ICSI or OT in order to determine an optimal concentration and its effects 
on oocyte developmental competence. 
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La jument est mono-ovulante et les protocoles de superovulation restent décevants chez les 
équins (Dippert and Squires, 1994; Bezard et al., 1995; Alvarenga et al., 2001b). Ceci se 
traduit par une faible disponibilité d’ovocytes matures qui limite le développement des 
technologies de production d’embryons dans cette espèce. Malgré des projets récents en 
matière de maturation in vitro (MIV) des ovocytes, les taux de maturation chez les équins 
restent inférieurs à ceux obtenus dans d’autres espèces (Goudet et al., 2000b). Il est à noter 
que la plupart des études se sont concentrées sur le pourcentage d’ovocytes qui atteignent le 
stade de métaphase II (maturation nucléaire) négligeant la maturation cytoplasmique ou 
acquisition de la compétence ovocytaire, c’est-à-dire la capacité que doit acquérir l’ovocyte à 
être fécondé, à donner un blastocyste et à établir une gestation évolutive. Le taux de 
blastocystes produits in vitro dépend non seulement des conditions de culture mais aussi de la 
qualité de la maturation ovocytaire. 
Dans les conditions de culture in vitro, les modifications des composantes cellulaires 
consécutives à l’augmentation des formes activées de l’oxygène (en Anglais: Reactive 
Oxygen Species ou ROS) constituent un facteur de souffrance cellulaire majeur (Johnson and 
Nasr-Esfahani, 1994). Différents systèmes anti-oxydants peuvent atténuer les effets délétères 
du stress oxydant en neutralisant les ROS (Del Corso et al., 1994). Le Glutathion (GSH), un 
tripeptide porteur d’un groupement thiol (R-SH) constitue le principal agent non protéique, 
qui protège la cellule contre les dégâts induits par le stress oxydant (Meister and Tate, 1976; 
Meister and Anderson, 1983). Il a été suggéré que le GSH présent dans les ovocytes pourrait 
servir de réserve pour assurer la protection du zygote et des stades précoces de l’embryon. 
Ceci contre les souffrances dues au stress oxydant en attendant que l’activation du génome du 
jeune embryon soit effective et qu’il soit capable de produire son propre GSH pour se 
protéger (Furnus et al., 1998; de Matos and Furnus, 2000). Il a été démontré, dans différentes 
espèces, que l’ajout de précurseurs de la synthèse de GSH, comme la cystéamine qui est un 
composé porteur d’un thiol, améliore la production in vitro d’embryons (Takahashi et al., 
1993; de Matos et al., 1995; Grupen et al., 1995; de Matos et al., 2002a; de Matos et al., 
2002b; de Matos et al., 2003; Gasparrini et al., 2003; Oyamada and Fukui, 2004; 
Balasubramanian and Rho, 2007; Anand et al., 2008; Singhal et al., 2008; Zhou et al., 2008). 
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A ce jour, peu d’informations quant à l’utilisation de ces composés thiols dans l’espèce 
équine sont disponibles. 
La fécondation in vitro (FIV) conventionnelle s’est avérée peu efficace chez le cheval et on 
peut considérer que dans l’état actuel des choses aucune méthode de FIV efficace et 
reproductible n’est disponible dans cette espèce (Alm et al., 2001). Afin de dépasser cette 
difficulté, d’autres techniques visant à produire in vitro ou in vivo des embryons à partir 
d’ovocytes ont été explorées. Parmi celles-ci, l’injection intra-cytoplasmique de 
spermatozoïde (ICSI) a permis de produire in vitro des taux corrects de blastocystes (Galli et 
al., 2002; Lazzari et al., 2002; Choi et al., 2006a; Choi et al., 2006c). Cependant, cette 
technique est très exigeante en termes de matériel et d’expertise ce qui limite malgré tout son 
utilisation. Après collecte, des ovocytes ont été réinjectés dans le follicule préovulatoire d’une 
jument receveuse inséminée, afin qu’ils soient libérés au moment de l’ovulation. Cette 
technique de transfert d’ovocyte intra-folliculaire (TOIF) a permis de produire des embryons 
mais le taux de succès est resté faible (Hinrichs and Digiorgio, 1991). Une autre approche, qui 
consiste à transférer un ou plusieurs ovocytes dans l’oviducte d’une jument receveuse qui est 
inséminée, a également été explorée et des programmes commerciaux utilisant cette technique 
de transfert intra-saplyngien d’ovocyte (OT) sont actuellement disponibles pour des juments 
souffrant de pathologies qui ne permettent pas de leur faire produire un embryon par d’autres 
méthodes (McKinnon et al., 1988; Carnevale, 1996; Hinrichs et al., 1997; Carnevale et al., 
2001; Carnevale et al., 2003; Carnevale, 2004). Malheureusement, le TOIF est peu 
documenté dans la littérature et les publications portant sur le transfert d’ovocytes émanent de 
nombreuses équipes et les différences dans leur méthodologie rendent les comparaisons entre 
leurs résultats très difficiles. En l’absence d’une étude comparative des différentes techniques, 
il serait très imprudent de décider laquelle doit être privilégiée comme technique substitutive 
à l’ICSI. 
Le premier objectif du présent travail est de déterminer l’effet de l’ajout de 100 µM de 
cystéamine au milieu de MIV sur les taux de succès de FIV conventionnelle. Les complexes 
cumulus-ovocytes (COCs) obtenus par ponction échoguidée ou ovum pick up (OPU) sont mis 
à maturer avec ou sans supplémentation du milieu avec de la cystéamine. Ils sont ensuite 
soumis à une technique conventionnelle de FIV utilisant un ionophore calcique ou de 
l’héparine comme agent de capacitation des spermatozoïdes. Les signes de pénétration par un 
spermatozoïde sont évalués sur 131 ovocytes. Les deux traitements du sperme (ionophore vs 
héparine) ont donné les mêmes taux de FIV (6%) et ces résultats sont identiques en présence 
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comme en absence de cystéamine dans le milieu de MIV. Ce taux de FIV est faible par 
rapport à certains résultats publiés dans la littérature (Palmer et al., 1991; Dell'Aquila et al., 
1996; McPartlin et al., 2009), mais similaire aux taux observés dans d’autres études (Choi et 
al., 1994; Dell'Aquila et al., 1997a). Bien qu’il semble que la cystéamine n’ait pas eu d’effet 
sur les taux de FIV, le faible taux de FIV global obtenu ne permet pas de tirer de conclusion 
définitive.  
Comme la technologie de l’ICSI ne nous était pas accessible, le deuxième objectif poursuivi a 
été de déterminer quelle technique in vivo permettait de contourner au mieux l’absence d’une 
technique de FIV conventionnelle efficace. Nous avons comparé les taux de production 
d’embryons après transferts d’ovocytes, collectés par OPU, (1) dans l’oviducte de juments 
receveuses, ou dans le follicule préovulatoire de juments receveuses, soit (2) immédiatement 
après leur collecte par OPU soit (3) après MIV. Toutes les juments receveuses sont 
inséminées avec du sperme d’un étalon de fertilité connue. Les taux d’embryons collectés 10 
jours plus tard, sont calculés après déduction du nombre d’ovulations des receveuses et 
comparés pour chacun des groupes. Les taux d’embryons sont de 32.5% (13/40), 5.5% (3/55) 
et 12.8% (6/47) pour les techniques de OT, post-MIV et TOIF immédiat respectivement. Le 
transfert d’ovocytes dans l’oviducte d’une receveuse donne significativement plus 
d’embryons que les transferts intra-folliculaires. Ces résultats montrent que lorsque l’ICSI 
n’est pas une option, la technique d’OT doit être préférée au TOIF comme alternative 
permettant de contourner la difficulté de l’absence d’une technique de FIV efficace et 
reproductible.  
Le troisième objectif poursuivi a été d’évaluer l’effet de l’ajout de 100 µM de cystéamine au 
milieu de MIV sur la maturation nucléaire et cytoplasmique des ovocytes, respectivement par 
une coloration spécifique de l’ADN et par leur compétence à être fécondés et produire un 
embryon. Les ovocytes sont collectés par OPU et maturés in vitro avec (groupe cystéamine) 
ou sans (groupe contrôle) cystéamine. Le stade nucléaire est évalué sous microscopie à 
fluorescence après coloration au bis-benzamide. Le taux global de maturation nucléaire 
observé est de 52%. Cette valeur est cohérente avec les taux de MIV rapportés dans littérature 
qui varient de 40 à 70% dans l’espèce équine (Goudet et al., 1997a; Bogh et al., 2002; 
Hinrichs et al., 2005; Galli et al., 2007). Les taux de maturation ne sont pas significativement 
différents (p>0,05) entre les ovocytes maturés avec ou sans cystéamine (respectivement 55% 
et 47%). Les taux d’embryons produits sont utilisés pour évaluer la maturation cytoplasmique. 
Un total de 57 ovocytes est transféré dans les oviductes des receveuses pour chacun des 
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groupes. Les nombres d’embryons collectés sont de 10 (17%) pour le groupe contrôle et 5 
pour le groupe cystéamine (9%). Ces deux pourcentages ne sont pas statistiquement différents 
(p>0.05). Contrairement à ce qui a été décrit dans les autres espèces, aucun effet de la 
supplémentation du milieu de MIV par la cystéamine n’a pu être mis en évidence dans nos 
conditions expérimentales.  
En conclusion, l’ajout de 100 µM de cystéamine au milieu de MIV n’a apparemment pas 
amélioré les résultats de FIV conventionnelle. Cependant, le faible taux global de FIV ne 
permet pas de conclure avec certitude quant à l’effet, ou l’absence d’effet, de la cystéamine. 
Après qu’il ait été établi que lorsque l’ICSI n’est pas disponible, le transfert d’ovocytes dans 
l’oviducte est préférable au TOIF, cette technique a été utilisée pour évaluer l’effet de l’ajout 
de100 µM de cystéamine au milieu de MIV sur l’aptitude de l’ovocyte à être fécondé et 
donner un embryon. Dans nos conditions, cette supplémentation du milieu de MIV avec de la 
cystéamine n’améliore ni la maturation nucléaire, ni la maturation cytoplasmique de l’ovocyte 
équin. Cependant, les effets rapportés de la cystéamine dépendent pour beaucoup de l’espèce 
et de la dose utilisée. Il est possible que la dose de cystéamine testée, bien que largement 
utilisée dans d’autres espèces, ne permette pas d’améliorer la MIV des ovocytes équins. La 
même dose s’est avérée ne pas induire d’augmentation de la concentration en GSH dans les 
ovocytes équins (Luciano et al., 2006). Il est également possible que certaines substances 
contenues dans le milieu de MIV interférent avec la synthèse de GSH. Ceci a été suggéré pour 
la FSH ou l’oestradiol (Bing et al., 2001). Bien que notre milieu de maturation ne contienne 
ni gonadotrope, ni stéroïdes sexuels ajoutés, certains facteurs présents dans le sérum de veau 
foetal ou l’EGF pourraient également avoir un effet sur la synthèse de GSH. 
Au vu de ses effets bénéfiques dans de nombreuses autres espèces, la cystéamine devrait faire 
l’objet d’études complémentaires. Idéalement en testant différentes doses et, grâce à l’ICSI et 
au OT, en mesurant leurs effets sur la concentration en GSH, les taux de clivage, la formation 
de blastocystes et la production d’embryons, afin de déterminer une éventuelle concentration 
optimale et ses effets sur la compétence de l’ovocyte. 
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 Part 9 : Index of abbreviations 
 
ARTs Assisted Reproductive Technologies 
CEG Crude Equine Gonadotropin 
COC Cumulus Oocyte Complex 
DNA Deoxyribonucleic Acid 
EGF Epidermal Growth Factor 
FSH Follicle-Stimulating Hormone 
GIFT Gamete Intra-Fallopian Transfer 
GPX Glutathione Peroxydase 
GSH Glutathione  
GSSG oxydized form of Glutathione 
GV Germinal Vesicle 
ICSI Intra-Cytoplasmic Sperm Injection 
IFOT Intra-Follicular Oocyte Transfer 
IVC In Vitro Culture 
IVF In Vitro Fertilization 
IVM In Vitro Maturation 
IVP In Vitro embryo Production 
LH Luteinzing Hormone 
M I Metaphase I  
M II Metaphase II 
mRNA messenger Ribonucleic Acid  
OT intra-oviductal Oocyte Transfer 
PBS Phosphate Buffered Solution 
ROS Reactive Oxygen Species 
  
